data_1m4q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m4q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.337 0.113 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.463 ' CD2' ' CG1' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.431 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.422 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.49 HG22 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.427 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.522 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.431 ' CE1' HG13 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.4 ' CD1' ' ND1' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.68 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.68 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.403 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.599 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.626 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.415 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.79 0.329 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' HG12 ' A' ' 29' ' ' ILE . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 26' ' ' VAL . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG21 ' ND2' ' A' ' 54' ' ' ASN . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.645 0.259 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD1' ' CE3' ' A' ' 75' ' ' TRP . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.444 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 32' ' ' TYR . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.461 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.474 HD13 HG13 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.414 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.513 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' HG13 ' A' ' 134' ' ' VAL . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.469 ' O ' ' CG2' ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.695 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.695 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 32' ' ' TYR . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.418 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 102' ' ' HIS . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.436 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG11 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.641 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.641 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.644 0.259 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG13 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CE1' HG13 ' A' ' 12' ' ' VAL . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CZ ' HD13 ' A' ' 132' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 1.1 p30 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' B' ' 207' ' ' PRO . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.448 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.409 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 89' ' ' VAL . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.452 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 97' ' ' ILE . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.692 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.692 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.425 HG23 ' CE2' ' A' ' 32' ' ' TYR . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.426 HD13 ' CZ ' ' A' ' 32' ' ' TYR . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.445 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.605 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.579 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.605 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.374 0.131 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG21 ' A' ' 12' ' ' VAL . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' CE1' HG13 ' A' ' 12' ' ' VAL . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.701 0.286 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' B' ' 209' ' ' ALA . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' PHE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.421 ' CD2' HG11 ' A' ' 134' ' ' VAL . 50.4 m80 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 113' ' ' TYR . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 111' ' ' LEU . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.681 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.681 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 102' ' ' HIS . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.61 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.573 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.61 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.417 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.596 0.236 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' O ' HG21 ' A' ' 12' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 120.656 0.265 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.416 HD12 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 70' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.436 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CE3' HD12 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 14.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 m-20 . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.425 ' CG ' HG21 ' A' ' 141' ' ' VAL . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 97' ' ' ILE . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 118' ' ' LYS . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 114' ' ' LEU . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.708 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.708 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.407 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.637 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.597 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.425 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 33' ' ' LYS . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.414 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.587 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.43 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.561 0.219 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.429 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.48 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.413 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' HA ' HG21 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CD2' ' CD1' ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' CD1' ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.441 ' CZ2' ' CD2' ' A' ' 119' ' ' HIS . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.705 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.705 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.609 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.605 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.45 0.167 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 53' ' ' MET . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.415 HD23 ' CE3' ' A' ' 75' ' ' TRP . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.488 ' HA ' ' HG ' ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 69' ' ' ASN . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.44 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG12 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.433 ' CD1' ' HA ' ' B' ' 210' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CE3' HD23 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.579 0.228 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.47 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.489 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.479 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.428 ' HA ' HG21 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HG11 ' A' ' 134' ' ' VAL . 56.8 m80 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.69 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.69 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.403 ' HA2' HG12 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.629 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 70' ' ' ILE . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.669 0.271 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 32' ' ' TYR . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE2' HG13 ' A' ' 28' ' ' VAL . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' ' CB ' ' A' ' 69' ' ' ASN . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 70' ' ' ILE . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 HG12 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' CD1' ' CD ' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.723 0.296 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.533 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' HG21 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.699 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.699 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.54 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.54 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.434 ' HA2' HG12 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.689 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.452 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 11' ' ' MET . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.53 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.426 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 78' ' ' ASP . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' MET . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.424 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 86' ' ' ILE . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.1 m120 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.636 0.255 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.45 ' CG ' HG23 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' HA ' HG22 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.9 m170 -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.698 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.698 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.426 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.598 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.598 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.598 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.726 0.298 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.462 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.462 ' CG2' ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 26' ' ' VAL . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.406 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.695 0.283 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 69' ' ' ASN . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.675 0.274 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.514 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.683 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.683 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.609 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.57 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.965 0.412 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 78' ' ' ASP . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 53' ' ' MET . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' CD1' ' CG ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' CD2' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 70' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.444 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CD1' ' CE1' ' A' ' 88' ' ' PHE . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.403 ' CD2' ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.47 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.45 ' CE ' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.449 ' CD2' HG11 ' A' ' 134' ' ' VAL . 21.0 m80 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.685 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.411 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' A' ' 102' ' ' HIS . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' OE1' ' CG ' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.58 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.636 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 12' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.768 0.318 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.604 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.604 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.43 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.49 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 105' ' ' ALA . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.43 ' CD2' HD23 ' A' ' 111' ' ' LEU . 5.3 t-80 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 99' ' ' THR . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 102' ' ' HIS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.694 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.694 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.433 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.613 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.613 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.617 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 32' ' ' TYR . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE2' HG11 ' A' ' 28' ' ' VAL . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.418 HD11 ' CE3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 HG13 ' HD2' ' A' ' 60' ' ' PRO . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.494 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.46 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.418 ' CE3' HD11 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.459 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 3.7 m-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 83' ' ' ASN . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.437 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.477 ' CG ' HG22 ' A' ' 141' ' ' VAL . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.565 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HG13 ' A' ' 134' ' ' VAL . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 100' ' ' GLY . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 99' ' ' THR . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 109' ' ' ILE . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.6 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.452 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.704 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.704 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.652 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB3' ' B' ' 212' ' ' GLU . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.592 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.602 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.652 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.46 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.437 ' CG2' ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.425 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.457 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.435 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HG21 ' A' ' 97' ' ' ILE . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.407 ' CD2' HG11 ' A' ' 134' ' ' VAL . 49.7 m80 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.677 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.677 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.64 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.594 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.594 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.464 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.44 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 29' ' ' ILE . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE1' ' CD1' ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG21 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.791 0.329 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.414 ' O ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 70' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.456 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' CD1' ' CD ' ' B' ' 210' ' ' PRO . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.403 ' CZ3' ' OD2' ' A' ' 40' ' ' ASP . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.488 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.301 0.112 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 83' ' ' ASN . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.483 ' HG2' HG23 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 96' ' ' THR . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.425 ' HA ' HG22 ' A' ' 141' ' ' VAL . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.416 ' CE1' ' CG1' ' A' ' 134' ' ' VAL . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.686 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.686 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.434 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.428 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.597 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.429 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.456 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.693 0.282 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' VAL . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.411 ' HG2' ' CD2' ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.433 ' CA ' ' HD2' ' A' ' 18' ' ' ARG . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HD2' ' CA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.411 ' CD2' ' HG2' ' A' ' 11' ' ' MET . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 70' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 59' ' ' ILE . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' B' ' 209' ' ' ALA . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.515 0.198 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.477 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 97' ' ' ILE . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.447 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.662 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.662 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.409 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 140' ' ' PRO . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.623 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.623 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.623 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.623 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.407 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.518 0.199 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.465 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 33' ' ' LYS . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.627 0.251 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 71' ' ' PRO . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.436 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.441 ' CG ' HG23 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 97' ' ' ILE . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.456 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.2 m170 -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.411 ' OD2' ' CG ' ' A' ' 110' ' ' TYR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.687 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.419 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 102' ' ' HIS . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.445 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.631 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.595 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 143' ' ' SER . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.631 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.405 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.596 0.236 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' MET . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.424 ' O ' HG21 ' A' ' 12' ' ' VAL . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 26' ' ' VAL . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' B' ' 207' ' ' PRO . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.4 ' CG1' ' HA2' ' A' ' 136' ' ' GLY . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.449 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 59' ' ' ILE . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.438 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 97' ' ' ILE . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HD21 ' A' ' 111' ' ' LEU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.682 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.682 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.425 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' B' ' 212' ' ' GLU . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.641 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.641 ' O ' ' HB2' ' A' ' 143' ' ' SER . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.457 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.619 0.247 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 29' ' ' ILE . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 26' ' ' VAL . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' CG1' HG23 ' A' ' 70' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.433 HG23 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 t30 . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.494 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 109' ' ' ILE . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.429 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.691 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.691 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.403 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.64 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.42 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.592 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.58 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.524 -0.046 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.463 ' CE2' ' CG1' ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.446 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.4 ' HB2' ' CD1' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 90' ' ' LYS . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 97' ' ' ILE . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' ' ND1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.42 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.689 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.689 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.674 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HD3' HD12 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.442 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.78 -23.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -16.74 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.108 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.463 ' CD2' ' CG1' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 9.1 t80 -138.76 168.7 19.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.98 144.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 56.1 m-85 -146.52 -67.07 0.28 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.733 0.302 . . . . 0.0 111.5 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -56.18 85.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.746 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.76 25.07 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.82 74.89 1.26 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.208 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 112.82 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.628 0.251 . . . . 0.0 110.705 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -48.55 143.32 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.453 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -139.93 139.83 36.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.431 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.422 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.49 HG22 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 -62.35 -56.44 18.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t 171.94 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -142.48 133.75 12.95 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.88 -23.92 11.42 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.859 -1.309 . . . . 0.0 111.979 0.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.12 -40.18 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -148.69 166.17 16.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.755 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.427 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.522 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.431 ' CE1' HG13 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.4 ' CD1' ' ND1' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.68 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.68 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.599 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.626 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.415 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.818 0.342 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.11 -47.13 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -79.0 -50.17 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' HG12 ' A' ' 29' ' ' ILE . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 26' ' ' VAL . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG21 ' ND2' ' A' ' 54' ' ' ASN . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -104.04 143.81 32.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.42 148.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 50' ' ' ARG . 81.5 m-85 -148.96 -67.44 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.963 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -58.76 83.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.286 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 54.62 23.29 4.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.326 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.5 13.54 24.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.742 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.31 124.72 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.322 -0.516 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.7 p -73.14 144.72 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.01 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -150.31 145.53 26.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD1' ' CE3' ' A' ' 75' ' ' TRP . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.444 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 32' ' ' TYR . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.461 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.474 HD13 HG13 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.414 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 -63.04 -56.25 18.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 2.7 t -178.22 47.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -152.13 145.9 18.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 3.1 Cg_exo -76.18 -28.41 7.63 Favored 'Cis proline' 0 C--N 1.347 0.45 0 C-N-CA 123.682 -1.383 . . . . 0.0 112.663 -0.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -158.97 -37.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -146.67 140.15 14.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.513 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' HG13 ' A' ' 134' ' ' VAL . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.469 ' O ' ' CG2' ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.695 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.695 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 32' ' ' TYR . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.418 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 102' ' ' HIS . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.436 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG11 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.641 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.641 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.841 0.353 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.4 -26.35 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.42 -19.85 52.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.237 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG13 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.445 ' CE1' HG13 ' A' ' 12' ' ' VAL . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CZ ' HD13 ' A' ' 132' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -138.36 163.89 30.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.9 m -86.6 147.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.394 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -148.99 -67.23 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.39 86.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.408 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.51 24.35 6.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.44 10.8 37.65 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.685 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -81.28 123.4 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.567 -0.372 . . . . 0.0 110.947 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 m -73.93 138.59 44.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.56 136.63 41.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 1.1 p30 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' B' ' 207' ' ' PRO . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.448 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.409 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 -63.51 -60.18 3.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.4 p -158.33 -36.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -111.96 169.66 6.1 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.793 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 44.4 Cg_endo -70.6 -54.33 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.297 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.293 0.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.8 71.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.645 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 63.91 128.42 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.716 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 89' ' ' VAL . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.452 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 97' ' ' ILE . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.692 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.692 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.425 HG23 ' CE2' ' A' ' 32' ' ' TYR . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.426 HD13 ' CZ ' ' A' ' 32' ' ' TYR . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.605 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.579 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.567 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.605 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.11 -30.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.135 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -79.05 -47.74 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG21 ' A' ' 12' ' ' VAL . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' CE1' HG13 ' A' ' 12' ' ' VAL . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 6.6 t80 -138.71 149.03 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.46 150.27 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 62.3 m-85 -146.76 -67.65 0.27 Allowed 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.375 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -56.91 82.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.695 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 54.0 m-20 50.44 25.42 1.92 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 77.0 1.25 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.285 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.32 95.97 1.76 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.507 0.67 . . . . 0.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -44.28 144.3 1.03 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.852 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.85 136.12 18.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.591 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' HB3' ' B' ' 209' ' ' ALA . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' PHE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -59.07 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 172.84 79.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -159.66 137.7 7.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.001 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -73.44 -68.29 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.169 -1.596 . . . . 0.0 112.523 -0.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.426 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -86.37 -65.51 1.0 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 -152.77 -50.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.914 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.421 ' CD2' HG11 ' A' ' 134' ' ' VAL . 50.4 m80 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 113' ' ' TYR . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 111' ' ' LEU . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HE3' ' CE1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.681 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.681 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 102' ' ' HIS . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.61 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.573 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.61 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.417 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.55 -23.03 4.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.04 -18.05 56.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.301 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' O ' HG21 ' A' ' 12' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 21.8 t80 -139.57 164.7 29.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -85.17 145.73 7.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 60.8 m-85 -146.08 -67.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.156 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.56 84.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.304 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' PHE . 60.6 m-20 51.77 24.73 2.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.68 75.55 1.23 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.203 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.85 108.39 2.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 122.831 -0.217 . . . . 0.0 110.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 p -49.84 146.11 4.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.419 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.33 139.23 40.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.416 HD12 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 70' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.436 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' CE3' HD12 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 14.8 m-20 -63.36 -53.94 44.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 1.6 t 168.14 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.654 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.05 142.93 18.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -12.27 30.45 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.456 -1.477 . . . . 0.0 112.657 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -54.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.609 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 m-20 -150.42 162.73 26.63 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.424 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.425 ' CG ' HG21 ' A' ' 141' ' ' VAL . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 97' ' ' ILE . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 118' ' ' LYS . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 114' ' ' LEU . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.708 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.708 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.407 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.637 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.597 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.425 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 -34.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p -78.95 -48.99 13.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 33' ' ' LYS . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.416 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.89 138.76 37.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.89 151.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.015 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 52' ' ' LEU . 96.8 m-85 -147.74 -66.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -55.99 85.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 111.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' PHE . 70.4 m-20 50.11 25.1 1.6 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 111.599 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 73.11 1.05 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.251 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 109.1 3.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.862 0.363 . . . . 0.0 110.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.1 p -45.48 147.38 0.85 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -145.3 145.92 31.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.761 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD12 ' CE2' ' A' ' 44' ' ' PHE . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.414 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.587 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.43 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 80' ' ' TYR . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 -61.81 -55.12 33.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t 177.08 39.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 44.5 p90 -170.0 153.56 4.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.34 -35.94 2.53 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.373 -1.511 . . . . 0.0 112.526 0.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.17 80.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.99 141.43 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.429 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.48 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.413 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' HA ' HG21 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CD2' ' CD1' ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' CD1' ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.441 ' CZ2' ' CD2' ' A' ' 119' ' ' HIS . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.705 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.705 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.609 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.605 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.34 -30.53 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.96 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 53' ' ' MET . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 3.4 t80 -139.21 149.72 44.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -85.67 147.89 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 78.7 m-85 -146.67 -67.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.492 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.97 83.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.75 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 25.7 m-20 51.3 25.27 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.421 0.629 . . . . 0.0 111.308 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 74.99 1.18 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.146 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.55 104.35 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 p -45.29 145.82 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.725 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -142.89 135.36 27.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.572 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.415 HD23 ' CE3' ' A' ' 75' ' ' TRP . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.488 ' HA ' ' HG ' ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 69' ' ' ASN . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.44 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG12 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.433 ' CD1' ' HA ' ' B' ' 210' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CE3' HD23 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 -62.78 -29.67 70.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 163.71 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.64 123.2 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.63 -32.61 3.54 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.972 0.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -37.15 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.818 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -146.94 163.47 28.55 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.47 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.489 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.479 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.428 ' HA ' HG21 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HG11 ' A' ' 134' ' ' VAL . 56.8 m80 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.69 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.69 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.403 ' HA2' HG12 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.629 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 70' ' ' ILE . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -107.96 -30.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -22.8 46.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 32' ' ' TYR . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE2' HG13 ' A' ' 28' ' ' VAL . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -138.89 168.33 20.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.66 146.94 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.721 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 84.1 m-85 -147.47 -67.25 0.25 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -56.25 84.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.472 0.309 . . . . 0.0 111.601 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.3 m-20 52.34 24.85 3.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.384 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.94 73.76 1.19 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -156.93 112.97 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.807 0.337 . . . . 0.0 110.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 p -47.52 133.48 13.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -125.16 138.88 54.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' ' CB ' ' A' ' 69' ' ' ASN . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG13 HG22 ' A' ' 70' ' ' ILE . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 HG12 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' CD1' ' CD ' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.37 -54.92 33.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 t 176.54 38.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -135.15 130.56 19.37 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.209 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.32 -29.43 6.66 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.812 -1.328 . . . . 0.0 111.884 0.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.427 ' CE2' ' HD3' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.29 -39.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -147.98 161.67 33.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.533 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' HG21 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.699 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.699 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.54 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.54 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.434 ' HA2' HG12 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.689 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.452 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.836 0.35 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.38 -24.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -21.19 51.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 11' ' ' MET . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.426 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 78' ' ' ASP . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' MET . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.26 168.1 20.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 27.3 m -86.33 149.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.489 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 68.3 m-85 -147.47 -67.19 0.26 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.77 80.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.025 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 14.7 m-20 54.75 23.74 5.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.49 9.05 18.02 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.971 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.93 119.85 24.47 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 p -74.66 129.42 37.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -117.56 135.25 54.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.424 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 86' ' ' ILE . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -62.28 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.412 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 5.0 t -179.92 38.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.49 130.52 22.5 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.51 -26.28 9.84 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.314 -0.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 120' ' ' PRO . 83.5 t80 -159.18 -37.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.1 m120 -146.81 163.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.45 ' CG ' HG23 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' HA ' HG22 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.9 m170 -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.698 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.698 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.426 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.598 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.598 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.598 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.21 -22.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.321 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -18.79 55.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.294 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.462 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.462 ' CG2' ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 26' ' ' VAL . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.406 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 4.0 t80 -140.06 164.33 30.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.5 146.31 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 52.8 m-85 -146.7 -66.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.715 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.16 84.33 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 6.6 m-20 52.16 25.04 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.64 75.79 1.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.571 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.27 106.26 2.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.0 p -49.21 134.31 18.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.351 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -120.41 135.59 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.855 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 69' ' ' ASN . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.98 33.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.33 18.78 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.235 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' HB2' ' HA ' ' A' ' 81' ' ' PRO . 29.0 p90 -43.41 162.03 0.19 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.232 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 80' ' ' TYR . 54.3 Cg_endo -69.38 119.8 4.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.81 -1.329 . . . . 0.0 112.778 0.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' N ' ' HA ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -159.72 -38.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.02 136.88 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.457 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.514 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.683 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.683 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.609 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.57 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.853 0.359 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.73 -26.5 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.376 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 -24.3 47.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 78' ' ' ASP . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 53' ' ' MET . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' CD1' ' CG ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 4.0 t80 -140.51 168.16 20.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 29.7 m -85.41 147.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.824 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' ASP . 5.0 m-85 -146.01 -67.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.33 84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.261 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.5 m-20 51.97 24.15 2.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.816 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.85 77.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.645 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.58 98.72 1.97 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.095 0.474 . . . . 0.0 110.209 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.2 t -55.26 132.65 48.31 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.257 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -138.18 135.2 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' CD2' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 70' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.444 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CD1' ' CE1' ' A' ' 88' ' ' PHE . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 ' CD2' ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 -61.86 -44.23 97.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 167.78 83.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.641 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -173.07 142.1 1.01 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.201 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.5 Cg_endo -74.44 -70.44 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.394 0 C-N-CA 123.209 -1.58 . . . . 0.0 112.736 0.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -64.68 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.121 0.486 . . . . 0.0 110.643 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 -152.46 -65.87 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.47 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.45 ' CE ' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.449 ' CD2' HG11 ' A' ' 134' ' ' VAL . 21.0 m80 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.685 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.411 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' A' ' 102' ' ' HIS . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' OE1' ' CG ' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.58 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.636 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.183 0.516 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -92.01 -31.66 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.407 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -79.07 -47.66 15.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 12' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 5.9 t80 -136.62 154.85 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.19 146.02 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.325 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 82.6 m-85 -146.47 -66.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.451 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -57.77 84.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 51.53 25.11 2.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.1 75.46 1.24 Allowed Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.217 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.84 107.83 2.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.261 0.553 . . . . 0.0 110.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.0 p -48.32 142.88 5.13 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 121.209 0.528 . . . . 0.0 111.618 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 -124.54 136.26 53.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.659 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -171.43 40.72 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' TYR . 67.5 m -153.88 -65.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.772 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 58.53 143.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.16 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 81.2 Cg_endo -87.76 117.82 4.02 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.735 -1.361 . . . . 0.0 112.223 -0.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -32.34 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.7 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.88 141.17 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.604 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.604 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.43 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.49 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 105' ' ' ALA . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.43 ' CD2' HD23 ' A' ' 111' ' ' LEU . 5.3 t-80 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 99' ' ' THR . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 102' ' ' HIS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.694 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.694 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.433 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.613 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.613 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.617 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.04 -43.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -23.91 43.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.935 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 78' ' ' ASP . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 32' ' ' TYR . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE2' HG11 ' A' ' 28' ' ' VAL . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 15.6 t80 -138.83 156.46 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.3 m -86.3 150.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.717 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 67.7 m-85 -147.63 -67.46 0.25 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.572 0.225 . . . . 0.0 111.356 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.09 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.486 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 51.19 25.04 2.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.89 76.4 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.57 98.75 1.97 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 120.813 0.339 . . . . 0.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.3 m -46.43 146.43 1.45 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.581 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -131.92 139.67 48.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.418 HD11 ' CE3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 HG13 ' HD2' ' A' ' 60' ' ' PRO . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.494 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.46 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.418 ' CE3' HD11 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 80' ' ' TYR . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 -61.39 -59.45 5.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 171.47 61.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' PRO . 27.2 p90 -166.63 133.31 1.97 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.464 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 6.2 Cg_exo -73.2 -72.01 0.01 OUTLIER 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 123.378 -1.509 . . . . 0.0 111.737 -0.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CG ' ' N ' ' A' ' 83' ' ' ASN . 20.4 p90 -92.64 -52.54 4.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 3.7 m-20 -154.59 168.48 11.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 83' ' ' ASN . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.437 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.477 ' CG ' HG22 ' A' ' 141' ' ' VAL . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.565 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HG13 ' A' ' 134' ' ' VAL . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 100' ' ' GLY . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 99' ' ' THR . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 109' ' ' ILE . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.6 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.452 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 82' ' ' TYR . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.704 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.704 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.652 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB3' ' B' ' 212' ' ' GLU . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.592 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.602 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.652 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.46 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.41 -26.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.17 -11.88 59.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.437 ' CG2' ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 14.9 t80 -140.13 168.17 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.25 144.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.104 0.478 . . . . 0.0 110.931 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 39.2 m-85 -146.22 -66.8 0.29 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.412 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -56.94 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' PHE . 30.7 m-20 52.09 25.44 3.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.658 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.33 75.69 1.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.91 109.8 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.439 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -51.38 141.97 14.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.918 0.389 . . . . 0.0 111.301 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.66 140.63 44.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.514 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.425 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.52 -46.02 90.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t 169.05 68.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 17.7 t80 -167.09 137.3 2.42 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.44 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.6 Cg_endo -73.48 -70.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.5 -0.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -87.17 -68.28 0.76 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 -151.86 -53.66 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.464 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.457 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.435 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HG21 ' A' ' 97' ' ' ILE . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.407 ' CD2' HG11 ' A' ' 134' ' ' VAL . 49.7 m80 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 82' ' ' TYR . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.677 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.677 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.64 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.594 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.594 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.23 -26.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.7 -11.87 60.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.464 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.44 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 29' ' ' ILE . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE1' ' CD1' ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG21 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 29.5 t80 -139.0 166.3 24.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 27.5 m -86.6 145.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.736 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 42' ' ' TYR . 4.1 m-85 -144.55 -67.47 0.32 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.61 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.551 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 2.4 m-20 50.56 24.55 1.67 Allowed 'General case' 0 N--CA 1.458 -0.064 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.57 77.76 1.35 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.154 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.1 98.6 2.03 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -57.35 128.7 38.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.161 0.505 . . . . 0.0 111.271 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.44 134.83 50.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.637 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.414 ' O ' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 70' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.456 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' CD1' ' CD ' ' B' ' 210' ' ' PRO . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' B' ' 207' ' ' PRO . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.403 ' CZ3' ' OD2' ' A' ' 40' ' ' ASP . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -47.4 84.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 t 174.88 40.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.38 134.6 22.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.775 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.97 -19.38 17.63 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.621 -1.408 . . . . 0.0 112.734 -0.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.4 -46.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.488 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 -151.9 -56.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.301 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 83' ' ' ASN . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.483 ' HG2' HG23 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 96' ' ' THR . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.425 ' HA ' HG22 ' A' ' 141' ' ' VAL . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.416 ' CE1' ' CG1' ' A' ' 134' ' ' VAL . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.686 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.686 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.434 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.428 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.597 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.429 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.456 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.827 0.346 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.65 -27.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -22.33 46.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.049 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' VAL . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.411 ' HG2' ' CD2' ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.433 ' CA ' ' HD2' ' A' ' 18' ' ' ARG . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HD2' ' CA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.411 ' CD2' ' HG2' ' A' ' 11' ' ' MET . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.407 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.3 t80 -140.12 169.18 18.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 16.1 m -84.35 149.85 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 46' ' ' ASP . 16.7 m-85 -147.27 -67.05 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.489 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -56.67 83.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.881 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' PHE . 63.7 m-20 52.16 24.31 2.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 0.0 111.365 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.47 77.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.531 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -155.55 98.1 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.699 0.285 . . . . 0.0 110.375 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m -50.82 139.87 16.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.489 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.59 135.49 30.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.642 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 70' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 59' ' ' ILE . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' B' ' 209' ' ' ALA . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -68.87 49.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.39 24.33 3.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 0.0 111.366 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -112.13 135.03 21.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.73 -19.14 18.8 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.351 0.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -158.97 -45.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.77 125.16 4.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.477 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 97' ' ' ILE . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.447 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.662 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.662 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.409 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 140' ' ' PRO . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.623 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' B' ' 210' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.623 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.623 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.623 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.407 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -93.68 -28.24 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -17.66 56.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.443 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.465 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 33' ' ' LYS . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 t80 -137.89 160.24 39.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.64 147.3 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.22 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 66.1 m-85 -147.05 -67.65 0.26 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.117 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.57 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.532 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.64 24.8 2.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.391 -0.193 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.76 75.7 1.24 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.13 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.58 106.37 2.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.381 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 p -48.07 142.96 4.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -130.0 135.8 48.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.629 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -168.71 31.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 80' ' ' TYR . 43.2 m -145.13 11.37 1.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.022 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 44.9 t80 -33.35 140.1 0.24 Allowed Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 122.442 0.297 . . . . 0.0 111.676 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 59.4 Cg_endo -71.91 124.62 8.91 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.729 -1.363 . . . . 0.0 112.737 0.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.84 -40.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.62 127.56 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 71' ' ' PRO . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.436 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.441 ' CG ' HG23 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 97' ' ' ILE . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.456 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.2 m170 -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.411 ' OD2' ' CG ' ' A' ' 110' ' ' TYR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.687 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.687 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.419 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 102' ' ' HIS . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.631 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.595 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 143' ' ' SER . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.631 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.405 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.6 -19.32 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.343 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -12.51 60.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' MET . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.424 ' O ' HG21 ' A' ' 12' ' ' VAL . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 26' ' ' VAL . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.6 t80 -138.42 168.15 20.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.8 146.82 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.882 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 32.6 m-85 -146.92 -67.22 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.148 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -56.72 84.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.804 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' PHE . 61.8 m-20 52.01 24.83 2.82 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.544 0.527 . . . . 0.0 111.31 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.24 74.49 1.19 Allowed Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.486 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -156.82 112.38 2.9 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.639 0.257 . . . . 0.0 110.604 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -51.5 145.06 9.28 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.236 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.79 136.11 28.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.817 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' B' ' 207' ' ' PRO . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.4 ' CG1' ' HA2' ' A' ' 136' ' ' GLY . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.449 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 59' ' ' ILE . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -64.3 -58.54 6.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t 179.08 49.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -174.02 108.48 0.3 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.03 -166.5 2.05 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.315 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.97 0.46 31.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.686 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -150.21 136.78 10.98 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.438 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 97' ' ' ILE . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.419 ' CD2' HD21 ' A' ' 111' ' ' LEU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.682 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.682 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.425 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' B' ' 212' ' ' GLU . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.641 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.641 ' O ' ' HB2' ' A' ' 143' ' ' SER . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.457 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.87 0.367 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.67 1.17 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.582 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.62 51.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.188 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 78' ' ' ASP . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 29' ' ' ILE . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 26' ' ' VAL . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -141.44 169.44 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.0 m -85.94 148.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.564 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.482 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 69.3 m-85 -147.63 -67.49 0.25 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.773 0.32 . . . . 0.0 111.436 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -56.82 85.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.607 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 51.63 24.46 2.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.139 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.45 76.58 1.3 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.5 99.21 2.02 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 110.458 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -52.83 130.42 33.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.304 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' NH1' ' CD1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -130.41 134.8 47.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.63 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' CG1' HG23 ' A' ' 70' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CG ' ' HA ' ' B' ' 210' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.433 HG23 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' CG2' ' A' ' 89' ' ' VAL . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 -65.98 -55.6 15.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 4.0 t 178.48 52.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -152.45 132.63 7.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.075 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -32.61 4.45 Favored 'Cis proline' 0 C--N 1.347 0.455 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.241 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.31 -42.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.455 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -149.08 131.8 7.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.444 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.494 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 109' ' ' ILE . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.429 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.691 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.691 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.403 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.64 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.42 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.592 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.58 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 68' ' ' TYR . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.819 0.343 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.87 -26.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -13.39 59.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.463 ' CE2' ' CG1' ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.0 t80 -139.55 163.41 32.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.36 146.07 7.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.805 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 47.4 m-85 -146.12 -67.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -57.38 84.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.414 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.2 m-20 51.71 25.02 2.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.484 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.88 74.04 1.15 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.093 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -156.75 111.13 2.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.571 0.224 . . . . 0.0 110.843 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 p -49.07 148.21 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.405 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -141.79 139.12 32.69 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.21 -56.27 20.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t 172.03 41.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.19 125.71 22.78 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.71 -20.82 13.69 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.76 -1.35 . . . . 0.0 112.361 0.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -159.17 -38.51 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.42 164.6 22.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.446 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.4 ' HB2' ' CD1' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 90' ' ' LYS . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 97' ' ' ILE . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' ' ND1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.42 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.689 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.689 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.674 ' O ' ' CB ' ' B' ' 209' ' ' ALA . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HD3' HD12 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.442 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.337 0.113 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.554 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.813 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 18' ' ' ARG . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.813 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 27' ' ' ASN . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.0 m-80 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 24' ' ' GLU . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.482 HG21 ' HD3' ' A' ' 37' ' ' PRO . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 55' ' ' LEU . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' O ' HG22 ' A' ' 56' ' ' THR . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' HG21 ' A' ' 29' ' ' ILE . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.626 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 35' ' ' LEU . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 36' ' ' LYS . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 72' ' ' ILE . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 59' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.626 ' CE3' HD13 ' A' ' 52' ' ' LEU . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 124' ' ' LEU . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HB2' HD11 ' A' ' 114' ' ' LEU . 1.2 m-80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.703 ' HG3' HD12 ' A' ' 76' ' ' LEU . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 86' ' ' ILE . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 71' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 97' ' ' ILE . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.709 HG21 ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.872 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.559 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.612 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.42 ' CE1' HG11 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.711 ' O ' HG22 ' A' ' 99' ' ' THR . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.767 HD12 ' HB2' ' A' ' 87' ' ' CYS . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 83' ' ' ASN . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.904 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 59' ' ' ILE . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.872 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.617 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.709 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.79 0.329 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.737 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.862 ' CE2' HG21 ' A' ' 21' ' ' THR . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.725 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.862 HG21 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 18' ' ' ARG . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 28' ' ' VAL . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.655 HG21 ' CE ' ' A' ' 53' ' ' MET . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD23 ' A' ' 8' ' ' LEU . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.893 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 24' ' ' GLU . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 35' ' ' LEU . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 55' ' ' LEU . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.656 ' CG1' HG22 ' A' ' 56' ' ' THR . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 38' ' ' VAL . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.645 0.259 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.539 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.656 HG22 ' CG1' ' A' ' 38' ' ' VAL . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.676 ' CG2' HD13 ' A' ' 35' ' ' LEU . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 89' ' ' VAL . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.656 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 73' ' ' CYS . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 3.1 t-20 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.528 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 71' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.965 HG21 ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.866 ' HG2' HG22 ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.576 HD11 ' CA ' ' A' ' 107' ' ' GLY . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 108' ' ' LYS . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 97' ' ' ILE . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 87' ' ' CYS . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 109' ' ' ILE . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.768 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.768 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.652 HD11 HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.893 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 70' ' ' ILE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.658 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.965 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.729 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.644 0.259 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.704 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.419 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.739 HG21 ' CD2' ' A' ' 15' ' ' TYR . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 18' ' ' ARG . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.407 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' ASN . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.787 ' OD1' HD22 ' A' ' 125' ' ' LEU . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 24' ' ' GLU . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 35' ' ' LEU . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 125' ' ' LEU . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 128' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.75 ' HA ' HD23 ' A' ' 55' ' ' LEU . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.647 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.909 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.825 HD12 ' CD ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.647 ' ND2' HG13 ' A' ' 38' ' ' VAL . 13.3 p-10 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 37' ' ' PRO . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.821 HD12 HG12 ' A' ' 132' ' ' ILE . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 136' ' ' GLY . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' B' ' 210' ' ' PRO . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' VAL . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.628 ' N ' HG23 ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' HE3' HD22 ' A' ' 52' ' ' LEU . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 52' ' ' LEU . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.499 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.695 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.879 ' O ' HG22 ' A' ' 99' ' ' THR . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.888 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 87' ' ' CYS . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' N ' HD22 ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 ' OD1' ' A' ' 27' ' ' ASN . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.77 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.749 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.821 HG12 HD12 ' A' ' 59' ' ' ILE . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' B' ' 212' ' ' GLU . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.457 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.374 0.131 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.822 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.5 ' H ' HG23 ' A' ' 12' ' ' VAL . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.843 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 15' ' ' TYR . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 18' ' ' ARG . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 124' ' ' LEU . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.779 HG23 HD21 ' A' ' 55' ' ' LEU . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.653 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 59' ' ' ILE . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG12 HG22 ' A' ' 56' ' ' THR . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 11' ' ' MET . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.707 ' N ' HD13 ' A' ' 39' ' ' LEU . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.701 0.286 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.595 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 38' ' ' VAL . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 25' ' ' THR . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 38' ' ' VAL . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.855 HD12 HG12 ' A' ' 132' ' ' ILE . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.557 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 70' ' ' ILE . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.534 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CE3' HD13 ' A' ' 52' ' ' LEU . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 55' ' ' LEU . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 77' ' ' LEU . 3.9 m-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.744 ' HB3' HD12 ' A' ' 109' ' ' ILE . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 107' ' ' GLY . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.622 ' HD3' HG13 ' A' ' 89' ' ' VAL . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.714 HG21 ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.796 ' HG2' HG22 ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 141' ' ' VAL . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.639 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 97' ' ' ILE . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.762 ' O ' HG22 ' A' ' 99' ' ' THR . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HE2' HG23 ' A' ' 86' ' ' ILE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.799 HG21 ' OH ' ' A' ' 113' ' ' TYR . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.488 HD12 HG21 ' A' ' 109' ' ' ILE . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.799 ' OH ' HG21 ' A' ' 109' ' ' ILE . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.855 HG12 HD12 ' A' ' 59' ' ' ILE . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' B' ' 212' ' ' GLU . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.796 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.633 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.714 ' HG2' HG21 ' A' ' 92' ' ' THR . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.462 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.596 0.236 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 22' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.673 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.701 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.792 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.792 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 9' ' ' LYS . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.641 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.9 t-20 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HG22 ' A' ' 56' ' ' THR . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 120.656 0.265 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.405 HG22 HG12 ' A' ' 38' ' ' VAL . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 132' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 136' ' ' GLY . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 59' ' ' ILE . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 72' ' ' ILE . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.655 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.453 ' CE3' HD13 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 124' ' ' LEU . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.544 ' H ' HD13 ' A' ' 77' ' ' LEU . 14.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 m-20 . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.705 ' HG3' HD12 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 109' ' ' ILE . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.439 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.414 ' HB2' ' OG1' ' A' ' 92' ' ' THR . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 141' ' ' VAL . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.588 HG21 ' O ' ' A' ' 104' ' ' ASP . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 104' ' ' ASP . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 99' ' ' THR . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.86 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 87' ' ' CYS . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 115' ' ' HIS . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.775 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 28' ' ' VAL . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.82 HG12 HD12 ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 12' ' ' VAL . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.678 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' ARG . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 28' ' ' VAL . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 27' ' ' ASN . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 m-80 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 35' ' ' LEU . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.94 HD23 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.94 ' HA ' HD23 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' HG13 ' A' ' 38' ' ' VAL . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.632 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 124' ' ' LEU . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 77' ' ' LEU . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 77' ' ' LEU . 1.4 t-20 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.561 0.219 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.5 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.737 ' HG2' HG22 ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' HG23 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.946 ' CD2' HD12 ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 99' ' ' THR . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.754 HG22 HD11 ' A' ' 132' ' ' ILE . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.666 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 128' ' ' ILE . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.74 ' O ' ' HB1' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.428 ' CD ' HD13 ' A' ' 70' ' ' ILE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.45 0.167 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.657 ' HG2' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.6 ' HE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.6 HG21 ' HE1' ' A' ' 15' ' ' TYR . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 18' ' ' ARG . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 37' ' ' PRO . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 29' ' ' ILE . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 125' ' ' LEU . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.859 HG22 ' HB3' ' A' ' 35' ' ' LEU . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 29' ' ' ILE . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 56' ' ' THR . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 29' ' ' ILE . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 40' ' ' ASP . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.876 ' N ' HD23 ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.68 HH11 HD12 ' A' ' 52' ' ' LEU . 9.3 ttm180 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 77' ' ' LEU . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.639 ' HG3' HD12 ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 36' ' ' LYS . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 72' ' ' ILE . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 89' ' ' VAL . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 59' ' ' ILE . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.553 ' O ' HD22 ' A' ' 74' ' ' LEU . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.606 ' CE3' HD22 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD21 HD21 ' A' ' 124' ' ' LEU . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 52' ' ' LEU . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.579 0.228 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 74' ' ' LEU . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 74' ' ' LEU . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.795 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.57 HG12 ' CA ' ' A' ' 107' ' ' GLY . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.882 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.87 ' HG2' HG22 ' A' ' 141' ' ' VAL . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.458 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.57 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.684 HD12 ' HB2' ' A' ' 87' ' ' CYS . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.795 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 59' ' ' ILE . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.87 HG22 ' HG2' ' A' ' 95' ' ' MET . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.644 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.882 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' HD12 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.448 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.669 0.271 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' A' ' 26' ' ' VAL . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.67 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.795 HG23 HD21 ' A' ' 55' ' ' LEU . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 26' ' ' VAL . 2.3 m-80 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.569 HG21 ' HD3' ' A' ' 37' ' ' PRO . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 125' ' ' LEU . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 59' ' ' ILE . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' HG21 ' A' ' 29' ' ' ILE . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 11' ' ' MET . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 52' ' ' LEU . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.415 ' CE ' HD22 ' A' ' 76' ' ' LEU . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.698 ' CG ' HG13 ' A' ' 38' ' ' VAL . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.795 HD21 HG23 ' A' ' 25' ' ' THR . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 35' ' ' LEU . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD12 ' HD3' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' VAL . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.723 0.296 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.598 ' HG3' HD12 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.9 ' HB2' HD12 ' A' ' 109' ' ' ILE . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 141' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.819 HG21 ' HG2' ' B' ' 207' ' ' PRO . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.727 ' HG2' HG22 ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.409 ' C ' HG23 ' A' ' 141' ' ' VAL . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.548 ' CD2' ' HG2' ' A' ' 138' ' ' GLU . 90.4 m-70 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.911 ' O ' HG22 ' A' ' 99' ' ' THR . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 87' ' ' CYS . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.77 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 28' ' ' VAL . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 132' ' ' ILE . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.553 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.73 HG12 HD12 ' A' ' 59' ' ' ILE . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.548 ' HG2' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.737 HG21 ' HB3' ' A' ' 91' ' ' PRO . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.819 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.712 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 70' ' ' ILE . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.719 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.448 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 12' ' ' VAL . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.73 ' CE1' HG12 ' A' ' 12' ' ' VAL . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.742 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.695 HG21 ' CD2' ' A' ' 15' ' ' TYR . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 18' ' ' ARG . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.55 ' CG2' HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 27' ' ' ASN . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.694 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.9 m-80 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 39' ' ' LEU . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.43 ' HG3' HD11 ' A' ' 8' ' ' LEU . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' HG13 ' A' ' 38' ' ' VAL . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 61' ' ' VAL . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CZ3' ' CG ' ' A' ' 40' ' ' ASP . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 52' ' ' LEU . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.1 m120 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.636 0.255 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.768 ' HG3' HD11 ' A' ' 124' ' ' LEU . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HB2' HD12 ' A' ' 109' ' ' ILE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.427 ' CG ' HG22 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.511 ' HA ' HG23 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.485 ' NE2' HG11 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.887 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' HG ' ' CE1' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.438 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.768 HD11 ' HG3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 72' ' ' ILE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 59' ' ' ILE . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 HG11 ' NE2' ' A' ' 102' ' ' HIS . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.451 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.726 0.298 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 25' ' ' THR . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.497 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.874 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 18' ' ' ARG . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.858 HG21 HD21 ' A' ' 8' ' ' LEU . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD23 ' A' ' 55' ' ' LEU . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' HD13 ' A' ' 39' ' ' LEU . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.695 0.283 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.8 HD21 HG23 ' A' ' 25' ' ' THR . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.943 HD12 HG12 ' A' ' 132' ' ' ILE . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.459 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 89' ' ' VAL . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.507 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.517 ' CB ' HD11 ' A' ' 114' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.675 0.274 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.62 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.839 ' HB2' HD12 ' A' ' 109' ' ' ILE . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.793 HG13 ' HD3' ' A' ' 91' ' ' PRO . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.793 ' HD3' HG13 ' A' ' 89' ' ' VAL . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.822 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.82 ' HG2' HG22 ' A' ' 141' ' ' VAL . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.473 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.69 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.664 ' CD2' HD23 ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.86 ' O ' HG22 ' A' ' 99' ' ' THR . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.839 HD12 ' HB2' ' A' ' 87' ' ' CYS . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.507 ' CD1' HD12 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.843 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 28' ' ' VAL . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.753 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD12 ' A' ' 59' ' ' ILE . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 129' ' ' GLN . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.607 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.62 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.822 ' HG2' HG21 ' A' ' 92' ' ' THR . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.459 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.965 0.412 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 39' ' ' LEU . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.741 ' CE1' HG12 ' A' ' 12' ' ' VAL . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.688 HG21 ' CD2' ' A' ' 15' ' ' TYR . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.445 HG23 HD21 ' A' ' 55' ' ' LEU . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 27' ' ' ASN . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.648 HD21 HG23 ' A' ' 59' ' ' ILE . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 56' ' ' THR . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.885 HD11 ' HG2' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.61 ' NH1' HD12 ' A' ' 77' ' ' LEU . 4.1 ttm180 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.885 ' HG2' HD11 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.51 ' CE ' HD23 ' A' ' 76' ' ' LEU . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG23 ' A' ' 25' ' ' THR . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 38' ' ' VAL . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.932 HD12 HG12 ' A' ' 132' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 72' ' ' ILE . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 71' ' ' PRO . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 72' ' ' ILE . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HE3' HD21 ' A' ' 52' ' ' LEU . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 114' ' ' LEU . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 74' ' ' LEU . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' A' ' 141' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.678 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.818 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.556 ' ND1' HD21 ' A' ' 111' ' ' LEU . 13.4 m-70 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.818 ' O ' HG22 ' A' ' 99' ' ' THR . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 111' ' ' LEU . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.62 ' H ' HG22 ' A' ' 109' ' ' ILE . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 28' ' ' VAL . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 132' ' ' ILE . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.742 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.932 HG12 HD12 ' A' ' 59' ' ' ILE . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.555 ' OE1' ' CD2' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.627 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.669 ' HG2' HG21 ' A' ' 92' ' ' THR . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.575 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.488 ' OE2' HD11 ' A' ' 29' ' ' ILE . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.811 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.584 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.435 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 15' ' ' TYR . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 23' ' ' ARG . 2.2 m-80 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 125' ' ' LEU . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.488 HD11 ' OE2' ' A' ' 5' ' ' GLU . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.768 0.318 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 76' ' ' LEU . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.813 ' SD ' HD22 ' A' ' 76' ' ' LEU . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 35' ' ' LEU . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.566 HG22 ' CG1' ' A' ' 38' ' ' VAL . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.899 HD12 HG12 ' A' ' 132' ' ' ILE . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 136' ' ' GLY . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 72' ' ' ILE . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 71' ' ' PRO . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.813 HD22 ' SD ' ' A' ' 53' ' ' MET . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' OD1' HD21 ' A' ' 52' ' ' LEU . 1.2 p-10 . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.753 ' HB3' HD11 ' A' ' 114' ' ' LEU . 1.2 t-20 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 76' ' ' LEU . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.81 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 89' ' ' VAL . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.808 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.591 ' HA ' HG23 ' A' ' 103' ' ' VAL . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.685 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.416 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.6 t60 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.883 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.81 HD12 ' HB2' ' A' ' 87' ' ' CYS . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 101' ' ' LYS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 83' ' ' ASN . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 132' ' ' ILE . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.83 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 109' ' ' ILE . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.899 HG12 HD12 ' A' ' 59' ' ' ILE . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 70' ' ' ILE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.808 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.626 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 22' ' ' VAL . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.456 ' HE2' HD23 ' A' ' 39' ' ' LEU . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CD2' HG21 ' A' ' 21' ' ' THR . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 22' ' ' VAL . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.631 HG21 ' CD2' ' A' ' 15' ' ' TYR . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 18' ' ' ARG . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 28' ' ' VAL . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.643 HG23 HD21 ' A' ' 55' ' ' LEU . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 125' ' ' LEU . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 24' ' ' GLU . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 35' ' ' LEU . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 55' ' ' LEU . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.415 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.549 ' ND2' HG13 ' A' ' 38' ' ' VAL . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 HG23 ' A' ' 25' ' ' THR . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 70' ' ' ILE . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 132' ' ' ILE . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.473 ' CE1' ' HD2' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 59' ' ' ILE . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.551 ' CE3' HD13 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 84' ' ' PRO . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD12 HD21 ' A' ' 52' ' ' LEU . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.461 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 3.7 m-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.825 ' HG3' HD12 ' A' ' 76' ' ' LEU . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.917 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.624 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.474 ' HE3' ' HB2' ' B' ' 207' ' ' PRO . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.593 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.831 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 111' ' ' LEU . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 104' ' ' ASP . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.831 ' O ' HG22 ' A' ' 99' ' ' THR . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.948 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 87' ' ' CYS . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.796 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.796 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.774 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.774 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 76' ' ' LEU . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 132' ' ' ILE . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.784 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.63 ' SD ' HD13 ' A' ' 109' ' ' ILE . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.771 HD11 HG22 ' A' ' 128' ' ' ILE . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.734 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.506 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.456 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.85 ' CD2' HG21 ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.85 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 18' ' ' ARG . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 125' ' ' LEU . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 24' ' ' GLU . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 37' ' ' PRO . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.646 HD22 HD23 ' A' ' 125' ' ' LEU . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.526 ' HA ' HD23 ' A' ' 55' ' ' LEU . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.838 HD13 ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.838 ' N ' HD13 ' A' ' 39' ' ' LEU . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.81 HD21 HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.636 ' CG ' HG13 ' A' ' 38' ' ' VAL . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 76' ' ' LEU . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 132' ' ' ILE . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG13 ' HA2' ' A' ' 136' ' ' GLY . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' O ' HD13 ' A' ' 72' ' ' ILE . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.408 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 109' ' ' ILE . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 107' ' ' GLY . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HG3' HD11 ' A' ' 97' ' ' ILE . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.485 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 91' ' ' PRO . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.838 ' O ' HG22 ' A' ' 99' ' ' THR . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.764 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.781 HD12 ' HB2' ' A' ' 87' ' ' CYS . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 111' ' ' LEU . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.75 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.646 HD23 HD22 ' A' ' 31' ' ' LEU . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 59' ' ' ILE . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.622 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.432 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.614 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.614 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.511 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.631 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 21' ' ' THR . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.493 HG21 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 28' ' ' VAL . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' HG23 ' A' ' 26' ' ' VAL . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 24' ' ' GLU . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 ' N ' HG13 ' A' ' 29' ' ' ILE . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.725 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HG2' HD11 ' A' ' 8' ' ' LEU . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.791 0.329 . . . . 0.0 110.637 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' ND2' HG22 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 76' ' ' LEU . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.573 HD12 HG12 ' A' ' 132' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 72' ' ' ILE . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 89' ' ' VAL . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.677 ' HE3' HD21 ' A' ' 52' ' ' LEU . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 55' ' ' LEU . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' H ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.301 0.112 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CB ' HD11 ' A' ' 127' ' ' LEU . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 88' ' ' PHE . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.71 ' HB2' HD12 ' A' ' 109' ' ' ILE . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 71' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG2' HG22 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 142' ' ' PHE . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 111' ' ' LEU . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.895 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 87' ' ' CYS . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 102' ' ' HIS . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.559 HD12 ' HG2' ' A' ' 84' ' ' PRO . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.741 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.741 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HD12 ' A' ' 128' ' ' ILE . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 132' ' ' ILE . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 128' ' ' ILE . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.521 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 96' ' ' THR . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.611 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.468 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.693 0.282 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.659 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 12' ' ' VAL . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 15' ' ' TYR . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 18' ' ' ARG . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 28' ' ' VAL . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.591 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 52' ' ' LEU . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 35' ' ' LEU . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 38' ' ' VAL . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 132' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 72' ' ' ILE . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.507 HD21 ' CE ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HE3' HD21 ' A' ' 52' ' ' LEU . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 124' ' ' LEU . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.591 HD21 ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.515 0.198 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 114' ' ' LEU . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.814 ' CB ' HD12 ' A' ' 109' ' ' ILE . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 107' ' ' GLY . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' HG13 ' A' ' 89' ' ' VAL . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 141' ' ' VAL . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 91' ' ' PRO . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.803 ' O ' HG22 ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.872 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 87' ' ' CYS . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.41 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.69 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.721 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.721 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 132' ' ' ILE . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 126' ' ' GLY . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.507 ' CE ' HD21 ' A' ' 74' ' ' LEU . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.662 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 129' ' ' GLN . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 131' ' ' MET . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.424 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.636 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.641 ' HG2' HG21 ' A' ' 92' ' ' THR . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.518 0.199 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.865 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.865 HG21 ' CD2' ' A' ' 15' ' ' TYR . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 28' ' ' VAL . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.569 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m-80 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 56' ' ' THR . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.691 ' H ' HD13 ' A' ' 39' ' ' LEU . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 52' ' ' LEU . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 38' ' ' VAL . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 132' ' ' ILE . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.471 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 71' ' ' PRO . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.402 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 124' ' ' LEU . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' OD2' HD21 ' A' ' 52' ' ' LEU . 1.1 p30 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.681 ' HB3' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.627 0.251 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.799 ' HG3' HD12 ' A' ' 76' ' ' LEU . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.737 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 107' ' ' GLY . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' HG22 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.827 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.853 ' O ' HG22 ' A' ' 99' ' ' THR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.892 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.763 ' HD2' HD13 ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.803 HD23 ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HG3' HD23 ' A' ' 114' ' ' LEU . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.767 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 76' ' ' LEU . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 127' ' ' LEU . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.939 HG12 HD12 ' A' ' 59' ' ' ILE . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.608 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.726 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.596 0.236 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 26' ' ' VAL . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG23 ' H ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 18' ' ' ARG . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 8' ' ' LEU . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.622 ' H ' HD13 ' A' ' 39' ' ' LEU . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.44 ' HG2' HD22 ' A' ' 39' ' ' LEU . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 132' ' ' ILE . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 61' ' ' VAL . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 89' ' ' VAL . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 71' ' ' PRO . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' HG3' ' A' ' 84' ' ' PRO . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' H ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' O ' HD11 ' A' ' 114' ' ' LEU . 12.9 m120 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 76' ' ' LEU . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 109' ' ' ILE . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.49 ' HG2' HG22 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' O ' ' A' ' 105' ' ' ALA . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.836 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 138' ' ' GLU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.715 ' O ' HG21 ' A' ' 97' ' ' ILE . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.766 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' A' ' 87' ' ' CYS . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HG3' HD23 ' A' ' 114' ' ' LEU . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 128' ' ' ILE . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 124' ' ' LEU . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.802 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 61' ' ' VAL . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.514 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.721 ' O ' HG13 ' A' ' 141' ' ' VAL . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.619 0.247 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.634 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 15' ' ' TYR . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.677 ' HB ' HD21 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 27' ' ' ASN . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.415 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.78 HG22 HD12 ' A' ' 125' ' ' LEU . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 35' ' ' LEU . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 29' ' ' ILE . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 56' ' ' THR . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 39' ' ' LEU . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.772 ' HD3' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD12 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 52' ' ' LEU . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.517 HG22 HG13 ' A' ' 38' ' ' VAL . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.867 HD12 HG12 ' A' ' 132' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' A' ' 136' ' ' GLY . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.515 ' O ' HD13 ' A' ' 72' ' ' ILE . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 71' ' ' PRO . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.714 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 52' ' ' LEU . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' NH2' ' A' ' 50' ' ' ARG . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.869 ' HB3' HD23 ' A' ' 114' ' ' LEU . 6.9 t30 . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.714 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.481 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.878 ' O ' HG22 ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 97' ' ' ILE . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 87' ' ' CYS . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 111' ' ' LEU . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 83' ' ' ASN . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.766 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 28' ' ' VAL . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 132' ' ' ILE . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 126' ' ' GLY . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 72' ' ' ILE . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.867 HG12 HD12 ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.45 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.524 -0.046 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' CG ' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.56 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.817 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.474 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.565 HG21 ' HD3' ' A' ' 37' ' ' PRO . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 29' ' ' ILE . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.541 HD22 ' CD2' ' A' ' 125' ' ' LEU . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 59' ' ' ILE . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' HG22 ' A' ' 56' ' ' THR . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD3' HG21 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.638 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.638 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 38' ' ' VAL . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 35' ' ' LEU . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' LYS . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG12 HD13 ' A' ' 35' ' ' LEU . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.695 HG13 ' HA2' ' A' ' 136' ' ' GLY . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.469 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 89' ' ' VAL . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 73' ' ' CYS . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.513 ' C ' HD23 ' A' ' 74' ' ' LEU . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.704 ' CE3' HD13 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 124' ' ' LEU . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 76' ' ' LEU . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 86' ' ' ILE . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 85' ' ' PRO . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.892 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 71' ' ' PRO . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.829 HG21 ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.47 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 141' ' ' VAL . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 99' ' ' THR . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 114' ' ' LEU . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.759 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.759 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.906 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 126' ' ' GLY . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 109' ' ' ILE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 128' ' ' ILE . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' GLN . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' PRO . . . . . 0.829 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.695 ' HD3' HD13 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.469 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.78 -23.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -16.74 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.108 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.554 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.813 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 18' ' ' ARG . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.813 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 27' ' ' ASN . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.0 m-80 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 24' ' ' GLU . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.482 HG21 ' HD3' ' A' ' 37' ' ' PRO . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 55' ' ' LEU . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' O ' HG22 ' A' ' 56' ' ' THR . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' HG21 ' A' ' 29' ' ' ILE . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 9.1 t80 -138.76 168.7 19.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 49' ' ' SER . 27.1 m -85.98 144.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 56.1 m-85 -146.52 -67.07 0.28 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.733 0.302 . . . . 0.0 111.5 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -56.18 85.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.746 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.76 25.07 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.82 74.89 1.26 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.208 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 112.82 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.628 0.251 . . . . 0.0 110.705 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 43' ' ' VAL . 14.8 p -48.55 143.32 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.453 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -139.93 139.83 36.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.626 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 35' ' ' LEU . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 36' ' ' LYS . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 72' ' ' ILE . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 59' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.626 ' CE3' HD13 ' A' ' 52' ' ' LEU . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 124' ' ' LEU . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 -62.35 -56.44 18.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 1.6 t 171.94 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -142.48 133.75 12.95 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.88 -23.92 11.42 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.859 -1.309 . . . . 0.0 111.979 0.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.12 -40.18 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HB2' HD11 ' A' ' 114' ' ' LEU . 1.2 m-80 -148.69 166.17 16.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.755 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.703 ' HG3' HD12 ' A' ' 76' ' ' LEU . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 86' ' ' ILE . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 71' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 97' ' ' ILE . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.709 HG21 ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.872 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.559 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.612 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.42 ' CE1' HG11 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.711 ' O ' HG22 ' A' ' 99' ' ' THR . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.767 HD12 ' HB2' ' A' ' 87' ' ' CYS . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 83' ' ' ASN . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.904 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 59' ' ' ILE . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.872 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.617 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.709 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.818 0.342 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.11 -47.13 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -79.0 -50.17 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.737 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.862 ' CE2' HG21 ' A' ' 21' ' ' THR . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.844 ' CB ' HG21 ' A' ' 79' ' ' THR . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.725 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.862 HG21 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 18' ' ' ARG . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 28' ' ' VAL . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.655 HG21 ' CE ' ' A' ' 53' ' ' MET . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD23 ' A' ' 8' ' ' LEU . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.893 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 24' ' ' GLU . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 35' ' ' LEU . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 55' ' ' LEU . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.656 ' CG1' HG22 ' A' ' 56' ' ' THR . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 38' ' ' VAL . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -104.04 143.81 32.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.42 148.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 50' ' ' ARG . 81.5 m-85 -148.96 -67.44 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.963 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.406 ' CB ' ' HB2' ' A' ' 48' ' ' SER . 1.2 m-80 -58.76 83.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 54.62 23.29 4.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.326 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.5 13.54 24.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.742 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -81.31 124.72 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.322 -0.516 . . . . 0.0 110.845 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.7 p -73.14 144.72 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.01 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -150.31 145.53 26.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.656 HG22 ' CG1' ' A' ' 38' ' ' VAL . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.676 ' CG2' HD13 ' A' ' 35' ' ' LEU . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 89' ' ' VAL . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.656 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 73' ' ' CYS . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 -63.04 -56.25 18.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.844 HG21 ' CB ' ' A' ' 16' ' ' LYS . 2.7 t -178.22 47.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -152.13 145.9 18.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 3.1 Cg_exo -76.18 -28.41 7.63 Favored 'Cis proline' 0 C--N 1.347 0.45 0 C-N-CA 123.682 -1.383 . . . . 0.0 112.663 -0.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -158.97 -37.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 3.1 t-20 -146.67 140.15 14.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.528 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 71' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.965 HG21 ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.866 ' HG2' HG22 ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.576 HD11 ' CA ' ' A' ' 107' ' ' GLY . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 108' ' ' LYS . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 97' ' ' ILE . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 87' ' ' CYS . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 109' ' ' ILE . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.768 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.768 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.652 HD11 HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.893 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 70' ' ' ILE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.658 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.965 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.729 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.841 0.353 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.4 -26.35 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.42 -19.85 52.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.237 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.704 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.419 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.739 HG21 ' CD2' ' A' ' 15' ' ' TYR . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 18' ' ' ARG . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.407 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' ASN . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.787 ' OD1' HD22 ' A' ' 125' ' ' LEU . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 24' ' ' GLU . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 35' ' ' LEU . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 125' ' ' LEU . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 128' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.75 ' HA ' HD23 ' A' ' 55' ' ' LEU . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.647 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.909 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -138.36 163.89 30.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 16.9 m -86.6 147.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.394 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -148.99 -67.23 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.39 86.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.408 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.51 24.35 6.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.44 10.8 37.65 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.685 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -81.28 123.4 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.567 -0.372 . . . . 0.0 110.947 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.1 m -73.93 138.59 44.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -135.56 136.63 41.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.933 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.825 HD12 ' CD ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.647 ' ND2' HG13 ' A' ' 38' ' ' VAL . 13.3 p-10 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 37' ' ' PRO . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.821 HD12 HG12 ' A' ' 132' ' ' ILE . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 136' ' ' GLY . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' B' ' 210' ' ' PRO . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' VAL . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.628 ' N ' HG23 ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' HE3' HD22 ' A' ' 52' ' ' LEU . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 52' ' ' LEU . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 -63.51 -60.18 3.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 16' ' ' LYS . 11.4 p -158.33 -36.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.487 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -111.96 169.66 6.1 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.793 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 44.4 Cg_endo -70.6 -54.33 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.297 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.293 0.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.8 71.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.645 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 63.91 128.42 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.716 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.499 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.695 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.879 ' O ' HG22 ' A' ' 99' ' ' THR . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.888 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 87' ' ' CYS . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' N ' HD22 ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 ' OD1' ' A' ' 27' ' ' ASN . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.77 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.749 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.821 HG12 HD12 ' A' ' 59' ' ' ILE . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' B' ' 212' ' ' GLU . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.457 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.11 -30.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.135 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -79.05 -47.74 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.822 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.5 ' H ' HG23 ' A' ' 12' ' ' VAL . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.843 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 15' ' ' TYR . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 18' ' ' ARG . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 124' ' ' LEU . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.779 HG23 HD21 ' A' ' 55' ' ' LEU . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.653 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 59' ' ' ILE . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG12 HG22 ' A' ' 56' ' ' THR . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 11' ' ' MET . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.707 ' N ' HD13 ' A' ' 39' ' ' LEU . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 6.6 t80 -138.71 149.03 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 49' ' ' SER . 35.7 m -84.46 150.27 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 52' ' ' LEU . 62.3 m-85 -146.76 -67.65 0.27 Allowed 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.375 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -56.91 82.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.695 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 54.0 m-20 50.44 25.42 1.92 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 77.0 1.25 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.285 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.32 95.97 1.76 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.507 0.67 . . . . 0.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.689 ' N ' HG12 ' A' ' 43' ' ' VAL . 4.2 m -44.28 144.3 1.03 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.85 136.12 18.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.591 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.597 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 38' ' ' VAL . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 25' ' ' THR . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 38' ' ' VAL . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.855 HD12 HG12 ' A' ' 132' ' ' ILE . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.557 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 70' ' ' ILE . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.534 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CE3' HD13 ' A' ' 52' ' ' LEU . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 55' ' ' LEU . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 77' ' ' LEU . 3.9 m-20 -61.2 -59.07 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 172.84 79.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -159.66 137.7 7.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.001 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -73.44 -68.29 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.169 -1.596 . . . . 0.0 112.523 -0.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.438 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -86.37 -65.51 1.0 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 -152.77 -50.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.914 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.744 ' HB3' HD12 ' A' ' 109' ' ' ILE . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 107' ' ' GLY . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.622 ' HD3' HG13 ' A' ' 89' ' ' VAL . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.714 HG21 ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.796 ' HG2' HG22 ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 141' ' ' VAL . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.639 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 97' ' ' ILE . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.762 ' O ' HG22 ' A' ' 99' ' ' THR . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HE2' HG23 ' A' ' 86' ' ' ILE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.799 HG21 ' OH ' ' A' ' 113' ' ' TYR . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.488 HD12 HG21 ' A' ' 109' ' ' ILE . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.799 ' OH ' HG21 ' A' ' 109' ' ' ILE . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.855 HG12 HD12 ' A' ' 59' ' ' ILE . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' B' ' 212' ' ' GLU . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.796 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.633 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.714 ' HG2' HG21 ' A' ' 92' ' ' THR . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.462 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.55 -23.03 4.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.04 -18.05 56.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.301 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 22' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.673 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.701 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.792 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB3' HG21 ' A' ' 79' ' ' THR . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.792 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 9' ' ' LYS . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.641 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.9 t-20 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HG22 ' A' ' 56' ' ' THR . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 21.8 t80 -139.57 164.7 29.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 49' ' ' SER . 35.5 m -85.17 145.73 7.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 60.8 m-85 -146.08 -67.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.156 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.56 84.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.304 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' PHE . 60.6 m-20 51.77 24.73 2.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.68 75.55 1.23 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.203 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.85 108.39 2.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 122.831 -0.217 . . . . 0.0 110.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.9 p -49.84 146.11 4.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.419 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.33 139.23 40.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.405 HG22 HG12 ' A' ' 38' ' ' VAL . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 132' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 136' ' ' GLY . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 59' ' ' ILE . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 72' ' ' ILE . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.655 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.453 ' CE3' HD13 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 124' ' ' LEU . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.544 ' H ' HD13 ' A' ' 77' ' ' LEU . 14.8 m-20 -63.36 -53.94 44.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.6 t 168.14 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.654 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.05 142.93 18.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -12.27 30.45 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.456 -1.477 . . . . 0.0 112.657 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -54.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.609 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.593 ' H ' HD11 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -150.42 162.73 26.63 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.424 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.705 ' HG3' HD12 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 109' ' ' ILE . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.439 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.414 ' HB2' ' OG1' ' A' ' 92' ' ' THR . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 141' ' ' VAL . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.588 HG21 ' O ' ' A' ' 104' ' ' ASP . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 104' ' ' ASP . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 99' ' ' THR . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.86 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 87' ' ' CYS . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 115' ' ' HIS . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.593 HD11 ' H ' ' A' ' 83' ' ' ASN . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.775 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 28' ' ' VAL . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.82 HG12 HD12 ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 -34.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p -78.95 -48.99 13.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.683 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 12' ' ' VAL . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 79' ' ' THR . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.678 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' ARG . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 28' ' ' VAL . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 27' ' ' ASN . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 m-80 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 35' ' ' LEU . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.94 HD23 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.89 138.76 37.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG12 ' N ' ' A' ' 49' ' ' SER . 35.8 m -86.89 151.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.015 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 42' ' ' TYR . 96.8 m-85 -147.74 -66.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -55.99 85.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 111.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' PHE . 70.4 m-20 50.11 25.1 1.6 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 111.599 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 73.11 1.05 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.251 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 109.1 3.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.862 0.363 . . . . 0.0 110.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 43' ' ' VAL . 64.1 p -45.48 147.38 0.85 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -145.3 145.92 31.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.761 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.94 ' HA ' HD23 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' HG13 ' A' ' 38' ' ' VAL . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.632 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 124' ' ' LEU . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 80' ' ' TYR . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 -61.81 -55.12 33.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 16' ' ' LYS . 2.2 t 177.08 39.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 44.5 p90 -170.0 153.56 4.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.34 -35.94 2.53 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.373 -1.511 . . . . 0.0 112.526 0.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -159.17 80.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 77' ' ' LEU . 1.4 t-20 64.99 141.43 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.5 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.737 ' HG2' HG22 ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' HG23 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.946 ' CD2' HD12 ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 99' ' ' THR . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.754 HG22 HD11 ' A' ' 132' ' ' ILE . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.666 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 128' ' ' ILE . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.74 ' O ' ' HB1' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.428 ' CD ' HD13 ' A' ' 70' ' ' ILE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.34 -30.53 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.96 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.657 ' HG2' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.6 ' HE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.6 HG21 ' HE1' ' A' ' 15' ' ' TYR . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 18' ' ' ARG . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 37' ' ' PRO . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 29' ' ' ILE . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 125' ' ' LEU . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.859 HG22 ' HB3' ' A' ' 35' ' ' LEU . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 29' ' ' ILE . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 56' ' ' THR . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 29' ' ' ILE . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 40' ' ' ASP . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.876 ' N ' HD23 ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 3.4 t80 -139.21 149.72 44.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 49' ' ' SER . 35.1 m -85.67 147.89 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 78.7 m-85 -146.67 -67.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.492 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.97 83.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.75 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 25.7 m-20 51.3 25.27 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.421 0.629 . . . . 0.0 111.308 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 74.99 1.18 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.146 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.55 104.35 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 43' ' ' VAL . 10.3 p -45.29 145.82 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.725 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.68 HH11 HD12 ' A' ' 52' ' ' LEU . 9.3 ttm180 -142.89 135.36 27.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 77' ' ' LEU . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.639 ' HG3' HD12 ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 36' ' ' LYS . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 72' ' ' ILE . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 89' ' ' VAL . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 59' ' ' ILE . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.553 ' O ' HD22 ' A' ' 74' ' ' LEU . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.606 ' CE3' HD22 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD21 HD21 ' A' ' 124' ' ' LEU . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 52' ' ' LEU . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 -62.78 -29.67 70.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 163.71 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.64 123.2 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' TYR . 83.8 Cg_endo -81.63 -32.61 3.54 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.972 0.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -37.15 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.818 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -146.94 163.47 28.55 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 74' ' ' LEU . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 74' ' ' LEU . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.795 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.57 HG12 ' CA ' ' A' ' 107' ' ' GLY . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.882 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.87 ' HG2' HG22 ' A' ' 141' ' ' VAL . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.458 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.57 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.684 HD12 ' HB2' ' A' ' 87' ' ' CYS . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.795 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 59' ' ' ILE . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.87 HG22 ' HG2' ' A' ' 95' ' ' MET . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.644 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.882 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' HD12 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.448 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -107.96 -30.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -22.8 46.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' A' ' 26' ' ' VAL . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.67 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HB3' HG21 ' A' ' 79' ' ' THR . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.795 HG23 HD21 ' A' ' 55' ' ' LEU . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 26' ' ' VAL . 2.3 m-80 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.569 HG21 ' HD3' ' A' ' 37' ' ' PRO . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 125' ' ' LEU . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 59' ' ' ILE . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' HG21 ' A' ' 29' ' ' ILE . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 11' ' ' MET . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -138.89 168.33 20.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 49' ' ' SER . 27.3 m -85.66 146.94 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.721 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 84.1 m-85 -147.47 -67.25 0.25 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -56.25 84.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.472 0.309 . . . . 0.0 111.601 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.3 m-20 52.34 24.85 3.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.384 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.94 73.76 1.19 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -156.93 112.97 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.807 0.337 . . . . 0.0 110.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 43' ' ' VAL . 13.5 p -47.52 133.48 13.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -125.16 138.88 54.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 52' ' ' LEU . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.415 ' CE ' HD22 ' A' ' 76' ' ' LEU . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.698 ' CG ' HG13 ' A' ' 38' ' ' VAL . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.795 HD21 HG23 ' A' ' 25' ' ' THR . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 35' ' ' LEU . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.48 HD12 ' HD3' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' VAL . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 79' ' ' THR . 2.8 p-10 -62.37 -54.92 33.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 t 176.54 38.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -135.15 130.56 19.37 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.209 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.32 -29.43 6.66 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.812 -1.328 . . . . 0.0 111.884 0.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.439 ' CE2' ' HD3' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.29 -39.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -147.98 161.67 33.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.598 ' HG3' HD12 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.9 ' HB2' HD12 ' A' ' 109' ' ' ILE . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 141' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.819 HG21 ' HG2' ' B' ' 207' ' ' PRO . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.727 ' HG2' HG22 ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.409 ' C ' HG23 ' A' ' 141' ' ' VAL . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.548 ' CD2' ' HG2' ' A' ' 138' ' ' GLU . 90.4 m-70 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.911 ' O ' HG22 ' A' ' 99' ' ' THR . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 87' ' ' CYS . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.77 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 28' ' ' VAL . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 132' ' ' ILE . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.553 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.73 HG12 HD12 ' A' ' 59' ' ' ILE . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.548 ' HG2' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.737 HG21 ' HB3' ' A' ' 91' ' ' PRO . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.819 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.712 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 70' ' ' ILE . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.836 0.35 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.38 -24.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -21.19 51.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.719 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.448 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 12' ' ' VAL . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.73 ' CE1' HG12 ' A' ' 12' ' ' VAL . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.797 ' CB ' HG21 ' A' ' 79' ' ' THR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.695 HG21 ' CD2' ' A' ' 15' ' ' TYR . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 18' ' ' ARG . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.55 ' CG2' HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 27' ' ' ASN . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.694 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.9 m-80 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 39' ' ' LEU . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.26 168.1 20.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 27.3 m -86.33 149.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.489 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 68.3 m-85 -147.47 -67.19 0.26 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.77 80.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.025 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 14.7 m-20 54.75 23.74 5.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 43' ' ' VAL . . . 113.49 9.05 18.02 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.971 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.93 119.85 24.47 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 p -74.66 129.42 37.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -117.56 135.25 54.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.43 ' HG3' HD11 ' A' ' 8' ' ' LEU . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' HG13 ' A' ' 38' ' ' VAL . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 61' ' ' VAL . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CZ3' ' CG ' ' A' ' 40' ' ' ASP . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 52' ' ' LEU . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -62.28 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.797 HG21 ' CB ' ' A' ' 16' ' ' LYS . 5.0 t -179.92 38.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.49 130.52 22.5 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.51 -26.28 9.84 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.314 -0.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 120' ' ' PRO . 83.5 t80 -159.18 -37.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.7 OUTLIER -146.81 163.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.768 ' HG3' HD11 ' A' ' 124' ' ' LEU . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HB2' HD12 ' A' ' 109' ' ' ILE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.427 ' CG ' HG22 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.511 ' HA ' HG23 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.485 ' NE2' HG11 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.887 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' HG ' ' CE1' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.438 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.768 HD11 ' HG3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 72' ' ' ILE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 59' ' ' ILE . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 HG11 ' NE2' ' A' ' 102' ' ' HIS . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.451 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB3' ' OE1' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.21 -22.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.321 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -18.79 55.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.294 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.745 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 25' ' ' THR . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.497 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.874 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 18' ' ' ARG . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.858 HG21 HD21 ' A' ' 8' ' ' LEU . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD23 ' A' ' 55' ' ' LEU . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' HD13 ' A' ' 39' ' ' LEU . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 4.0 t80 -140.06 164.33 30.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 49' ' ' SER . 32.5 m -85.5 146.31 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 52.8 m-85 -146.7 -66.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.715 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.16 84.33 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 6.6 m-20 52.16 25.04 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.64 75.79 1.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.571 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.27 106.26 2.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' N ' HG12 ' A' ' 43' ' ' VAL . 96.0 p -49.21 134.31 18.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.351 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -120.41 135.59 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.855 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.8 HD21 HG23 ' A' ' 25' ' ' THR . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.943 HD12 HG12 ' A' ' 132' ' ' ILE . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.459 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 89' ' ' VAL . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.507 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.98 33.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.33 18.78 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.235 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 81' ' ' PRO . 29.0 p90 -43.41 162.03 0.19 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.232 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 80' ' ' TYR . 54.3 Cg_endo -69.38 119.8 4.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.81 -1.329 . . . . 0.0 112.778 0.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -159.72 -38.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.517 ' CB ' HD11 ' A' ' 114' ' ' LEU . 0.8 OUTLIER 67.02 136.88 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.62 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.62 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.839 ' HB2' HD12 ' A' ' 109' ' ' ILE . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.793 HG13 ' HD3' ' A' ' 91' ' ' PRO . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.793 ' HD3' HG13 ' A' ' 89' ' ' VAL . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.822 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.82 ' HG2' HG22 ' A' ' 141' ' ' VAL . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.473 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.69 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.664 ' CD2' HD23 ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.86 ' O ' HG22 ' A' ' 99' ' ' THR . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.839 HD12 ' HB2' ' A' ' 87' ' ' CYS . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.507 ' CD1' HD12 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.843 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 28' ' ' VAL . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.753 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD12 ' A' ' 59' ' ' ILE . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 129' ' ' GLN . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.607 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.62 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.822 ' HG2' HG21 ' A' ' 92' ' ' THR . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.459 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.853 0.359 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.73 -26.5 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.376 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 -24.3 47.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 39' ' ' LEU . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.741 ' CE1' HG12 ' A' ' 12' ' ' VAL . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' CB ' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.688 HG21 ' CD2' ' A' ' 15' ' ' TYR . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.445 HG23 HD21 ' A' ' 55' ' ' LEU . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 27' ' ' ASN . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.648 HD21 HG23 ' A' ' 59' ' ' ILE . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 56' ' ' THR . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.885 HD11 ' HG2' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 4.0 t80 -140.51 168.16 20.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 49' ' ' SER . 29.7 m -85.41 147.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.824 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' ASP . 5.0 m-85 -146.01 -67.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.33 84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.261 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.5 m-20 51.97 24.15 2.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.816 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.85 77.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.645 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.58 98.72 1.97 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.095 0.474 . . . . 0.0 110.209 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.792 ' N ' HG12 ' A' ' 43' ' ' VAL . 10.2 t -55.26 132.65 48.31 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.61 ' NH1' HD12 ' A' ' 77' ' ' LEU . 4.1 ttm180 -138.18 135.2 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.885 ' HG2' HD11 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.51 ' CE ' HD23 ' A' ' 76' ' ' LEU . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG23 ' A' ' 25' ' ' THR . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 38' ' ' VAL . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.932 HD12 HG12 ' A' ' 132' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 72' ' ' ILE . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 71' ' ' PRO . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 72' ' ' ILE . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HE3' HD21 ' A' ' 52' ' ' LEU . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 -61.86 -44.23 97.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 167.78 83.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.641 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -173.07 142.1 1.01 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.201 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.5 Cg_endo -74.44 -70.44 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.394 0 C-N-CA 123.209 -1.58 . . . . 0.0 112.736 0.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -64.68 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.121 0.486 . . . . 0.0 110.643 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 -152.46 -65.87 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 114' ' ' LEU . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 74' ' ' LEU . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' A' ' 141' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.678 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.818 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.556 ' ND1' HD21 ' A' ' 111' ' ' LEU . 13.4 m-70 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.818 ' O ' HG22 ' A' ' 99' ' ' THR . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 111' ' ' LEU . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.62 ' H ' HG22 ' A' ' 109' ' ' ILE . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 28' ' ' VAL . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 132' ' ' ILE . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.742 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.932 HG12 HD12 ' A' ' 59' ' ' ILE . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.555 ' OE1' ' CD2' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.627 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.669 ' HG2' HG21 ' A' ' 92' ' ' THR . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.575 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.183 0.516 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -92.01 -31.66 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.407 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -79.07 -47.66 15.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.488 ' OE2' HD11 ' A' ' 29' ' ' ILE . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.811 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.584 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.435 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 15' ' ' TYR . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 23' ' ' ARG . 2.2 m-80 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 125' ' ' LEU . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.488 HD11 ' OE2' ' A' ' 5' ' ' GLU . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 5.9 t80 -136.62 154.85 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 49' ' ' SER . 35.0 m -85.19 146.02 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.325 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 82.6 m-85 -146.47 -66.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.451 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -57.77 84.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 51.53 25.11 2.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.1 75.46 1.24 Allowed Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.217 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.84 107.83 2.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.261 0.553 . . . . 0.0 110.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 43' ' ' VAL . 54.0 p -48.32 142.88 5.13 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 121.209 0.528 . . . . 0.0 111.618 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 -124.54 136.26 53.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.659 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 76' ' ' LEU . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.813 ' SD ' HD22 ' A' ' 76' ' ' LEU . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 35' ' ' LEU . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.566 HG22 ' CG1' ' A' ' 38' ' ' VAL . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.899 HD12 HG12 ' A' ' 132' ' ' ILE . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 136' ' ' GLY . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 72' ' ' ILE . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 71' ' ' PRO . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.813 HD22 ' SD ' ' A' ' 53' ' ' MET . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' OD1' HD21 ' A' ' 52' ' ' LEU . 1.2 p-10 -171.43 40.72 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' TYR . 67.5 m -153.88 -65.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.772 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 58.53 143.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.16 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.76 117.82 4.02 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.735 -1.361 . . . . 0.0 112.223 -0.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.562 ' HB3' HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -158.71 -32.34 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.7 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.753 ' HB3' HD11 ' A' ' 114' ' ' LEU . 1.2 t-20 69.88 141.17 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 76' ' ' LEU . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.81 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 89' ' ' VAL . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.808 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.591 ' HA ' HG23 ' A' ' 103' ' ' VAL . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.416 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.6 t60 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.883 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.81 HD12 ' HB2' ' A' ' 87' ' ' CYS . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 101' ' ' LYS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 83' ' ' ASN . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 132' ' ' ILE . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.83 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 109' ' ' ILE . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.899 HG12 HD12 ' A' ' 59' ' ' ILE . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 70' ' ' ILE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.808 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.626 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 4' ' ' SER . 11.8 p -108.04 -43.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.342 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -79.22 -23.91 43.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.935 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 22' ' ' VAL . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.456 ' HE2' HD23 ' A' ' 39' ' ' LEU . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CD2' HG21 ' A' ' 21' ' ' THR . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.738 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 22' ' ' VAL . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.631 HG21 ' CD2' ' A' ' 15' ' ' TYR . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 18' ' ' ARG . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 28' ' ' VAL . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.643 HG23 HD21 ' A' ' 55' ' ' LEU . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 125' ' ' LEU . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 24' ' ' GLU . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 35' ' ' LEU . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 55' ' ' LEU . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 15.6 t80 -138.83 156.46 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.791 HG12 ' N ' ' A' ' 49' ' ' SER . 20.3 m -86.3 150.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 67.7 m-85 -147.63 -67.46 0.25 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.572 0.225 . . . . 0.0 111.356 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.09 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.486 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 51.19 25.04 2.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.89 76.4 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.57 98.75 1.97 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 120.813 0.339 . . . . 0.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.791 ' N ' HG12 ' A' ' 43' ' ' VAL . 4.3 m -46.43 146.43 1.45 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.581 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -131.92 139.67 48.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.415 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.549 ' ND2' HG13 ' A' ' 38' ' ' VAL . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 HG23 ' A' ' 25' ' ' THR . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 70' ' ' ILE . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 132' ' ' ILE . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' CE1' ' HD2' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 59' ' ' ILE . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.551 ' CE3' HD13 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 84' ' ' PRO . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD12 HD21 ' A' ' 52' ' ' LEU . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 -61.39 -59.45 5.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 171.47 61.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.648 ' CE1' HD23 ' A' ' 77' ' ' LEU . 27.2 p90 -166.63 133.31 1.97 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.464 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 6.2 Cg_exo -73.2 -72.01 0.01 OUTLIER 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 123.378 -1.509 . . . . 0.0 111.737 -0.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CG ' ' N ' ' A' ' 83' ' ' ASN . 20.4 p90 -92.64 -52.54 4.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 3.7 m-20 -154.59 168.48 11.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.825 ' HG3' HD12 ' A' ' 76' ' ' LEU . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.917 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.624 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.474 ' HE3' ' HB2' ' B' ' 207' ' ' PRO . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.593 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.831 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 111' ' ' LEU . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 104' ' ' ASP . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.831 ' O ' HG22 ' A' ' 99' ' ' THR . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.948 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 87' ' ' CYS . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.796 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.796 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 82' ' ' TYR . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.774 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.774 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 76' ' ' LEU . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 132' ' ' ILE . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.784 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.63 ' SD ' HD13 ' A' ' 109' ' ' ILE . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.771 HD11 HG22 ' A' ' 128' ' ' ILE . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.734 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.506 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.41 -26.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.17 -11.88 59.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.456 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.85 ' CD2' HG21 ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.85 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 18' ' ' ARG . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 125' ' ' LEU . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 24' ' ' GLU . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 37' ' ' PRO . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.646 HD22 HD23 ' A' ' 125' ' ' LEU . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.526 ' HA ' HD23 ' A' ' 55' ' ' LEU . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.838 HD13 ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.838 ' N ' HD13 ' A' ' 39' ' ' LEU . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 14.9 t80 -140.13 168.17 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 49' ' ' SER . 35.6 m -85.25 144.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.104 0.478 . . . . 0.0 110.931 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 39.2 m-85 -146.22 -66.8 0.29 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.412 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -56.94 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' PHE . 30.7 m-20 52.09 25.44 3.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.658 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.33 75.69 1.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.91 109.8 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.439 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.7 p -51.38 141.97 14.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.918 0.389 . . . . 0.0 111.301 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.66 140.63 44.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.514 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.81 HD21 HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.636 ' CG ' HG13 ' A' ' 38' ' ' VAL . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 76' ' ' LEU . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 132' ' ' ILE . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG13 ' HA2' ' A' ' 136' ' ' GLY . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' O ' HD13 ' A' ' 72' ' ' ILE . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 79' ' ' THR . 95.5 m-20 -62.52 -46.02 90.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 16' ' ' LYS . 1.6 t 169.05 68.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 17.7 t80 -167.09 137.3 2.42 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.6 Cg_endo -73.48 -70.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.5 -0.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.711 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -87.17 -68.28 0.76 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 -151.86 -53.66 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.464 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.408 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 109' ' ' ILE . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 107' ' ' GLY . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HG3' HD11 ' A' ' 97' ' ' ILE . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.485 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 91' ' ' PRO . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.838 ' O ' HG22 ' A' ' 99' ' ' THR . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.764 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.781 HD12 ' HB2' ' A' ' 87' ' ' CYS . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 111' ' ' LEU . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HG3' ' CD2' ' A' ' 82' ' ' TYR . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.75 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.646 HD23 HD22 ' A' ' 31' ' ' LEU . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 59' ' ' ILE . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.622 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.432 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.614 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.614 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.23 -26.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.7 -11.87 60.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.511 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.631 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 21' ' ' THR . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.493 HG21 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 28' ' ' VAL . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' HG23 ' A' ' 26' ' ' VAL . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 24' ' ' GLU . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 ' N ' HG13 ' A' ' 29' ' ' ILE . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.725 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HG2' HD11 ' A' ' 8' ' ' LEU . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 29.5 t80 -139.0 166.3 24.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.809 HG12 ' N ' ' A' ' 49' ' ' SER . 27.5 m -86.6 145.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.736 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' A' ' 42' ' ' TYR . 4.1 m-85 -144.55 -67.47 0.32 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.61 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.551 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 2.4 m-20 50.56 24.55 1.67 Allowed 'General case' 0 N--CA 1.458 -0.064 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.57 77.76 1.35 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.154 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.1 98.6 2.03 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.809 ' N ' HG12 ' A' ' 43' ' ' VAL . 6.2 p -57.35 128.7 38.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.161 0.505 . . . . 0.0 111.271 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -126.44 134.83 50.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.637 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' ND2' HG22 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 76' ' ' LEU . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.573 HD12 HG12 ' A' ' 132' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 72' ' ' ILE . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 89' ' ' VAL . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.677 ' HE3' HD21 ' A' ' 52' ' ' LEU . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 55' ' ' LEU . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' H ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -62.58 -47.4 84.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 t 174.88 40.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.38 134.6 22.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.775 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.97 -19.38 17.63 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.621 -1.408 . . . . 0.0 112.734 -0.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.4 -46.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 -151.9 -56.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.301 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CB ' HD11 ' A' ' 127' ' ' LEU . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 88' ' ' PHE . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.71 ' HB2' HD12 ' A' ' 109' ' ' ILE . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 71' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG2' HG22 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 142' ' ' PHE . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 111' ' ' LEU . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.895 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 87' ' ' CYS . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 102' ' ' HIS . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.559 HD12 ' HG2' ' A' ' 84' ' ' PRO . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.741 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.741 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HD12 ' A' ' 128' ' ' ILE . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 132' ' ' ILE . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 128' ' ' ILE . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 96' ' ' THR . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.611 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.468 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.827 0.346 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.65 -27.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -22.33 46.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.049 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.659 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 12' ' ' VAL . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 15' ' ' TYR . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 18' ' ' ARG . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 28' ' ' VAL . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.407 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.3 t80 -140.12 169.18 18.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG12 ' N ' ' A' ' 49' ' ' SER . 16.1 m -84.35 149.85 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 46' ' ' ASP . 16.7 m-85 -147.27 -67.05 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.489 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -56.67 83.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.881 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' PHE . 63.7 m-20 52.16 24.31 2.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 0.0 111.365 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.47 77.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.531 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -155.55 98.1 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.699 0.285 . . . . 0.0 110.375 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.876 ' N ' HG12 ' A' ' 43' ' ' VAL . 1.9 m -50.82 139.87 16.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.489 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -141.59 135.49 30.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.642 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 52' ' ' LEU . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 35' ' ' LEU . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 38' ' ' VAL . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 132' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 72' ' ' ILE . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.507 HD21 ' CE ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HE3' HD21 ' A' ' 52' ' ' LEU . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 124' ' ' LEU . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.591 HD21 ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' C ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -68.87 49.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER 53.39 24.33 3.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 0.0 111.366 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -112.13 135.03 21.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.73 -19.14 18.8 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.351 0.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -158.97 -45.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.77 125.16 4.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 114' ' ' LEU . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.814 ' CB ' HD12 ' A' ' 109' ' ' ILE . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 107' ' ' GLY . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' HG13 ' A' ' 89' ' ' VAL . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 141' ' ' VAL . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 91' ' ' PRO . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.803 ' O ' HG22 ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.872 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 87' ' ' CYS . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.69 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.721 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.721 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 132' ' ' ILE . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 126' ' ' GLY . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.507 ' CE ' HD21 ' A' ' 74' ' ' LEU . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.662 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 129' ' ' GLN . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 131' ' ' MET . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.424 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.636 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.641 ' HG2' HG21 ' A' ' 92' ' ' THR . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -93.68 -28.24 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -17.66 56.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.443 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.865 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.865 HG21 ' CD2' ' A' ' 15' ' ' TYR . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 28' ' ' VAL . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m-80 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 56' ' ' THR . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.691 ' H ' HD13 ' A' ' 39' ' ' LEU . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 t80 -137.89 160.24 39.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 49' ' ' SER . 33.4 m -84.64 147.3 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.22 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 66.1 m-85 -147.05 -67.65 0.26 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.117 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.57 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.532 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.64 24.8 2.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.391 -0.193 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.76 75.7 1.24 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.13 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.58 106.37 2.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.381 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' HG12 ' A' ' 43' ' ' VAL . 75.8 p -48.07 142.96 4.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -130.0 135.8 48.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.629 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 52' ' ' LEU . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 38' ' ' VAL . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 132' ' ' ILE . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.471 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 71' ' ' PRO . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.402 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 124' ' ' LEU . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' OD2' HD21 ' A' ' 52' ' ' LEU . 1.1 p30 -168.71 31.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 79' ' ' THR . 43.2 m -145.13 11.37 1.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.022 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 44.9 t80 -33.35 140.1 0.24 Allowed Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 122.442 0.297 . . . . 0.0 111.676 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 59.4 Cg_endo -71.91 124.62 8.91 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.729 -1.363 . . . . 0.0 112.737 0.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' N ' ' HA ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -158.84 -40.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.681 ' HB3' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER 64.62 127.56 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.799 ' HG3' HD12 ' A' ' 76' ' ' LEU . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.737 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 107' ' ' GLY . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' HG22 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.827 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.853 ' O ' HG22 ' A' ' 99' ' ' THR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.892 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.763 ' HD2' HD13 ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.803 HD23 ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HG3' HD23 ' A' ' 114' ' ' LEU . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.767 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 76' ' ' LEU . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 127' ' ' LEU . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.939 HG12 HD12 ' A' ' 59' ' ' ILE . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.608 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.726 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.6 -19.32 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.343 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -12.51 60.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 26' ' ' VAL . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG23 ' H ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 18' ' ' ARG . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 8' ' ' LEU . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.622 ' H ' HD13 ' A' ' 39' ' ' LEU . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.6 t80 -138.42 168.15 20.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 49' ' ' SER . 35.9 m -85.8 146.82 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 32.6 m-85 -146.92 -67.22 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.148 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -56.72 84.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.804 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' PHE . 61.8 m-20 52.01 24.83 2.82 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.544 0.527 . . . . 0.0 111.31 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.24 74.49 1.19 Allowed Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.486 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -156.82 112.38 2.9 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.639 0.257 . . . . 0.0 110.604 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.401 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.6 p -51.5 145.06 9.28 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.236 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.79 136.11 28.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.817 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.44 ' HG2' HD22 ' A' ' 39' ' ' LEU . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 132' ' ' ILE . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 61' ' ' VAL . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 89' ' ' VAL . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 71' ' ' PRO . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' HG3' ' A' ' 84' ' ' PRO . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' H ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.3 -58.54 6.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.8 t 179.08 49.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.644 ' O ' HD22 ' A' ' 77' ' ' LEU . 5.5 t80 -174.02 108.48 0.3 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.03 -166.5 2.05 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.315 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.97 0.46 31.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.686 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' O ' HD11 ' A' ' 114' ' ' LEU . 12.9 m120 -150.21 136.78 10.98 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 76' ' ' LEU . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 109' ' ' ILE . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.49 ' HG2' HG22 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' O ' ' A' ' 105' ' ' ALA . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.836 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 138' ' ' GLU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.715 ' O ' HG21 ' A' ' 97' ' ' ILE . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.766 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' A' ' 87' ' ' CYS . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HG3' HD23 ' A' ' 114' ' ' LEU . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 128' ' ' ILE . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 124' ' ' LEU . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.802 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 61' ' ' VAL . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.514 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.721 ' O ' HG13 ' A' ' 141' ' ' VAL . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.87 0.367 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 3' ' ' VAL . 21.2 t -100.67 1.17 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.62 51.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.188 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.634 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' CB ' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 15' ' ' TYR . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.677 ' HB ' HD21 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 27' ' ' ASN . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.415 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.78 HG22 HD12 ' A' ' 125' ' ' LEU . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 35' ' ' LEU . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 29' ' ' ILE . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 56' ' ' THR . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 39' ' ' LEU . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -141.44 169.44 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.778 HG12 ' N ' ' A' ' 49' ' ' SER . 31.0 m -85.94 148.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.564 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.482 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 69.3 m-85 -147.63 -67.49 0.25 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.773 0.32 . . . . 0.0 111.436 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -56.82 85.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.607 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 51.63 24.46 2.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.139 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.45 76.58 1.3 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.5 99.21 2.02 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 110.458 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.778 ' N ' HG12 ' A' ' 43' ' ' VAL . 7.6 t -52.83 130.42 33.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.304 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.772 ' HD3' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.41 134.8 47.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.63 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD12 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 52' ' ' LEU . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.517 HG22 HG13 ' A' ' 38' ' ' VAL . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.867 HD12 HG12 ' A' ' 132' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' A' ' 136' ' ' GLY . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.515 ' O ' HD13 ' A' ' 72' ' ' ILE . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 71' ' ' PRO . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.714 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 52' ' ' LEU . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' NH2' ' A' ' 50' ' ' ARG . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 -65.98 -55.6 15.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.868 HG21 ' CB ' ' A' ' 16' ' ' LYS . 4.0 t 178.48 52.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.536 ' O ' HD13 ' A' ' 77' ' ' LEU . 3.8 m-85 -152.45 132.63 7.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.075 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -32.61 4.45 Favored 'Cis proline' 0 C--N 1.347 0.455 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.241 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.31 -42.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.455 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.869 ' HB3' HD23 ' A' ' 114' ' ' LEU . 6.9 t30 -149.08 131.8 7.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.444 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.714 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.481 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.878 ' O ' HG22 ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 97' ' ' ILE . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 87' ' ' CYS . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 111' ' ' LEU . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 83' ' ' ASN . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.766 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 28' ' ' VAL . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 132' ' ' ILE . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 126' ' ' GLY . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 72' ' ' ILE . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.867 HG12 HD12 ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.45 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.819 0.343 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.87 -26.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -13.39 59.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 8' ' ' LEU . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' CG ' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.56 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.817 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.474 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.565 HG21 ' HD3' ' A' ' 37' ' ' PRO . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 29' ' ' ILE . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.541 HD22 ' CD2' ' A' ' 125' ' ' LEU . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 59' ' ' ILE . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' HG22 ' A' ' 56' ' ' THR . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD3' HG21 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.638 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.638 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.0 t80 -139.55 163.41 32.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.36 146.07 7.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.805 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 47.4 m-85 -146.12 -67.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -57.38 84.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.414 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.2 m-20 51.71 25.02 2.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.484 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.88 74.04 1.15 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.093 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -156.75 111.13 2.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.571 0.224 . . . . 0.0 110.843 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 p -49.07 148.21 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.405 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -141.79 139.12 32.69 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 38' ' ' VAL . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 35' ' ' LEU . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' LYS . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.811 HG12 HD13 ' A' ' 35' ' ' LEU . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.695 HG13 ' HA2' ' A' ' 136' ' ' GLY . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.469 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 89' ' ' VAL . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 73' ' ' CYS . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.513 ' C ' HD23 ' A' ' 74' ' ' LEU . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.704 ' CE3' HD13 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 124' ' ' LEU . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 79' ' ' THR . 3.0 p-10 -62.21 -56.27 20.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 1.6 t 172.03 41.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.19 125.71 22.78 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.71 -20.82 13.69 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.76 -1.35 . . . . 0.0 112.361 0.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -159.17 -38.51 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.42 164.6 22.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 76' ' ' LEU . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 86' ' ' ILE . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 85' ' ' PRO . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.892 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 71' ' ' PRO . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.829 HG21 ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.47 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 141' ' ' VAL . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 99' ' ' THR . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 114' ' ' LEU . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.759 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.759 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.906 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 126' ' ' GLY . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 109' ' ' ILE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 128' ' ' ILE . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' GLN . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' PRO . . . . . 0.829 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.695 ' HD3' HD13 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.469 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.337 0.113 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.554 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.813 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 18' ' ' ARG . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.813 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 27' ' ' ASN . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.4 m120 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 24' ' ' GLU . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.482 HG21 ' HD3' ' A' ' 37' ' ' PRO . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 55' ' ' LEU . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' O ' HG22 ' A' ' 56' ' ' THR . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' HG21 ' A' ' 29' ' ' ILE . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.626 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 35' ' ' LEU . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 36' ' ' LYS . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 72' ' ' ILE . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 59' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.626 ' CE3' HD13 ' A' ' 52' ' ' LEU . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 124' ' ' LEU . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HB2' HD11 ' A' ' 114' ' ' LEU . 1.8 m120 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.703 ' HG3' HD12 ' A' ' 76' ' ' LEU . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 86' ' ' ILE . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 71' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 97' ' ' ILE . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.709 HG21 ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.872 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.559 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.612 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.42 ' CE1' HG11 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.711 ' O ' HG22 ' A' ' 99' ' ' THR . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.767 HD12 ' HB2' ' A' ' 87' ' ' CYS . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 83' ' ' ASN . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 HD22 ' A' ' 83' ' ' ASN . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.904 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 59' ' ' ILE . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.872 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.617 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.709 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.79 0.329 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.737 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.862 ' CE2' HG21 ' A' ' 21' ' ' THR . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.725 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.862 HG21 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 18' ' ' ARG . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 28' ' ' VAL . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.655 HG21 ' CE ' ' A' ' 53' ' ' MET . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD23 ' A' ' 8' ' ' LEU . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.893 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 24' ' ' GLU . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 35' ' ' LEU . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 55' ' ' LEU . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.656 ' CG1' HG22 ' A' ' 56' ' ' THR . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 38' ' ' VAL . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.645 0.259 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.539 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.656 HG22 ' CG1' ' A' ' 38' ' ' VAL . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.676 ' CG2' HD13 ' A' ' 35' ' ' LEU . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 89' ' ' VAL . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.656 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 73' ' ' CYS . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 3.1 t-20 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.528 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 71' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.965 HG21 ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.866 ' HG2' HG22 ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.576 HD11 ' CA ' ' A' ' 107' ' ' GLY . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 108' ' ' LYS . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 97' ' ' ILE . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 87' ' ' CYS . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 109' ' ' ILE . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.768 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.768 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.652 HD11 HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.893 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 70' ' ' ILE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.658 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.965 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.729 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.644 0.259 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.704 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.419 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.739 HG21 ' CD2' ' A' ' 15' ' ' TYR . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 18' ' ' ARG . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.407 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' ASN . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.787 ' OD1' HD22 ' A' ' 125' ' ' LEU . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 24' ' ' GLU . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 35' ' ' LEU . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 125' ' ' LEU . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 128' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.75 ' HA ' HD23 ' A' ' 55' ' ' LEU . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.909 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.825 HD12 ' CD ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.574 ' CG ' HG13 ' A' ' 38' ' ' VAL . 1.1 p30 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 37' ' ' PRO . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.821 HD12 HG12 ' A' ' 132' ' ' ILE . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 136' ' ' GLY . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' B' ' 210' ' ' PRO . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' VAL . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.628 ' N ' HG23 ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' HE3' HD22 ' A' ' 52' ' ' LEU . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 52' ' ' LEU . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.499 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.695 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.879 ' O ' HG22 ' A' ' 99' ' ' THR . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.888 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 87' ' ' CYS . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' N ' HD22 ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 ' OD1' ' A' ' 27' ' ' ASN . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.77 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.749 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.821 HG12 HD12 ' A' ' 59' ' ' ILE . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' B' ' 212' ' ' GLU . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.457 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.374 0.131 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.822 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.5 ' H ' HG23 ' A' ' 12' ' ' VAL . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.843 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 15' ' ' TYR . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 18' ' ' ARG . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 124' ' ' LEU . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.779 HG23 HD21 ' A' ' 55' ' ' LEU . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.653 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 59' ' ' ILE . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG12 HG22 ' A' ' 56' ' ' THR . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 11' ' ' MET . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.707 ' N ' HD13 ' A' ' 39' ' ' LEU . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.701 0.286 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.595 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 38' ' ' VAL . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 25' ' ' THR . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 38' ' ' VAL . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.855 HD12 HG12 ' A' ' 132' ' ' ILE . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.557 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 70' ' ' ILE . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.534 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CE3' HD13 ' A' ' 52' ' ' LEU . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 55' ' ' LEU . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 77' ' ' LEU . 3.9 m-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.744 ' HB3' HD12 ' A' ' 109' ' ' ILE . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 107' ' ' GLY . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.622 ' HD3' HG13 ' A' ' 89' ' ' VAL . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.714 HG21 ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.796 ' HG2' HG22 ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 141' ' ' VAL . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.639 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.578 ' HD2' HD11 ' A' ' 111' ' ' LEU . 50.4 m80 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 97' ' ' ILE . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.762 ' O ' HG22 ' A' ' 99' ' ' THR . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HE2' HG23 ' A' ' 86' ' ' ILE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.799 HG21 ' OH ' ' A' ' 113' ' ' TYR . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.578 HD11 ' HD2' ' A' ' 102' ' ' HIS . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.799 ' OH ' HG21 ' A' ' 109' ' ' ILE . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.855 HG12 HD12 ' A' ' 59' ' ' ILE . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 102' ' ' HIS . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' B' ' 212' ' ' GLU . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.796 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.633 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.714 ' HG2' HG21 ' A' ' 92' ' ' THR . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.462 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.596 0.236 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 22' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.673 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.701 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.792 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.792 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 9' ' ' LYS . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.641 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' VAL . 2.1 t30 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HG22 ' A' ' 56' ' ' THR . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 120.656 0.265 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.405 HG22 HG12 ' A' ' 38' ' ' VAL . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 132' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 136' ' ' GLY . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 59' ' ' ILE . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 72' ' ' ILE . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.655 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.453 ' CE3' HD13 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 124' ' ' LEU . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.544 ' H ' HD13 ' A' ' 77' ' ' LEU . 14.8 m-20 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 m-20 . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.705 ' HG3' HD12 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 109' ' ' ILE . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.439 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.414 ' HB2' ' OG1' ' A' ' 92' ' ' THR . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 141' ' ' VAL . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.588 HG21 ' O ' ' A' ' 104' ' ' ASP . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 104' ' ' ASP . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 99' ' ' THR . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.86 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 87' ' ' CYS . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 115' ' ' HIS . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.775 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 28' ' ' VAL . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.82 HG12 HD12 ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 12' ' ' VAL . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.678 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' ARG . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 28' ' ' VAL . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 27' ' ' ASN . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.9 m120 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 35' ' ' LEU . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.94 HD23 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.94 ' HA ' HD23 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' HG13 ' A' ' 38' ' ' VAL . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.632 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 124' ' ' LEU . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 77' ' ' LEU . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 77' ' ' LEU . 1.4 t-20 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.561 0.219 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.5 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.737 ' HG2' HG22 ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' HG23 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.946 ' CD2' HD12 ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 99' ' ' THR . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.441 ' CZ2' ' CD2' ' A' ' 119' ' ' HIS . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.754 HG22 HD11 ' A' ' 132' ' ' ILE . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.666 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 128' ' ' ILE . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.74 ' O ' ' HB1' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.428 ' CD ' HD13 ' A' ' 70' ' ' ILE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.45 0.167 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.657 ' HG2' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.6 ' HE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.6 HG21 ' HE1' ' A' ' 15' ' ' TYR . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 18' ' ' ARG . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 37' ' ' PRO . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 29' ' ' ILE . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 125' ' ' LEU . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.859 HG22 ' HB3' ' A' ' 35' ' ' LEU . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 29' ' ' ILE . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 56' ' ' THR . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 29' ' ' ILE . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 40' ' ' ASP . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.876 ' N ' HD23 ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.68 HH11 HD12 ' A' ' 52' ' ' LEU . 9.3 ttm180 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 77' ' ' LEU . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.639 ' HG3' HD12 ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 36' ' ' LYS . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 72' ' ' ILE . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 89' ' ' VAL . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 59' ' ' ILE . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.553 ' O ' HD22 ' A' ' 74' ' ' LEU . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.606 ' CE3' HD22 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD21 HD21 ' A' ' 124' ' ' LEU . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 52' ' ' LEU . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.579 0.228 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 74' ' ' LEU . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 74' ' ' LEU . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.795 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.882 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.87 ' HG2' HG22 ' A' ' 141' ' ' VAL . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.458 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.527 ' CD2' HD11 ' A' ' 111' ' ' LEU . 56.8 m80 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.57 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.684 HD12 ' HB2' ' A' ' 87' ' ' CYS . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 102' ' ' HIS . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.435 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.795 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 59' ' ' ILE . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.87 HG22 ' HG2' ' A' ' 95' ' ' MET . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.644 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.882 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' HD12 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.448 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.669 0.271 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' A' ' 26' ' ' VAL . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.67 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.795 HG23 HD21 ' A' ' 55' ' ' LEU . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 26' ' ' VAL . 3.0 m120 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.569 HG21 ' HD3' ' A' ' 37' ' ' PRO . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 125' ' ' LEU . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 59' ' ' ILE . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' HG21 ' A' ' 29' ' ' ILE . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 11' ' ' MET . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 52' ' ' LEU . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.698 ' CG ' HG13 ' A' ' 38' ' ' VAL . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.795 HD21 HG23 ' A' ' 25' ' ' THR . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 35' ' ' LEU . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD12 ' HD3' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' VAL . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.723 0.296 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.598 ' HG3' HD12 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.9 ' HB2' HD12 ' A' ' 109' ' ' ILE . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 141' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.819 HG21 ' HG2' ' B' ' 207' ' ' PRO . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.727 ' HG2' HG22 ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.409 ' C ' HG23 ' A' ' 141' ' ' VAL . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CD2' HD21 ' A' ' 111' ' ' LEU . 41.0 m80 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.911 ' O ' HG22 ' A' ' 99' ' ' THR . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 87' ' ' CYS . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' CD2' ' A' ' 102' ' ' HIS . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.77 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 28' ' ' VAL . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 132' ' ' ILE . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.553 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.73 HG12 HD12 ' A' ' 59' ' ' ILE . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.737 HG21 ' HB3' ' A' ' 91' ' ' PRO . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.819 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.712 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 70' ' ' ILE . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.719 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.448 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 12' ' ' VAL . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.73 ' CE1' HG12 ' A' ' 12' ' ' VAL . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.742 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.695 HG21 ' CD2' ' A' ' 15' ' ' TYR . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 18' ' ' ARG . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.55 ' CG2' HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 27' ' ' ASN . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.694 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.4 m120 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.43 ' HG3' HD11 ' A' ' 8' ' ' LEU . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' HG13 ' A' ' 38' ' ' VAL . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 61' ' ' VAL . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CZ3' ' CG ' ' A' ' 40' ' ' ASP . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 52' ' ' LEU . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.1 m120 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.636 0.255 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.768 ' HG3' HD11 ' A' ' 124' ' ' LEU . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HB2' HD12 ' A' ' 109' ' ' ILE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.427 ' CG ' HG22 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.511 ' HA ' HG23 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 134' ' ' VAL . 3.9 m170 -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.887 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.438 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.768 HD11 ' HG3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 72' ' ' ILE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 59' ' ' ILE . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.688 HG11 ' CE1' ' A' ' 102' ' ' HIS . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.451 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.726 0.298 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 25' ' ' THR . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.497 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.874 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 18' ' ' ARG . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.858 HG21 HD21 ' A' ' 8' ' ' LEU . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD23 ' A' ' 55' ' ' LEU . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' HD13 ' A' ' 39' ' ' LEU . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.695 0.283 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.8 HD21 HG23 ' A' ' 25' ' ' THR . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.943 HD12 HG12 ' A' ' 132' ' ' ILE . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.459 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 89' ' ' VAL . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.507 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.517 ' CB ' HD11 ' A' ' 114' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.675 0.274 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.62 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.839 ' HB2' HD12 ' A' ' 109' ' ' ILE . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.793 HG13 ' HD3' ' A' ' 91' ' ' PRO . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.793 ' HD3' HG13 ' A' ' 89' ' ' VAL . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.822 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.82 ' HG2' HG22 ' A' ' 141' ' ' VAL . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.473 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.69 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.664 ' CD2' HD23 ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.86 ' O ' HG22 ' A' ' 99' ' ' THR . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.839 HD12 ' HB2' ' A' ' 87' ' ' CYS . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.507 ' CD1' HD12 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.843 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 28' ' ' VAL . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.753 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD12 ' A' ' 59' ' ' ILE . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 129' ' ' GLN . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.607 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.62 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.822 ' HG2' HG21 ' A' ' 92' ' ' THR . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.459 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.965 0.412 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 39' ' ' LEU . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.741 ' CE1' HG12 ' A' ' 12' ' ' VAL . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' HD2' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.688 HG21 ' CD2' ' A' ' 15' ' ' TYR . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.445 HG23 HD21 ' A' ' 55' ' ' LEU . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 27' ' ' ASN . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.648 HD21 HG23 ' A' ' 59' ' ' ILE . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 56' ' ' THR . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.885 HD11 ' HG2' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.61 ' NH1' HD12 ' A' ' 77' ' ' LEU . 4.1 ttm180 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.885 ' HG2' HD11 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.51 ' CE ' HD23 ' A' ' 76' ' ' LEU . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG23 ' A' ' 25' ' ' THR . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 38' ' ' VAL . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.932 HD12 HG12 ' A' ' 132' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 72' ' ' ILE . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 71' ' ' PRO . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 72' ' ' ILE . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HE3' HD21 ' A' ' 52' ' ' LEU . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 114' ' ' LEU . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 74' ' ' LEU . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' A' ' 141' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.678 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.818 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.763 ' CD2' HD21 ' A' ' 111' ' ' LEU . 21.0 m80 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.818 ' O ' HG22 ' A' ' 99' ' ' THR . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 111' ' ' LEU . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.763 HD21 ' CD2' ' A' ' 102' ' ' HIS . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 28' ' ' VAL . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 132' ' ' ILE . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.742 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.932 HG12 HD12 ' A' ' 59' ' ' ILE . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 102' ' ' HIS . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' OE1' ' CG ' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.627 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.669 ' HG2' HG21 ' A' ' 92' ' ' THR . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.575 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.488 ' OE2' HD11 ' A' ' 29' ' ' ILE . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.811 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.584 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.435 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 15' ' ' TYR . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 125' ' ' LEU . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.488 HD11 ' OE2' ' A' ' 5' ' ' GLU . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.768 0.318 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 76' ' ' LEU . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.813 ' SD ' HD22 ' A' ' 76' ' ' LEU . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 35' ' ' LEU . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.566 HG22 ' CG1' ' A' ' 38' ' ' VAL . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.899 HD12 HG12 ' A' ' 132' ' ' ILE . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 136' ' ' GLY . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 72' ' ' ILE . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 71' ' ' PRO . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.813 HD22 ' SD ' ' A' ' 53' ' ' MET . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' OD1' HD21 ' A' ' 52' ' ' LEU . 1.2 p-10 . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.753 ' HB3' HD11 ' A' ' 114' ' ' LEU . 1.2 t-20 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 76' ' ' LEU . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.81 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 89' ' ' VAL . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.808 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.591 ' HA ' HG23 ' A' ' 103' ' ' VAL . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.685 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.481 ' CE1' HG23 ' A' ' 109' ' ' ILE . 5.3 t-80 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.883 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.81 HD12 ' HB2' ' A' ' 87' ' ' CYS . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 101' ' ' LYS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 83' ' ' ASN . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 132' ' ' ILE . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.83 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 109' ' ' ILE . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.899 HG12 HD12 ' A' ' 59' ' ' ILE . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 70' ' ' ILE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.808 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.626 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 22' ' ' VAL . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.456 ' HE2' HD23 ' A' ' 39' ' ' LEU . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CD2' HG21 ' A' ' 21' ' ' THR . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 22' ' ' VAL . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.631 HG21 ' CD2' ' A' ' 15' ' ' TYR . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 18' ' ' ARG . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 28' ' ' VAL . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.643 HG23 HD21 ' A' ' 55' ' ' LEU . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 125' ' ' LEU . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 24' ' ' GLU . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 35' ' ' LEU . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 55' ' ' LEU . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.415 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.549 ' ND2' HG13 ' A' ' 38' ' ' VAL . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 HG23 ' A' ' 25' ' ' THR . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 70' ' ' ILE . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 132' ' ' ILE . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.473 ' CE1' ' HD2' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 59' ' ' ILE . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.551 ' CE3' HD13 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 84' ' ' PRO . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD12 HD21 ' A' ' 52' ' ' LEU . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.461 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 3.7 m-20 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.825 ' HG3' HD12 ' A' ' 76' ' ' LEU . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.917 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.624 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.474 ' HE3' ' HB2' ' B' ' 207' ' ' PRO . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.593 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.831 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 111' ' ' LEU . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 104' ' ' ASP . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.831 ' O ' HG22 ' A' ' 99' ' ' THR . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.948 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 87' ' ' CYS . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.796 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.796 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.774 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.774 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 76' ' ' LEU . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 132' ' ' ILE . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.784 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.63 ' SD ' HD13 ' A' ' 109' ' ' ILE . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.771 HD11 HG22 ' A' ' 128' ' ' ILE . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.734 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.506 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.456 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.85 ' CD2' HG21 ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.85 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 18' ' ' ARG . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 125' ' ' LEU . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 24' ' ' GLU . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 37' ' ' PRO . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.646 HD22 HD23 ' A' ' 125' ' ' LEU . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.526 ' HA ' HD23 ' A' ' 55' ' ' LEU . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.838 HD13 ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.838 ' N ' HD13 ' A' ' 39' ' ' LEU . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.81 HD21 HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.636 ' CG ' HG13 ' A' ' 38' ' ' VAL . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 76' ' ' LEU . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 132' ' ' ILE . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG13 ' HA2' ' A' ' 136' ' ' GLY . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' O ' HD13 ' A' ' 72' ' ' ILE . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.408 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 109' ' ' ILE . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 107' ' ' GLY . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HG3' HD11 ' A' ' 97' ' ' ILE . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.485 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 91' ' ' PRO . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.567 ' HD2' HD11 ' A' ' 111' ' ' LEU . 49.7 m80 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.838 ' O ' HG22 ' A' ' 99' ' ' THR . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.764 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.781 HD12 ' HB2' ' A' ' 87' ' ' CYS . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.567 HD11 ' HD2' ' A' ' 102' ' ' HIS . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 111' ' ' LEU . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.75 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.646 HD23 HD22 ' A' ' 31' ' ' LEU . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 59' ' ' ILE . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.622 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.432 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.614 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.614 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.511 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.631 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 21' ' ' THR . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.493 HG21 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 28' ' ' VAL . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' HG23 ' A' ' 26' ' ' VAL . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 24' ' ' GLU . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 ' N ' HG13 ' A' ' 29' ' ' ILE . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.725 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HG2' HD11 ' A' ' 8' ' ' LEU . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.791 0.329 . . . . 0.0 110.637 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' ND2' HG22 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 76' ' ' LEU . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.573 HD12 HG12 ' A' ' 132' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 72' ' ' ILE . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 89' ' ' VAL . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.677 ' HE3' HD21 ' A' ' 52' ' ' LEU . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 55' ' ' LEU . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' H ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.301 0.112 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CB ' HD11 ' A' ' 127' ' ' LEU . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 88' ' ' PHE . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.71 ' HB2' HD12 ' A' ' 109' ' ' ILE . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 71' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG2' HG22 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 142' ' ' PHE . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 111' ' ' LEU . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.895 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 87' ' ' CYS . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 102' ' ' HIS . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.559 HD12 ' HG2' ' A' ' 84' ' ' PRO . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.741 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.741 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HD12 ' A' ' 128' ' ' ILE . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 132' ' ' ILE . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 128' ' ' ILE . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.521 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 96' ' ' THR . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.611 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.468 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.693 0.282 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.659 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 12' ' ' VAL . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 15' ' ' TYR . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 18' ' ' ARG . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 28' ' ' VAL . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.591 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.855 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 52' ' ' LEU . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 35' ' ' LEU . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 38' ' ' VAL . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 132' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 72' ' ' ILE . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.507 HD21 ' CE ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HE3' HD21 ' A' ' 52' ' ' LEU . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 124' ' ' LEU . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.591 HD21 ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.515 0.198 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 114' ' ' LEU . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.814 ' CB ' HD12 ' A' ' 109' ' ' ILE . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 107' ' ' GLY . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' HG13 ' A' ' 89' ' ' VAL . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 141' ' ' VAL . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 91' ' ' PRO . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.803 ' O ' HG22 ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.872 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 87' ' ' CYS . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.69 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.721 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.721 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 132' ' ' ILE . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 126' ' ' GLY . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.507 ' CE ' HD21 ' A' ' 74' ' ' LEU . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.662 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 129' ' ' GLN . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 131' ' ' MET . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.424 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.636 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.641 ' HG2' HG21 ' A' ' 92' ' ' THR . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.518 0.199 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.865 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.865 HG21 ' CD2' ' A' ' 15' ' ' TYR . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 28' ' ' VAL . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.569 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.6 m120 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 56' ' ' THR . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.691 ' H ' HD13 ' A' ' 39' ' ' LEU . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 52' ' ' LEU . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 38' ' ' VAL . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 132' ' ' ILE . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.471 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 71' ' ' PRO . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.402 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 124' ' ' LEU . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' OD2' HD21 ' A' ' 52' ' ' LEU . 1.1 p30 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.681 ' HB3' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.627 0.251 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.799 ' HG3' HD12 ' A' ' 76' ' ' LEU . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.737 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 107' ' ' GLY . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' HG22 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.827 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.2 m170 -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.853 ' O ' HG22 ' A' ' 99' ' ' THR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.892 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.763 ' HD2' HD13 ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.803 HD23 ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HG3' HD23 ' A' ' 114' ' ' LEU . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.767 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 76' ' ' LEU . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 127' ' ' LEU . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.939 HG12 HD12 ' A' ' 59' ' ' ILE . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.422 HG11 ' CE1' ' A' ' 102' ' ' HIS . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.608 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.726 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.596 0.236 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 26' ' ' VAL . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG23 ' H ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 18' ' ' ARG . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 8' ' ' LEU . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.622 ' H ' HD13 ' A' ' 39' ' ' LEU . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.6 t80 . . . . . 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.44 ' HG2' HD22 ' A' ' 39' ' ' LEU . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 132' ' ' ILE . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 61' ' ' VAL . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 89' ' ' VAL . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 71' ' ' PRO . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' HG3' ' A' ' 84' ' ' PRO . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' H ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' O ' HD11 ' A' ' 114' ' ' LEU . 12.9 m120 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 76' ' ' LEU . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 109' ' ' ILE . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.49 ' HG2' HG22 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' O ' ' A' ' 105' ' ' ALA . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.836 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 138' ' ' GLU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.715 ' O ' HG21 ' A' ' 97' ' ' ILE . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.766 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' A' ' 87' ' ' CYS . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HG3' HD23 ' A' ' 114' ' ' LEU . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 128' ' ' ILE . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 124' ' ' LEU . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.802 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 61' ' ' VAL . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.514 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.721 ' O ' HG13 ' A' ' 141' ' ' VAL . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.619 0.247 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.634 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 15' ' ' TYR . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.677 ' HB ' HD21 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 27' ' ' ASN . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.415 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.78 HG22 HD12 ' A' ' 125' ' ' LEU . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 35' ' ' LEU . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 29' ' ' ILE . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 56' ' ' THR . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 39' ' ' LEU . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.772 ' HD3' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD12 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 52' ' ' LEU . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.517 HG22 HG13 ' A' ' 38' ' ' VAL . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.867 HD12 HG12 ' A' ' 132' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' A' ' 136' ' ' GLY . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.515 ' O ' HD13 ' A' ' 72' ' ' ILE . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 71' ' ' PRO . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.714 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 52' ' ' LEU . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' NH2' ' A' ' 50' ' ' ARG . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.869 ' HB3' HD23 ' A' ' 114' ' ' LEU . 6.9 t30 . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.714 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.481 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.452 ' CD2' HD23 ' A' ' 111' ' ' LEU . 9.5 m80 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.878 ' O ' HG22 ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 97' ' ' ILE . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 87' ' ' CYS . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 111' ' ' LEU . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 83' ' ' ASN . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.766 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 28' ' ' VAL . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 132' ' ' ILE . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 126' ' ' GLY . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 72' ' ' ILE . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.867 HG12 HD12 ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.45 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.524 -0.046 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' CG ' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.56 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.817 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.474 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.565 HG21 ' HD3' ' A' ' 37' ' ' PRO . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 29' ' ' ILE . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.541 HD22 ' CD2' ' A' ' 125' ' ' LEU . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 59' ' ' ILE . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' HG22 ' A' ' 56' ' ' THR . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD3' HG21 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.638 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.638 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 38' ' ' VAL . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 35' ' ' LEU . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' LYS . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG12 HD13 ' A' ' 35' ' ' LEU . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.695 HG13 ' HA2' ' A' ' 136' ' ' GLY . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.469 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 89' ' ' VAL . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 73' ' ' CYS . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.513 ' C ' HD23 ' A' ' 74' ' ' LEU . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.704 ' CE3' HD13 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 124' ' ' LEU . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 76' ' ' LEU . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 86' ' ' ILE . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 85' ' ' PRO . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.892 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 71' ' ' PRO . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.829 HG21 ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.47 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 141' ' ' VAL . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 99' ' ' THR . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 114' ' ' LEU . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.759 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.759 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.906 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 126' ' ' GLY . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 109' ' ' ILE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 128' ' ' ILE . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' GLN . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' PRO . . . . . 0.829 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.695 ' HD3' HD13 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.469 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.78 -23.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -16.74 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.108 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -52.65 -45.95 66.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.852 0.358 . . . . 0.0 110.971 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.5 -47.35 85.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.698 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -27.07 63.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.689 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.4 tp -58.63 -50.66 73.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.924 0.392 . . . . 0.0 110.549 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -55.0 -43.83 73.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -71.2 -24.9 62.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.958 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.554 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.24 -22.19 64.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.113 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.813 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.07 -81.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.889 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 18' ' ' ARG . 1.5 m 54.47 28.92 10.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.733 0.302 . . . . 0.0 111.379 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -153.38 -1.28 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.813 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.88 161.93 30.21 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.668 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -36.72 82.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.18 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -140.23 72.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 29.9 mtm-85 -47.96 -50.41 27.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.343 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.77 -55.47 34.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -81.64 -47.37 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.0 t -61.87 -46.47 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.91 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -59.61 -44.33 93.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.2 mm-40 -62.09 -43.47 98.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.1 m -59.42 -58.82 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.912 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 27' ' ' ASN . 28.1 m -54.22 -42.58 57.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.4 m120 -55.78 -40.67 72.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.242 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 24' ' ' GLU . 43.2 t -63.18 -49.32 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.482 HG21 ' HD3' ' A' ' 37' ' ' PRO . 38.6 pt -73.07 -32.21 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.9 m -67.7 -26.21 66.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.19 -43.05 10.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -80.65 -48.85 12.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 0.83 2.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -114.11 -24.12 9.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.749 0.309 . . . . 0.0 110.992 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 55' ' ' LEU . 1.2 tp -87.06 156.21 19.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' O ' HG22 ' A' ' 56' ' ' THR . 3.7 mtpt -150.34 134.89 9.48 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' HG21 ' A' ' 29' ' ' ILE . 35.5 Cg_endo -65.75 122.94 10.67 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.32 2.013 . . . . 0.0 112.528 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.3 p -106.43 143.04 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.633 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -91.26 148.71 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.559 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 t -164.94 128.51 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.194 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 9.1 t80 -138.76 168.7 19.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.686 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 49' ' ' SER . 27.1 m -85.98 144.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 56.1 m-85 -146.52 -67.07 0.28 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.733 0.302 . . . . 0.0 111.5 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -56.18 85.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.746 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.76 25.07 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.82 74.89 1.26 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.208 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 112.82 2.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.628 0.251 . . . . 0.0 110.705 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 43' ' ' VAL . 14.8 p -48.55 143.32 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.453 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -139.93 139.83 36.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.36 119.71 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.626 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -141.98 110.84 6.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -80.1 158.15 26.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.912 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.1 p-10 -148.28 166.7 27.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.772 HD12 HD23 ' A' ' 35' ' ' LEU . 3.3 mm? -100.13 144.62 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.272 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 36' ' ' LYS . 12.2 t -147.4 163.04 37.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.12 165.14 12.42 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -92.0 127.01 37.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 72' ' ' ILE . 5.3 mt -94.61 136.83 22.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 42.8 Cg_endo -68.43 116.55 4.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.348 2.032 . . . . 0.0 112.625 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.3 t -109.17 105.82 57.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 69.9 Cg_endo -76.38 129.97 11.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.845 2.364 . . . . 0.0 112.554 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -101.86 -161.32 0.85 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -55.27 -27.82 49.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.64 25.55 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.641 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 31.2 m-80 -144.17 -173.4 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.332 . . . . 0.0 110.629 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -157.85 109.67 2.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.751 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 10.9 m-85 -97.35 -175.99 3.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.5 OUTLIER -120.01 92.66 3.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.555 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -74.01 127.63 87.79 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.397 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.4 Cg_endo -84.43 130.47 4.57 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.618 2.212 . . . . 0.0 112.159 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 59' ' ' ILE . 15.8 mt -148.57 161.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 0.0 111.679 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 16.2 t -157.64 129.03 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.46 145.58 37.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.98 0.419 . . . . 0.0 111.495 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.626 ' CE3' HD13 ' A' ' 52' ' ' LEU . 32.4 m95 -81.34 131.03 35.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 124' ' ' LEU . 5.0 tp -96.91 101.42 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.3 mt -69.9 168.91 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 2.5 p-10 -62.35 -56.44 18.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 1.6 t 171.94 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -142.48 133.75 12.95 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.88 -23.92 11.42 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.859 -1.309 . . . . 0.0 111.979 0.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.12 -40.18 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HB2' HD11 ' A' ' 114' ' ' LEU . 1.8 m120 -148.69 166.17 16.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.755 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.703 ' HG3' HD12 ' A' ' 76' ' ' LEU . 35.4 Cg_endo -65.1 110.27 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.647 2.232 . . . . 0.0 112.423 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 86' ' ' ILE . 98.1 Cg_endo -79.36 -30.36 2.61 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.525 2.15 . . . . 0.0 112.32 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.4 mp -64.43 113.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.37 123.29 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.367 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.84 153.27 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 71' ' ' PRO . 12.4 p -93.99 142.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 92.74 5.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.122 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 97' ' ' ILE . 97.3 Cg_endo -82.36 135.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.666 2.244 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.709 HG21 ' HG2' ' B' ' 207' ' ' PRO . 62.3 p -77.86 165.23 24.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -55.19 -28.65 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -98.57 6.27 47.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.488 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.872 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.6 ttm -93.89 166.83 11.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 0.0 110.771 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.559 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.68 111.53 8.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 111.572 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.612 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.1 mt -70.76 136.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.5 121.64 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.1 p -70.22 142.42 52.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -178.39 176.7 48.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.147 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -26.98 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.467 -0.431 . . . . 0.0 111.17 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.42 ' CE1' HG11 ' A' ' 134' ' ' VAL . 78.4 m-70 -97.03 3.22 52.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 100' ' ' GLY . 43.5 t -155.73 135.47 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.181 0.515 . . . . 0.0 111.584 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.711 ' O ' HG22 ' A' ' 99' ' ' THR . 0.8 OUTLIER -85.54 -63.31 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.463 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.39 -26.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.01 9.56 37.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.719 0.295 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 92.74 -12.6 69.49 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.027 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -68.85 137.73 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.767 HD12 ' HB2' ' A' ' 87' ' ' CYS . 15.5 mt -81.11 132.89 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.04 -164.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.632 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER 68.93 149.12 0.12 Allowed Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.86 -46.27 8.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.649 2.233 . . . . 0.0 112.242 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 63.97 -80.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 83' ' ' ASN . 1.1 tt -72.44 -44.58 62.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -63.01 -14.23 45.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.81 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -95.06 -58.83 2.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.109 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 24.0 t-105 -75.18 -86.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.064 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.6 OUTLIER 44.84 56.32 5.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 111.484 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -73.9 -39.23 4.27 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 47.7 Cg_endo -71.32 -56.69 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.761 -1.349 . . . . 0.0 113.099 0.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 4.1 mm100 70.48 -53.5 0.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.385 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 130.76 35.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.96 -179.52 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -42.09 -49.04 4.8 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.331 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -68.95 -38.58 79.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.685 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.75 79.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 HD22 ' A' ' 83' ' ' ASN . 1.7 tt -58.04 -64.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.78 -30.3 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.904 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.28 80.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.25 -48.64 84.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -58.68 -38.75 78.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.846 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 59' ' ' ILE . 87.3 mt -66.79 -38.69 82.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.3 t -66.44 -52.36 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.315 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 102' ' ' HIS . 48.6 t -61.65 -51.85 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 7.8 m-30 -67.52 -9.17 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.672 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.47 -29.08 66.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.442 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.93 -46.45 3.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.758 0.313 . . . . 0.0 110.739 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.41 111.07 43.35 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.18 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 37.3 Cg_endo -65.28 110.09 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.751 2.3 . . . . 0.0 111.814 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 84.1 Cg_endo -77.42 -33.58 2.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.47 2.114 . . . . 0.0 112.788 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.872 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.9 p -155.42 91.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.5 p90 -90.32 131.51 36.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.114 0.483 . . . . 0.0 111.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB2' ' HG3' ' A' ' 95' ' ' MET . 31.3 t -89.06 166.64 13.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.853 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.94 149.13 82.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 122.61 2.206 . . . . 0.0 112.308 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 N-CA-C 111.532 -0.219 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.617 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.73 171.84 0.97 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.455 0.645 . . . . 0.0 111.109 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.709 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.5 Cg_endo -93.14 -79.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 123.624 2.882 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.04 -55.87 0.3 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.613 178.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.52 158.59 0.07 OUTLIER Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 120.573 0.225 . . . . 0.0 111.37 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.4 Cg_exo -66.68 154.72 73.46 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.849 2.366 . . . . 0.0 112.332 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 73.7 Cg_endo -77.53 177.28 9.02 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.582 2.188 . . . . 0.0 112.537 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.83 -138.56 0.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.288 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.818 0.342 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.11 -47.13 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -79.0 -50.17 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.13 -46.22 68.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -59.57 -46.63 88.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 110.595 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.01 -28.77 65.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.001 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.04 -46.09 90.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.708 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -71.69 -21.27 61.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.729 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 7.9 mtm -63.97 -21.97 66.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.035 0.445 . . . . 0.0 111.335 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.737 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.57 -85.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.59 -54.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -0.23 26.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.862 ' CE2' HG21 ' A' ' 21' ' ' THR . 2.0 m-85 -68.84 141.08 55.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.844 ' CB ' HG21 ' A' ' 79' ' ' THR . 26.6 tttt -58.83 -29.92 67.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.16 0.505 . . . . 0.0 109.894 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -140.27 49.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.725 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -45.6 -37.3 5.44 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.075 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.56 -58.04 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.759 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.22 -27.24 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.862 HG21 ' CE2' ' A' ' 15' ' ' TYR . 32.3 m -77.23 -49.37 15.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 18' ' ' ARG . 79.8 t -59.25 -46.18 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -45.25 92.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.454 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 28' ' ' VAL . 79.9 mt-10 -63.78 -43.5 96.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.162 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.655 HG21 ' CE ' ' A' ' 53' ' ' MET . 13.6 m -60.51 -58.08 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.868 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD23 ' A' ' 8' ' ' LEU . 35.7 m -52.94 -40.68 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.014 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.893 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.57 -44.75 81.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 24' ' ' GLU . 45.6 t -63.43 -55.2 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 35' ' ' LEU . 27.2 pt -63.08 -37.62 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.9 m -67.15 -34.25 77.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.47 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -80.98 -35.28 32.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE1' ' HB ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -77.93 -56.4 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 80.88 -8.31 1.46 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.573 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -117.4 -24.18 7.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.723 0.297 . . . . 0.0 111.167 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -87.21 104.64 16.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.94 142.72 27.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 55' ' ' LEU . 97.6 Cg_endo -78.99 140.77 16.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.707 2.271 . . . . 0.0 112.046 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.656 ' CG1' HG22 ' A' ' 56' ' ' THR . 1.4 m -139.03 138.77 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 111.182 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 53' ' ' MET . 0.7 OUTLIER -92.89 154.52 18.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 38' ' ' VAL . 5.0 m-20 -157.54 116.56 3.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 t -76.79 95.59 4.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.37 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -104.04 143.81 32.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.42 148.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 50' ' ' ARG . 81.5 m-85 -148.96 -67.44 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.963 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.406 ' CB ' ' HB2' ' A' ' 48' ' ' SER . 1.2 m-80 -58.76 83.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 54.62 23.29 4.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.326 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.5 13.54 24.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.742 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -81.31 124.72 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.322 -0.516 . . . . 0.0 110.845 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.7 p -73.14 144.72 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.01 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -150.31 145.53 26.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.79 101.36 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.0 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.5 tm? -98.66 115.06 27.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.655 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -80.58 134.14 35.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' TRP . 1.4 p-10 -149.18 172.21 15.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.236 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -134.75 145.06 48.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.215 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.656 HG22 ' CG1' ' A' ' 38' ' ' VAL . 13.0 t -144.63 154.27 42.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.744 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.45 176.88 22.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.686 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -91.33 113.03 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.283 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.676 ' CG2' HD13 ' A' ' 35' ' ' LEU . 19.9 pt -93.21 145.37 29.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 32' ' ' TYR . 59.4 Cg_endo -72.09 117.45 5.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.683 2.255 . . . . 0.0 112.65 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.6 t -127.2 113.04 21.55 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 47.5 Cg_endo -69.39 127.03 14.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.721 2.281 . . . . 0.0 112.135 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.5 t80 -110.72 -168.76 1.35 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -56.51 -16.33 5.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.868 0.366 . . . . 0.0 110.648 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.04 -57.72 0.3 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.457 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -154.85 -177.03 6.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.634 0.731 . . . . 0.0 111.885 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -83.43 117.2 22.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.13 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 21.2 m-85 -96.78 162.94 13.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -98.46 76.29 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.373 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -74.56 125.31 89.82 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 89' ' ' VAL . 87.8 Cg_endo -78.38 138.17 15.5 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.516 2.144 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.34 178.29 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.029 0.443 . . . . 0.0 111.355 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.656 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.1 t -156.87 137.8 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 73' ' ' CYS . 1.6 mm? -136.75 125.17 23.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 8.4 m95 -86.64 110.29 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -94.82 105.87 17.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.145 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -71.61 174.59 6.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 1.1 m-20 -63.04 -56.25 18.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.844 HG21 ' CB ' ' A' ' 16' ' ' LYS . 2.7 t -178.22 47.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -152.13 145.9 18.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 3.1 Cg_exo -76.18 -28.41 7.63 Favored 'Cis proline' 0 C--N 1.347 0.45 0 C-N-CA 123.682 -1.383 . . . . 0.0 112.663 -0.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -158.97 -37.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 3.1 t-20 -146.67 140.15 14.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 76' ' ' LEU . 10.4 Cg_endo -53.49 106.43 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.761 2.307 . . . . 0.0 112.524 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' ILE . 84.5 Cg_endo -85.09 -100.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.647 2.231 . . . . 0.0 112.258 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mt 12.33 109.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.528 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.1 m -136.94 121.09 17.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -148.64 152.2 36.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.005 0.431 . . . . 0.0 111.276 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 71' ' ' PRO . 8.4 p -97.57 130.18 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.33 106.6 24.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.907 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 2.8 Cg_endo -79.49 148.09 20.47 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.61 2.207 . . . . 0.0 112.131 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.965 HG21 ' HG2' ' B' ' 207' ' ' PRO . 40.1 p -77.73 -73.08 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.023 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -39.38 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.359 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -92.12 6.87 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.955 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.866 ' HG2' HG22 ' A' ' 141' ' ' VAL . 2.7 ttm -88.02 168.77 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.755 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.82 121.84 16.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.576 HD11 ' CA ' ' A' ' 107' ' ' GLY . 1.1 mt -69.18 128.14 32.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -102.83 109.69 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 104' ' ' ASP . 61.1 p -71.26 131.66 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.36 34.91 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.43 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -23.6 23.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.627 0.251 . . . . 0.0 111.333 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -94.32 -10.15 33.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 108' ' ' LYS . 61.3 t -156.26 135.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 111.068 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 99' ' ' THR . 11.7 m-20 -85.32 -62.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.03 41.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.171 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 8.39 9.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.482 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 97' ' ' ILE . . . 63.14 39.42 97.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.977 -1.106 . . . . 0.0 111.673 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 2.2 pttp -162.72 167.87 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 111.271 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 87' ' ' CYS . 3.0 mt -80.4 141.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.079 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -96.22 -28.41 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.193 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.14 134.35 80.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 114' ' ' LEU . 30.0 Cg_endo -63.86 -38.65 37.64 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.163 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 109' ' ' ILE . 4.8 m-85 65.62 -69.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 112' ' ' PRO . 0.8 OUTLIER -71.29 -49.15 45.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.711 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -15.23 52.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -67.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 18.7 t-105 -74.37 -89.77 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.827 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 1.3 ptpt 45.28 55.47 6.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.092 0.472 . . . . 0.0 111.373 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.768 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -73.75 -38.02 3.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.768 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 53.1 Cg_endo -71.74 -55.96 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.661 0 C-N-CA 123.993 -1.253 . . . . 0.0 113.148 0.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER 69.63 -60.25 0.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.978 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.19 132.96 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.066 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.65 -179.7 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.652 HD11 HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -46.72 -39.6 11.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.893 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.2 mm? -69.11 -51.43 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.76 -29.88 76.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -57.94 10.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.77 -33.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.48 -44.98 81.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.43 -47.63 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -41.88 87.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.899 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 61.9 mt -62.2 -43.56 98.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.39 -52.11 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.8 -51.54 71.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 4.2 m-30 -67.28 -19.29 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -57.42 -39.22 90.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.684 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -37.47 6.53 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.648 -0.325 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 107.24 13.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.211 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 111.26 2.69 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.779 2.319 . . . . 0.0 111.722 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 70' ' ' ILE . 73.3 Cg_endo -75.87 -37.53 1.59 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.591 2.194 . . . . 0.0 112.612 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.9 p -156.24 92.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' ' OE1' ' B' ' 212' ' ' GLU . 52.3 p90 -87.79 132.24 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.02 166.76 14.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 63.18 154.56 0.12 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.719 2.279 . . . . 0.0 112.087 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 111.508 -0.228 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.658 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.4 pm0 -60.1 173.41 0.58 Allowed Pre-proline 0 CA--C 1.512 -0.494 0 CA-C-O 121.36 0.6 . . . . 0.0 110.91 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.965 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.6 Cg_endo -91.64 -78.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 123.529 2.819 . . . . 0.0 109.542 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.729 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.75 -56.9 0.27 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.231 177.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 86.71 158.63 0.1 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' HD12 ' A' ' 70' ' ' ILE . 17.4 Cg_exo -65.06 151.65 85.02 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.799 2.333 . . . . 0.0 112.013 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 81.3 Cg_endo -77.64 177.86 8.31 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.566 2.177 . . . . 0.0 112.318 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.413 ' OE1' ' CE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -153.74 -137.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.286 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.115 179.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.841 0.353 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.4 -26.35 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.42 -19.85 52.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.237 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.62 -45.45 66.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.35 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.56 -47.34 85.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.516 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.05 64.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.312 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.6 tp -59.14 -50.42 74.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -54.25 -37.31 64.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -72.93 -24.33 60.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.704 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.0 ttm -62.15 -29.3 70.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.148 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -101.64 -85.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.848 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.419 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER 65.94 -59.6 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.58 3.8 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.8 m-30 -69.63 137.96 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.456 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.3 OUTLIER -59.71 -24.83 64.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.39 54.89 1.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.0 ttp180 -46.53 -44.3 17.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.069 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -53.74 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -25.03 66.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.739 HG21 ' CD2' ' A' ' 15' ' ' TYR . 93.7 m -83.04 -44.47 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.91 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 18' ' ' ARG . 86.8 t -64.66 -41.65 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -59.42 -44.11 92.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -64.21 -43.55 94.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.333 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.407 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.8 m -61.73 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' ASN . 34.7 m -53.54 -44.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.432 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.787 ' OD1' HD22 ' A' ' 125' ' ' LEU . 30.2 t-20 -57.21 -47.18 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.226 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 24' ' ' GLU . 46.0 t -63.35 -51.02 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 35' ' ' LEU . 21.4 pt -69.18 -41.48 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.615 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.6 m -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 125' ' ' LEU . 4.4 tp -80.97 -41.74 22.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.11 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 128' ' ' ILE . 17.4 m-85 -81.66 -48.08 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.04 -2.44 2.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.594 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -117.08 -24.02 7.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.9 tp -85.82 106.81 17.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -90.8 144.28 30.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.274 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.75 ' HA ' HD23 ' A' ' 55' ' ' LEU . 86.5 Cg_endo -78.18 136.8 14.75 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.667 2.245 . . . . 0.0 112.184 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -136.15 144.43 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.063 0.459 . . . . 0.0 111.053 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.8 tm? -93.31 152.35 19.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.759 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.909 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -156.42 162.66 40.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.697 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 t -164.32 131.3 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.063 0.459 . . . . 0.0 111.071 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -138.36 163.89 30.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.656 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 16.9 m -86.6 147.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.394 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -148.99 -67.23 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.39 86.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.408 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.51 24.35 6.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.44 10.8 37.65 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.685 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -81.28 123.4 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.567 -0.372 . . . . 0.0 110.947 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.1 m -73.93 138.59 44.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -135.56 136.63 41.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.933 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.37 126.21 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.825 HD12 ' CD ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -142.98 111.13 6.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.797 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -79.85 157.77 26.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.574 ' CG ' HG13 ' A' ' 38' ' ' VAL . 1.1 p30 -148.07 171.21 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.595 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 37' ' ' PRO . 5.5 mt -129.86 139.66 51.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -143.84 155.68 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.049 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 154.28 168.1 17.26 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.427 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.8 p -92.21 109.34 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.74 0.305 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.821 HD12 HG12 ' A' ' 132' ' ' ILE . 26.8 pt -92.08 147.13 34.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.811 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.99 117.53 4.97 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.506 2.138 . . . . 0.0 112.788 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.531 HG13 ' HA2' ' A' ' 136' ' ' GLY . 27.2 t -113.98 106.74 53.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.228 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.82 135.54 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.79 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -107.87 -161.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.086 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -53.4 -28.68 30.89 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.19 25.55 0.14 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -144.0 -173.71 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.693 0.282 . . . . 0.0 110.501 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -158.13 110.5 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.7 m-85 -98.12 -178.2 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.006 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -115.0 82.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' B' ' 210' ' ' PRO . 3.0 tp -74.43 122.77 88.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' VAL . 89.9 Cg_endo -81.34 149.43 16.95 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.583 2.189 . . . . 0.0 112.228 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -149.28 -179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.231 0.539 . . . . 0.0 111.83 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.628 ' N ' HG23 ' A' ' 72' ' ' ILE . 26.3 t -156.92 130.47 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.887 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -137.63 125.4 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' HE3' HD22 ' A' ' 52' ' ' LEU . 16.5 m95 -81.8 158.95 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.946 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 52' ' ' LEU . 1.5 tp -144.0 117.54 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 111.68 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 52' ' ' LEU . 38.0 mt -72.39 -178.96 2.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.339 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 22.8 m-20 -63.51 -60.18 3.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 16' ' ' LYS . 11.4 p -158.33 -36.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.487 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -111.96 169.66 6.1 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.793 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 44.4 Cg_endo -70.6 -54.33 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.297 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.293 0.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.8 71.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.645 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 63.91 128.42 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.716 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.35 129.32 11.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 112.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 -2.77 13.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.488 2.126 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 8.9 mt -64.07 115.64 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -147.94 131.2 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.72 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.01 147.5 28.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.9 p -94.12 144.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.586 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.91 105.29 22.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.5 Cg_endo -91.7 128.69 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.709 2.273 . . . . 0.0 112.952 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 61.7 p -78.0 161.46 27.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.694 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -25.73 26.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.323 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.31 6.56 42.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 141' ' ' VAL . 18.3 ttm -92.99 166.13 12.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.744 0.307 . . . . 0.0 110.895 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.499 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -138.47 110.55 7.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.285 0.564 . . . . 0.0 111.47 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.695 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.7 mt -71.64 139.86 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.96 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -102.54 108.88 20.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -71.04 144.8 50.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 161.84 -173.15 38.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -55.73 -20.54 14.9 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 m80 -92.34 -17.88 24.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' GLY . 29.5 t -155.4 150.74 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.879 ' O ' HG22 ' A' ' 99' ' ' THR . 17.8 m-20 -85.76 -64.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.319 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.38 -22.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.93 10.32 31.76 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.513 0.197 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.888 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 88.82 -12.61 65.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.903 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -68.77 148.37 50.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.964 0.411 . . . . 0.0 111.06 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 87' ' ' CYS . 42.2 mt -80.89 122.72 36.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.751 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -143.13 99.16 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.357 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -174.75 163.26 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' N ' HD22 ' A' ' 111' ' ' LEU . 28.9 Cg_endo -62.73 70.62 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.448 2.099 . . . . 0.0 112.559 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 114' ' ' LEU . 71.7 t80 -104.05 -75.8 0.61 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -72.89 -38.78 66.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.076 0.465 . . . . 0.0 110.502 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -63.58 -13.87 45.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.558 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 -66.13 0.94 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -75.12 -100.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.676 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 tttp 51.76 66.17 1.28 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.006 0.432 . . . . 0.0 111.146 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.25 -38.08 3.39 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 11.1 Cg_exo -71.42 -67.43 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.805 0.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 77.38 -49.87 0.53 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.263 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.82 126.93 32.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 -179.72 4.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -44.38 -38.79 4.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.381 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 ' OD1' ' A' ' 27' ' ' ASN . 6.4 tp -68.55 -60.26 2.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.06 -28.34 66.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.236 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -61.74 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.35 . . . . 0.0 110.981 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.77 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.4 mt -57.81 -33.71 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.147 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.749 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.17 -46.37 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.699 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.7 t -64.53 -47.1 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.7 ttm -58.72 -34.37 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.002 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.821 HG12 HD12 ' A' ' 59' ' ' ILE . 64.2 mt -70.02 -39.27 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.316 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.14 -52.1 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.256 0.551 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.97 -48.26 88.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.1 m-30 -63.92 -29.32 70.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.93 -27.73 73.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.25 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -22.84 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.617 -0.343 . . . . 0.0 110.739 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -154.33 132.77 6.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' B' ' 212' ' ' GLU . 58.8 Cg_endo -72.47 115.55 4.37 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.304 2.003 . . . . 0.0 112.385 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 57.2 Cg_endo -70.52 -24.69 25.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.284 1.989 . . . . 0.0 112.458 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 95' ' ' MET . 8.2 p -155.58 99.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 49.3 p90 -94.44 133.5 37.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' B' ' 208' ' ' THR . 21.9 t -88.11 167.04 13.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.839 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -76.16 148.42 81.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 122.805 2.336 . . . . 0.0 112.38 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.525 -0.221 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.59 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.86 171.49 1.08 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.483 0.658 . . . . 0.0 111.167 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 6.4 Cg_endo -86.72 -78.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.357 2.705 . . . . 0.0 109.479 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.7 -58.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.707 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.15 157.5 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.58 0.228 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.457 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.5 Cg_exo -71.78 137.89 30.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.877 2.384 . . . . 0.0 111.954 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.6 Cg_endo -65.99 169.0 14.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.557 2.171 . . . . 0.0 112.78 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -153.82 -136.31 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.064 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.859 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.11 -30.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.135 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -79.05 -47.74 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.79 -45.56 70.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -59.04 -43.43 91.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.72 -34.26 73.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.189 0.518 . . . . 0.0 110.838 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.72 -37.35 81.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -55.1 -43.74 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.795 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -73.78 -17.91 61.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.822 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.45 -26.42 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.318 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.704 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -99.75 -85.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.809 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.5 ' H ' HG23 ' A' ' 12' ' ' VAL . 1.2 m 63.95 -59.88 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -81.78 0.12 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.843 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.9 m-85 -70.39 143.21 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.852 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -28.78 68.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.665 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -136.93 70.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.7 mtm105 -47.36 -56.29 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.34 -52.96 63.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.526 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -23.14 67.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.286 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 15' ' ' TYR . 97.0 m -83.82 -44.17 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 0.0 110.555 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 18' ' ' ARG . 60.8 t -64.06 -45.11 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -59.54 -42.97 93.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 124' ' ' LEU . 6.5 mt-10 -62.4 -43.48 98.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.656 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.779 HG23 HD21 ' A' ' 55' ' ' LEU . 55.3 m -59.72 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 29' ' ' ILE . 28.9 m -53.8 -40.95 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.653 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -56.93 -46.67 81.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.25 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 47.7 t -62.76 -51.9 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 26' ' ' VAL . 18.8 pt -66.91 -40.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.483 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 91.7 m -68.9 -30.19 68.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -80.96 -42.56 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.5 m-85 -82.47 -33.82 28.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 68.08 1.98 3.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.01 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -117.26 -24.17 7.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.78 0.324 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 59' ' ' ILE . 1.8 tp -86.86 154.6 20.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.844 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.26 150.98 28.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 139.51 24.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.615 2.21 . . . . 0.0 112.268 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG12 HG22 ' A' ' 56' ' ' THR . 0.5 OUTLIER -137.84 136.57 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.194 0.521 . . . . 0.0 111.117 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 11' ' ' MET . 0.4 OUTLIER -95.26 142.43 27.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.707 ' N ' HD13 ' A' ' 39' ' ' LEU . 62.5 m-20 -158.14 116.97 3.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 t -77.75 123.42 26.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.341 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 6.6 t80 -138.71 149.03 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 49' ' ' SER . 35.7 m -84.46 150.27 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 52' ' ' LEU . 62.3 m-85 -146.76 -67.65 0.27 Allowed 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.375 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -56.91 82.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.695 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 54.0 m-20 50.44 25.42 1.92 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 77.0 1.25 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.285 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.32 95.97 1.76 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.507 0.67 . . . . 0.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.689 ' N ' HG12 ' A' ' 43' ' ' VAL . 4.2 m -44.28 144.3 1.03 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.85 136.12 18.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.591 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.4 93.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.91 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.597 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -97.7 116.79 30.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -80.64 96.18 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 38' ' ' VAL . 10.8 p-10 -93.8 157.59 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 25' ' ' THR . 3.3 mm? -99.21 142.1 31.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.433 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 38' ' ' VAL . 8.8 t -143.17 168.94 18.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 131.12 161.22 10.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.443 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 p -92.44 116.85 29.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.855 HD12 HG12 ' A' ' 132' ' ' ILE . 19.0 pt -93.91 147.51 33.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.88 116.02 4.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.57 2.18 . . . . 0.0 112.869 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.557 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.4 t -115.9 107.83 47.52 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.5 Cg_endo -76.17 130.59 12.24 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.76 2.307 . . . . 0.0 112.809 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -100.49 -157.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.354 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -29.64 50.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.972 0.415 . . . . 0.0 111.028 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.48 24.31 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 20.2 p30 -143.94 -167.94 2.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.664 0.268 . . . . 0.0 110.762 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -157.72 110.24 2.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.639 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.2 m-85 -97.69 167.12 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -99.26 85.1 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.414 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 70' ' ' ILE . 1.8 tp -73.84 122.64 88.06 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.667 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.73 151.88 25.19 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.541 2.161 . . . . 0.0 111.995 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -146.37 177.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.796 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.534 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.8 t -157.47 94.77 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.93 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -99.17 125.73 44.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.624 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CE3' HD13 ' A' ' 52' ' ' LEU . 96.9 m95 -80.16 113.34 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.164 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 55' ' ' LEU . 1.5 tp -93.17 78.51 4.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.88 177.9 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 77' ' ' LEU . 3.9 m-20 -61.2 -59.07 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 172.84 79.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -159.66 137.7 7.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.001 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -73.44 -68.29 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.169 -1.596 . . . . 0.0 112.523 -0.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.438 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -86.37 -65.51 1.0 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 39.3 t30 -152.77 -50.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.914 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.3 Cg_exo -64.44 111.04 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.153 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -86.53 -167.21 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.773 2.315 . . . . 0.0 112.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.0 mp -61.0 163.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.604 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.744 ' HB3' HD12 ' A' ' 109' ' ' ILE . 16.8 m -141.88 134.76 28.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 110.899 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 21.8 m-85 -146.04 146.3 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.038 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 107' ' ' GLY . 13.3 p -95.13 152.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.569 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -107.22 77.25 0.53 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.444 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.622 ' HD3' HG13 ' A' ' 89' ' ' VAL . 91.8 Cg_endo -78.73 123.76 5.98 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.33 2.02 . . . . 0.0 112.417 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.714 HG21 ' HG2' ' B' ' 207' ' ' PRO . 69.7 p -79.6 171.16 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -54.99 -42.7 72.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -82.54 -3.95 56.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.285 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.796 ' HG2' HG22 ' A' ' 141' ' ' VAL . 31.1 ttm -93.11 158.28 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 141' ' ' VAL . 59.0 m -136.1 120.22 17.71 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.528 0.68 . . . . 0.0 111.45 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.639 ' HA ' HG23 ' A' ' 141' ' ' VAL . 5.6 mt -70.71 136.19 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.221 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -104.58 102.91 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -70.21 133.7 47.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.81 -165.99 29.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.294 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -56.45 -23.58 39.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.578 ' HD2' HD11 ' A' ' 111' ' ' LEU . 50.4 m80 -95.39 -60.05 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 97' ' ' ILE . 5.9 t -83.82 146.51 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.637 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.762 ' O ' HG22 ' A' ' 99' ' ' THR . 27.4 m-20 -89.63 -67.3 0.85 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.64 -28.12 0.0 OUTLIER 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.284 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.95 -10.82 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.124 0.265 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 120.99 -24.59 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.745 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HE2' HG23 ' A' ' 86' ' ' ILE . 20.8 tttm -69.22 142.05 54.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.698 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.799 HG21 ' OH ' ' A' ' 113' ' ' TYR . 4.7 mt -81.42 133.18 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -98.89 60.44 1.24 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.024 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD11 ' HD2' ' A' ' 102' ' ' HIS . 13.0 mt -122.57 137.02 27.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.16 55.3 5.6 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.582 2.188 . . . . 0.0 112.436 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.799 ' OH ' HG21 ' A' ' 109' ' ' ILE . 45.0 m-85 -48.26 -52.33 21.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -73.04 -46.3 52.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.0 -23.76 67.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.712 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.07 -74.48 0.55 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.313 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -75.33 -116.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.809 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER 62.32 54.64 2.53 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.952 0.405 . . . . 0.0 110.949 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.36 -38.48 3.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.6 Cg_exo -70.55 -62.78 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 124.169 -1.179 . . . . 0.0 112.931 0.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 79.85 -55.03 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.054 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.08 165.4 18.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -132.1 -179.8 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 tp -46.35 -39.5 10.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.6 -42.68 77.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.83 77.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -57.7 -60.71 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.877 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -57.63 -31.72 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.59 -40.62 79.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.41 -49.08 82.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.594 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.418 ' O ' ' CD2' ' A' ' 135' ' ' PHE . 1.4 mpp? -58.71 -38.93 79.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.468 . . . . 0.0 109.92 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.855 HG12 HD12 ' A' ' 59' ' ' ILE . 73.4 mt -65.61 -42.02 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.378 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.9 t -66.61 -52.09 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.304 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 102' ' ' HIS . 52.9 t -59.63 -51.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 140' ' ' PRO . 22.8 m-85 -66.53 -14.6 62.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.007 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.64 -34.88 78.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.309 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.65 -39.75 3.71 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 120.92 0.391 . . . . 0.0 110.622 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 106.61 11.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' B' ' 212' ' ' GLU . 34.8 Cg_endo -64.94 110.6 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.116 1.877 . . . . 0.0 112.085 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 92.6 Cg_endo -80.57 -35.86 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.615 2.21 . . . . 0.0 112.767 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.796 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.0 p -155.45 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 52.6 p90 -86.91 132.09 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.8 t -88.54 167.52 13.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -75.65 149.11 83.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.842 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.575 2.184 . . . . 0.0 112.298 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 N-CA-C 111.535 -0.217 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.633 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.1 pm0 -61.08 172.84 0.79 Allowed Pre-proline 0 CA--C 1.511 -0.556 0 CA-C-O 121.321 0.581 . . . . 0.0 111.223 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.714 ' HG2' HG21 ' A' ' 92' ' ' THR . 25.3 Cg_endo -91.55 -76.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 123.576 2.851 . . . . 0.0 109.507 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.23 -56.87 0.3 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.687 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.56 157.67 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.576 0.227 . . . . 0.0 111.097 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' ILE . 16.5 Cg_exo -65.79 152.73 80.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.439 2.092 . . . . 0.0 112.233 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 72.5 Cg_endo -76.68 176.35 10.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.674 2.25 . . . . 0.0 112.326 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.462 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.3 -138.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.57 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.257 1.461 0 CA-C-O 118.106 -0.95 . . . . 0.0 111.023 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.55 -23.03 4.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.04 -18.05 56.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.301 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -46.04 65.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.34 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.343 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -58.25 -48.38 80.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.731 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 22' ' ' VAL . 4.2 tttt -55.23 -40.5 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.604 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -72.49 -23.81 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.52 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.673 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.2 ttm -61.59 -27.86 68.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.071 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.701 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.72 -84.06 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.079 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.95 28.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 111.416 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -153.99 -9.91 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.792 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.0 m-30 -68.82 163.79 23.39 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 122.166 -0.333 . . . . 0.0 110.818 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB3' HG21 ' A' ' 79' ' ' THR . 2.4 tptt -61.41 -32.85 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -138.25 77.86 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.38 -47.26 47.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.176 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.71 -57.48 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.05 -21.84 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.361 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.792 HG21 ' CD2' ' A' ' 15' ' ' TYR . 88.7 m -83.71 -49.13 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 9' ' ' LYS . 58.3 t -68.78 -41.88 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -59.55 -44.93 93.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -62.49 -43.53 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.641 ' HB ' HD21 ' A' ' 8' ' ' LEU . 2.3 m -60.15 -58.72 7.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.905 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.4 m -54.16 -42.24 55.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' VAL . 2.1 t30 -56.26 -39.6 72.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.6 t -63.34 -51.11 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.3 pt -73.04 -34.04 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.351 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.1 m -68.49 -29.03 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.9 m-85 -80.1 -44.41 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 69.74 10.64 7.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.09 -24.07 7.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.161 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 162.43 17.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.764 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -150.19 137.11 11.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.89 139.39 24.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.414 2.076 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HG22 ' A' ' 56' ' ' THR . 1.1 p -137.24 142.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 40' ' ' ASP . 2.4 tm? -92.06 149.81 21.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.169 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.2 t0 -157.04 162.69 39.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.354 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 t -164.56 137.27 4.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.955 0.407 . . . . 0.0 111.425 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 21.8 t80 -139.57 164.7 29.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.639 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 49' ' ' SER . 35.5 m -85.17 145.73 7.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 60.8 m-85 -146.08 -67.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.156 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.56 84.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.304 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' PHE . 60.6 m-20 51.77 24.73 2.57 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.68 75.55 1.23 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.203 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.85 108.39 2.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 122.831 -0.217 . . . . 0.0 110.477 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.9 p -49.84 146.11 4.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.419 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.33 139.23 40.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 116.54 9.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.006 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.14 108.5 5.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 111.022 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 ttp -80.4 161.06 25.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -147.74 158.4 44.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 144.91 29.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.405 HG22 HG12 ' A' ' 38' ' ' VAL . 5.1 t -146.33 161.44 40.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.55 -150.37 21.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.548 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -148.41 121.16 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 132' ' ' ILE . 18.1 pt -92.99 145.94 31.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.94 116.42 4.57 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.796 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 136' ' ' GLY . 11.9 t -106.48 104.22 49.65 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.227 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 73.1 Cg_endo -78.81 130.42 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.744 2.296 . . . . 0.0 112.681 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.44 -161.91 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -56.28 -26.13 50.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.92 24.81 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.787 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 14.7 m120 -143.53 -173.08 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 0.0 111.039 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 m -159.08 105.16 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.4 m-85 -98.08 -173.09 2.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.051 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.5 97.59 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 59' ' ' ILE . 1.5 tp -73.78 132.13 80.96 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 72' ' ' ILE . 52.7 Cg_endo -70.58 147.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.317 2.012 . . . . 0.0 112.134 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.9 mm -144.52 142.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.15 0.5 . . . . 0.0 111.36 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -158.51 97.74 1.49 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.655 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -134.57 151.42 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 111.461 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.453 ' CE3' HD13 ' A' ' 52' ' ' LEU . 38.3 m95 -78.7 173.12 12.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 124' ' ' LEU . 8.8 tp -145.57 97.72 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -69.82 172.52 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.08 0.467 . . . . 0.0 110.927 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.544 ' H ' HD13 ' A' ' 77' ' ' LEU . 14.8 m-20 -63.36 -53.94 44.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.654 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.6 t 168.14 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.654 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.05 142.93 18.3 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -12.27 30.45 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.456 -1.477 . . . . 0.0 112.657 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -54.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.609 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.593 ' H ' HD11 ' A' ' 114' ' ' LEU . 1.7 m-20 -150.42 162.73 26.63 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.424 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.705 ' HG3' HD12 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.36 108.78 2.58 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.657 2.238 . . . . 0.0 112.541 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 84.3 Cg_endo -87.9 -25.99 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.681 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 32.6 mm -63.12 119.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 109' ' ' ILE . 4.5 m -144.55 142.01 29.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.659 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 55.1 m-85 -146.98 137.89 23.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.328 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.6 p -94.76 144.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.645 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -98.51 104.53 24.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.175 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 69.6 Cg_endo -90.04 124.02 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.827 2.351 . . . . 0.0 112.834 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.439 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 29.8 p -79.48 162.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.0 110.699 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -54.87 -32.01 60.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.17 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.49 4.68 50.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.73 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.414 ' HB2' ' OG1' ' A' ' 92' ' ' THR . 54.1 ttm -93.6 162.68 13.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.73 0.3 . . . . 0.0 110.737 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -138.88 120.22 14.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.324 0.583 . . . . 0.0 111.211 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 141' ' ' VAL . 26.0 mt -70.78 153.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.604 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -140.08 88.89 2.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.588 HG21 ' O ' ' A' ' 104' ' ' ASP . 24.8 p -72.1 161.37 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.732 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 149.23 45.25 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.111 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 0.4 OUTLIER 98.68 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.328 0.651 . . . . 0.0 110.642 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -94.98 -14.23 24.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 104' ' ' ASP . 35.8 t -156.04 154.89 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.959 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 99' ' ' THR . 1.4 m-20 -86.7 -64.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.916 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.13 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.85 10.01 38.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.86 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.69 -13.67 60.85 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.002 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -68.44 141.19 55.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 87' ' ' CYS . 33.5 mt -80.98 124.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -97.56 43.33 1.07 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.336 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.7 mt -119.46 118.94 32.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 115' ' ' HIS . 74.5 Cg_endo -77.48 58.12 6.21 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.378 2.052 . . . . 0.0 112.42 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -48.36 -47.01 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.3 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.593 HD11 ' H ' ' A' ' 83' ' ' ASN . 3.6 tt -71.94 -47.39 52.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.136 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -63.04 -12.49 26.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.746 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -95.25 -75.05 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.523 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 47.4 t-105 -75.39 -85.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 9.4 pttp 45.39 53.48 8.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.937 0.398 . . . . 0.0 111.65 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.775 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.02 -40.54 6.0 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.2 Cg_endo -73.28 -61.65 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.868 -1.305 . . . . 0.0 113.191 0.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.72 -51.91 0.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.599 0.238 . . . . 0.0 111.247 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.16 122.51 27.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 110.968 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.99 -179.74 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.065 HD11 HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -45.78 -38.48 7.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.32 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 28' ' ' VAL . 2.0 mm? -68.3 -45.66 72.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.41 -32.98 79.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -66.73 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.5 mp -57.69 -30.41 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.056 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.99 -43.22 81.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.45 -48.53 84.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.26 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.4 ttm -58.7 -33.94 70.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.975 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.82 HG12 HD12 ' A' ' 59' ' ' ILE . 33.0 mt -70.03 -40.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.538 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.1 t -66.35 -52.23 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.414 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.01 -51.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -66.83 -15.72 63.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.333 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.4 -38.4 96.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.89 -42.56 4.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.85 108.14 21.67 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.75 110.78 3.18 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.312 2.008 . . . . 0.0 112.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 95.7 Cg_endo -84.01 -25.0 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 0.0 112.545 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.45 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.247 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.2 p90 -91.73 130.09 37.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 0.0 111.197 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.11 165.47 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 149.81 83.9 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 122.302 2.001 . . . . 0.0 112.322 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 120.726 0.219 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.3 OUTLIER -60.51 172.32 0.82 Allowed Pre-proline 0 CA--C 1.512 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.151 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -88.96 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 123.45 2.767 . . . . 0.0 109.918 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.15 -57.99 0.28 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.613 178.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.13 159.58 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 15.6 Cg_exo -66.39 148.41 84.15 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.759 2.306 . . . . 0.0 112.216 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -75.31 173.85 13.8 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.581 2.188 . . . . 0.0 112.565 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.09 -138.41 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.357 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 -34.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.4 p -78.95 -48.99 13.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.683 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 3.6 mt-10 -53.26 -46.13 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.982 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -45.83 89.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -29.86 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.8 tp -59.77 -47.6 85.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 12' ' ' VAL . 10.4 ttpt -55.18 -36.12 65.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -25.09 61.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.2 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 31.4 mtm -61.58 -20.89 63.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.441 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.08 -81.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.106 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 46.25 30.97 1.1 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -155.32 -18.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.7 m-30 -65.68 151.24 47.01 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 79' ' ' THR . 1.6 tptt -61.47 -28.54 69.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.958 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -136.19 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 13.0 ttp-105 -49.59 -47.13 49.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -56.81 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -22.24 66.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.678 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.7 m -82.96 -46.34 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.959 0.409 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' ARG . 61.0 t -63.73 -44.62 98.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -44.71 92.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 28' ' ' VAL . 40.2 mt-10 -63.19 -43.51 97.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.502 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -60.55 -58.33 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.928 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 27' ' ' ASN . 29.0 m -53.85 -41.24 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.342 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.9 m120 -56.85 -47.3 80.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.26 -51.78 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.474 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 35' ' ' LEU . 31.4 pt -68.88 -35.96 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.683 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -70.22 -30.75 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.188 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.02 -43.68 19.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.5 m-85 -86.51 -30.36 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.071 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 4.3 ptpp? 54.82 14.94 0.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.141 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.48 -24.37 7.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.723 0.297 . . . . 0.0 111.314 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.4 mp -87.67 113.4 23.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 110.994 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.59 129.44 42.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.88 129.77 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.338 2.025 . . . . 0.0 112.063 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.7 OUTLIER -137.8 140.81 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 111.292 -179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.94 HD23 ' HA ' ' A' ' 53' ' ' MET . 3.0 mt -93.9 166.34 12.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.307 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 11.5 t0 -163.11 125.44 2.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.435 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -83.03 125.31 31.31 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.182 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.89 138.76 37.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.518 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG12 ' N ' ' A' ' 49' ' ' SER . 35.8 m -86.89 151.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.015 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 42' ' ' TYR . 96.8 m-85 -147.74 -66.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -55.99 85.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 111.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' PHE . 70.4 m-20 50.11 25.1 1.6 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 111.599 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 73.11 1.05 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.251 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 109.1 3.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.862 0.363 . . . . 0.0 110.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 43' ' ' VAL . 64.1 p -45.48 147.38 0.85 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -145.3 145.92 31.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.761 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 111.5 5.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -140.98 110.45 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.94 ' HA ' HD23 ' A' ' 39' ' ' LEU . 2.5 tmm? -79.86 162.61 24.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.492 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' HG13 ' A' ' 38' ' ' VAL . 5.6 p-10 -147.98 172.07 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.466 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.32 134.44 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -144.64 144.61 31.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 170.91 169.21 33.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.732 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.9 p -94.94 106.0 17.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.709 0.29 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.632 HG13 ' HD2' ' A' ' 60' ' ' PRO . 16.2 tt -94.19 136.07 23.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 59' ' ' ILE . 61.3 Cg_endo -76.71 117.38 4.5 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.034 . . . . 0.0 112.644 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.81 127.01 26.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.788 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.18 140.01 33.42 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.48 2.12 . . . . 0.0 112.372 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 20.2 t80 -115.33 29.35 8.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.18 28.45 3.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.644 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.9 -42.67 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.073 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.84 127.07 16.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.235 0.541 . . . . 0.0 110.853 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -82.92 113.34 20.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.24 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m-85 -97.56 164.74 12.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -98.52 90.48 4.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.601 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' CG2' ' A' ' 59' ' ' ILE . 3.3 tp -76.8 127.84 83.06 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.509 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.0 Cg_endo -74.42 145.44 33.86 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.429 2.086 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -148.12 152.69 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -157.99 112.96 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -139.78 148.53 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.026 0.441 . . . . 0.0 111.386 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 59.7 m95 -78.45 -179.8 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 124' ' ' LEU . 1.4 tp -145.64 104.47 3.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.934 HD22 ' O ' ' A' ' 80' ' ' TYR . 2.7 pp -70.43 164.45 24.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.463 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 4.9 m-20 -61.81 -55.12 33.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.082 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 16' ' ' LYS . 2.2 t 177.08 39.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.934 ' O ' HD22 ' A' ' 77' ' ' LEU . 44.5 p90 -170.0 153.56 4.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.34 -35.94 2.53 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.373 -1.511 . . . . 0.0 112.526 0.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -159.17 80.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 77' ' ' LEU . 1.4 t-20 64.99 141.43 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.32 108.38 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.696 2.264 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.19 -23.93 4.92 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.262 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.5 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 34.7 mm -63.33 110.9 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.157 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.09 128.58 17.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.24 150.4 35.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.147 0.499 . . . . 0.0 111.21 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.2 p -95.29 145.84 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.716 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -96.8 104.68 19.29 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.903 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 71.0 Cg_endo -86.77 125.47 2.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.729 2.286 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 63.7 p -77.64 164.61 25.16 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.7 m -54.56 -23.46 16.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 m -106.16 5.9 30.42 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.737 ' HG2' HG22 ' A' ' 141' ' ' VAL . 23.4 ttm -92.79 161.98 14.3 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.6 118.23 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 0.0 111.147 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' HG23 ' A' ' 141' ' ' VAL . 11.6 mt -70.79 140.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.456 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -103.53 111.64 24.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.235 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -70.72 148.38 48.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.819 0.342 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.64 -171.8 32.42 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.85 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 -20.39 16.22 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 111.802 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.946 ' CD2' HD12 ' A' ' 111' ' ' LEU . 33.2 m80 -91.5 -20.57 21.59 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -156.06 141.92 10.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 99' ' ' THR . 66.1 m-20 -85.44 -66.6 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.035 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 35.72 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.45 1.43 1.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.692 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 91.2 -24.79 17.11 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.794 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.4 pttm -69.89 151.39 45.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.264 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.5 mt -81.2 132.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.693 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -96.51 -46.21 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' CD2' ' A' ' 102' ' ' HIS . 7.8 mt -55.49 108.7 1.25 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 87.4 Cg_endo -82.4 69.64 7.31 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.856 2.371 . . . . 0.0 112.028 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -48.08 -38.38 17.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.565 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -72.23 -43.99 63.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.53 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 6.6 t-160 -63.34 -11.08 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.614 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.36 -54.01 3.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.445 0.164 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.441 ' CZ2' ' CD2' ' A' ' 119' ' ' HIS . 34.8 t-105 -75.2 -80.26 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 pttm 44.58 52.19 7.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 111.591 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.04 -40.25 5.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.7 Cg_endo -73.31 -61.05 0.05 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.813 -1.328 . . . . 0.0 113.172 0.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 73.0 -54.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 111.159 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.4 116.99 22.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.45 -179.74 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -45.81 -38.85 7.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.1 mp -68.5 -40.78 80.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.63 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.39 73.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.323 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -61.65 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.754 HG22 HD11 ' A' ' 132' ' ' ILE . 5.2 mp -57.83 -32.03 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.666 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.62 -44.25 81.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.47 -48.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.401 ' CG ' ' CZ ' ' A' ' 135' ' ' PHE . 29.9 ttm -58.58 -33.71 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.069 0.462 . . . . 0.0 109.973 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 128' ' ' ILE . 31.8 mt -68.27 -44.59 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.6 t -66.3 -51.12 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.168 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.028 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 5.7 m-30 -63.73 -36.06 82.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.5 -25.01 68.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.27 -20.61 22.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.784 0.326 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.93 137.75 10.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.719 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.72 109.74 2.28 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.588 2.192 . . . . 0.0 112.457 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 48.0 Cg_endo -68.62 -25.38 34.48 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.248 1.965 . . . . 0.0 112.255 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.74 ' O ' ' HB1' ' B' ' 209' ' ' ALA . 7.8 p -155.22 99.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.801 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.6 p90 -95.18 134.83 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' B' ' 208' ' ' THR . 13.1 t -86.8 168.79 13.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.75 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 69.59 145.28 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.516 2.144 . . . . 0.0 112.184 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 111.575 -0.202 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.6 pm0 -60.78 172.01 0.94 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.393 0.616 . . . . 0.0 111.208 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 8.3 Cg_endo -86.72 -76.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.45 2.767 . . . . 0.0 109.356 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.94 -59.31 0.25 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.756 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 141' ' ' VAL . . . 89.54 156.25 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.341 0 CA-C-O 120.608 0.242 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.428 ' CD ' HD13 ' A' ' 70' ' ' ILE . 15.8 Cg_exo -66.23 138.39 51.24 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.139 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 37.8 Cg_endo -66.33 168.58 15.77 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.618 2.212 . . . . 0.0 112.328 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -157.76 -142.77 0.1 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.241 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.049 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.34 -30.53 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.96 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -43.71 58.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.899 0.38 . . . . 0.0 110.704 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -55.12 38.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.423 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -16.6 63.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.82 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -58.65 -52.27 66.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.968 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.2 -36.63 63.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.049 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -69.79 -28.89 66.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.657 ' HG2' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.78 -29.24 70.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.152 0.501 . . . . 0.0 110.658 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -110.01 -87.19 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.221 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 75.0 -22.64 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -157.72 69.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.362 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.6 ' HE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -167.85 129.08 1.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 4.2 tttt 32.89 36.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.656 0.741 . . . . 0.0 112.012 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' TYR . 9.2 m-85 60.91 87.07 0.09 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -44.44 -47.44 9.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.47 -52.95 63.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -32.38 73.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.6 HG21 ' HE1' ' A' ' 15' ' ' TYR . 89.1 m -75.9 -45.71 33.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.952 0.406 . . . . 0.0 110.732 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 18' ' ' ARG . 70.1 t -58.2 -48.08 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.718 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -45.41 91.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 22.9 mt-10 -64.35 -43.59 94.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.334 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 37' ' ' PRO . 19.4 m -61.48 -57.33 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.044 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 29' ' ' ILE . 34.3 m -53.22 -41.43 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.402 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.4 m120 -55.5 -48.46 74.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.181 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 125' ' ' LEU . 48.3 t -63.81 -58.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.859 HG22 ' HB3' ' A' ' 35' ' ' LEU . 26.3 pt -59.82 -39.75 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.608 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 29' ' ' ILE . 94.2 m -69.29 -26.56 64.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.197 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.95 -39.37 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.6 m-85 -88.96 -32.77 17.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.085 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.46 9.39 5.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.688 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -117.33 -23.17 7.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.713 0.292 . . . . 0.0 111.132 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.41 164.84 17.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.867 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 56' ' ' THR . 0.0 OUTLIER -149.85 136.45 10.82 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.473 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 29' ' ' ILE . 58.0 Cg_endo -71.27 135.11 26.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.295 1.997 . . . . 0.0 112.448 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 39' ' ' LEU . 2.3 p -132.63 159.44 43.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.441 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 40' ' ' ASP . 2.4 tt -144.61 155.49 43.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.494 . . . . 0.0 110.667 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.876 ' N ' HD23 ' A' ' 39' ' ' LEU . 25.2 m-20 -162.74 126.31 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.377 0.608 . . . . 0.0 110.575 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -81.03 126.95 32.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 3.4 t80 -139.21 149.72 44.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 49' ' ' SER . 35.1 m -85.67 147.89 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 78.7 m-85 -146.67 -67.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.492 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.97 83.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.75 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 25.7 m-20 51.3 25.27 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.421 0.629 . . . . 0.0 111.308 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 74.99 1.18 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.146 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.55 104.35 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 43' ' ' VAL . 10.3 p -45.29 145.82 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.725 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.68 HH11 HD12 ' A' ' 52' ' ' LEU . 9.3 ttm180 -142.89 135.36 27.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.6 84.81 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 77' ' ' LEU . 3.1 tt -99.55 111.01 23.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.639 ' HG3' HD12 ' A' ' 39' ' ' LEU . 2.7 ttp -81.44 152.64 27.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.349 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -147.04 164.94 31.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.76 151.1 24.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 36' ' ' LYS . 5.2 t -147.56 175.06 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.76 168.23 20.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.613 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' PRO . 11.5 p -90.66 131.77 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.3 . . . . 0.0 110.717 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 72' ' ' ILE . 2.3 mt -94.14 136.72 23.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 42.7 Cg_endo -67.59 116.27 4.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.463 2.109 . . . . 0.0 112.419 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 ' HA2' ' A' ' 136' ' ' GLY . 4.7 t -113.33 109.15 51.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.47 130.9 14.33 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.805 2.337 . . . . 0.0 112.402 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -103.35 -151.61 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.191 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 52.52 2.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.756 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.06 2.09 6.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.919 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.17 -167.82 2.56 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.733 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -158.49 115.65 2.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.704 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 25.5 m-85 -95.7 -176.74 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -135.04 86.72 2.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.546 0.213 . . . . 0.0 111.311 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' B' ' 209' ' ' ALA . 0.1 OUTLIER -76.82 137.63 66.27 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.701 0.286 . . . . 0.0 111.561 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 89' ' ' VAL . 91.7 Cg_endo -78.06 131.34 10.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.69 2.26 . . . . 0.0 112.148 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.992 HD12 HD12 ' A' ' 59' ' ' ILE . 5.2 mt -147.59 167.9 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 111.181 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.553 ' O ' HD22 ' A' ' 74' ' ' LEU . 14.4 t -153.57 149.14 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.795 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -135.56 125.73 26.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.262 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.606 ' CE3' HD22 ' A' ' 52' ' ' LEU . 18.0 m95 -81.1 110.31 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD21 HD21 ' A' ' 124' ' ' LEU . 1.1 mp -93.79 108.81 20.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 52' ' ' LEU . 3.2 mm? -73.01 157.37 37.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.597 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 1.1 p-10 -62.78 -29.67 70.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.492 HG22 ' C ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 163.71 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.64 123.2 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' TYR . 83.8 Cg_endo -81.63 -32.61 3.54 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.972 0.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -37.15 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.818 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -146.94 163.47 28.55 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 74' ' ' LEU . 13.5 Cg_endo -56.27 106.67 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.742 2.295 . . . . 0.0 112.387 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.13 -46.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.496 2.131 . . . . 0.0 112.447 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 74' ' ' LEU . 4.3 mt -64.62 118.95 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.216 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.795 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.1 m -141.82 123.28 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.19 162.34 39.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.022 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 71' ' ' PRO . 11.9 p -94.62 144.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.634 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -99.87 86.18 0.57 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.987 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 28.5 Cg_endo -62.18 142.96 93.7 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 122.237 1.958 . . . . 0.0 111.927 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.882 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.9 p -77.04 -75.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.189 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.7 t 176.26 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.439 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.13 6.55 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.147 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.87 ' HG2' HG22 ' A' ' 141' ' ' VAL . 20.0 ttm -88.58 169.23 11.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.744 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.458 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.3 OUTLIER -136.11 110.73 8.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.454 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.5 mt -71.86 137.49 23.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.174 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -106.05 113.42 26.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.782 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.66 159.16 34.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.057 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 151.33 -177.31 29.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -55.67 -22.93 25.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.527 ' CD2' HD11 ' A' ' 111' ' ' LEU . 56.8 m80 -96.79 -4.95 39.58 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 100' ' ' GLY . 24.1 t -155.45 144.41 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.947 0.404 . . . . 0.0 111.756 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -85.73 -66.11 0.94 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.861 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.38 -32.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.403 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.22 10.65 38.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.57 ' CA ' HG12 ' A' ' 89' ' ' VAL . . . 101.5 -7.74 56.24 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.008 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -69.26 133.71 48.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.684 HD12 ' HB2' ' A' ' 87' ' ' CYS . 37.0 mt -81.15 124.93 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.012 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.4 67.14 2.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 102' ' ' HIS . 86.2 mt -144.9 143.57 21.26 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.65 -58.9 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.426 2.084 . . . . 0.0 112.226 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 63.23 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tt -72.08 -46.45 56.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.136 0.493 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -16.47 58.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.417 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -95.86 -69.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 14.9 t-105 -75.14 -90.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.403 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 45.37 55.53 6.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.084 0.468 . . . . 0.0 111.433 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.59 -37.9 3.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.3 Cg_endo -70.54 -53.3 0.16 OUTLIER 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.918 -1.284 . . . . 0.0 113.065 0.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.435 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 69.09 -57.91 0.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.268 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 131.46 35.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.022 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.93 -179.79 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -49.22 -35.42 17.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -68.23 -50.16 55.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.03 -30.97 67.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.17 -66.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.9 mp -57.7 -31.55 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.795 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.7 -44.04 81.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.805 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 57.8 t -64.5 -47.96 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.418 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttm -58.62 -34.76 71.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.05 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 59' ' ' ILE . 76.8 mt -70.07 -40.82 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.527 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.9 t -66.16 -52.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.264 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 102' ' ' HIS . 54.4 t -59.59 -51.26 74.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.868 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.8 m-30 -65.84 -18.63 65.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -60.76 -40.87 98.73 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.468 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 -40.86 6.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.0 110.74 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.48 110.31 30.67 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.952 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 109.83 1.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.854 2.369 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.1 Cg_endo -82.56 -37.6 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.449 2.099 . . . . 0.0 112.884 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.87 HG22 ' HG2' ' A' ' 95' ' ' MET . 10.9 p -155.85 85.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.048 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.4 p90 -86.71 131.39 34.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 111.353 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' B' ' 208' ' ' THR . 30.5 t -88.67 166.53 14.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -163.67 143.63 6.69 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.499 2.133 . . . . 0.0 112.255 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 120.76 0.233 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.644 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.9 OUTLIER -63.48 172.82 1.46 Allowed Pre-proline 0 CA--C 1.511 -0.545 0 CA-C-O 121.564 0.697 . . . . 0.0 111.297 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.882 ' HG2' HG21 ' A' ' 92' ' ' THR . 28.8 Cg_endo -91.97 -94.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.578 2.852 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.3 OUTLIER 64.97 -59.42 0.25 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 87.4 160.07 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.473 ' HD3' HD12 ' A' ' 70' ' ' ILE . 8.3 Cg_exo -69.48 148.76 67.62 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 69.4 Cg_endo -74.41 174.58 12.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.548 2.165 . . . . 0.0 112.448 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.448 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.86 -139.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.557 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.276 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -107.96 -30.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -22.8 46.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' A' ' 26' ' ' VAL . 10.2 tt0 -52.67 -43.27 65.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -43.75 90.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.648 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -38.23 74.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.9 tp -60.23 -56.62 19.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.55 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -38.43 68.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -29.17 65.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.04 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.67 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.07 -24.49 66.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.991 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.66 -84.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m 55.89 20.97 4.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.7 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.1 7.67 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.3 m-85 -72.88 154.73 40.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.708 0.29 . . . . 0.0 110.678 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HB3' HG21 ' A' ' 79' ' ' THR . 3.2 tttt -61.11 -30.97 70.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 110.219 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -138.74 60.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.29 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -47.07 -48.22 22.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -58.3 -53.75 54.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -24.01 67.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.0 m -82.95 -44.47 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 110.676 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.6 t -65.35 -44.38 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.99 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -59.4 -44.61 92.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.5 mt-10 -63.05 -43.49 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.584 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.795 HG23 HD21 ' A' ' 55' ' ' LEU . 56.6 m -60.37 -58.3 9.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.5 m -53.63 -42.31 50.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.353 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 26' ' ' VAL . 3.0 m120 -55.71 -42.99 76.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 24' ' ' GLU . 37.5 t -63.77 -56.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.569 HG21 ' HD3' ' A' ' 37' ' ' PRO . 28.7 pt -64.28 -36.65 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.359 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -68.57 -28.12 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 125' ' ' LEU . 14.1 tp -88.31 -44.61 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.36 -50.9 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.34 8.02 5.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.49 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.53 -21.26 10.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.659 0.266 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 59' ' ' ILE . 1.6 mp -85.61 167.69 15.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.559 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.32 122.17 4.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' HG21 ' A' ' 29' ' ' ILE . 25.5 Cg_endo -62.7 121.05 8.82 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.401 2.067 . . . . 0.0 112.437 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -110.2 142.46 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.571 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 11' ' ' MET . 1.8 tm? -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -82.96 156.24 23.57 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.78 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 t -164.72 118.76 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.982 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -138.89 168.33 20.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.781 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 49' ' ' SER . 27.3 m -85.66 146.94 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.721 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 84.1 m-85 -147.47 -67.25 0.25 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -56.25 84.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.472 0.309 . . . . 0.0 111.601 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.3 m-20 52.34 24.85 3.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.384 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.94 73.76 1.19 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -156.93 112.97 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.807 0.337 . . . . 0.0 110.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 43' ' ' VAL . 13.5 p -47.52 133.48 13.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -125.16 138.88 54.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 115.69 9.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 52' ' ' LEU . 7.0 mt -142.37 107.11 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 4.4 tmm? -80.53 154.37 27.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.698 ' CG ' HG13 ' A' ' 38' ' ' VAL . 9.0 p-10 -148.72 172.37 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.795 HD21 HG23 ' A' ' 25' ' ' THR . 4.6 mt -133.33 136.02 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.959 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 11.7 t -145.46 166.74 24.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 166.14 10.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -91.01 112.01 23.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.82 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 35' ' ' LEU . 1.2 pt -93.35 149.96 38.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.13 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 117.62 4.79 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.724 2.283 . . . . 0.0 112.725 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -120.32 112.31 34.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.495 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 154.22 61.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.67 2.247 . . . . 0.0 112.286 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -137.79 30.13 2.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.74 67.62 0.54 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.934 0.397 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.68 -26.42 4.31 Favored Glycine 0 N--CA 1.454 -0.148 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.022 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -141.57 -173.79 3.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.7 0.286 . . . . 0.0 110.426 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -157.55 114.88 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.661 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 14.1 m-85 -98.32 162.92 12.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.127 0.489 . . . . 0.0 110.826 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -101.1 87.14 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.48 HD12 ' HD3' ' B' ' 210' ' ' PRO . 1.2 tp -73.8 123.85 89.7 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.377 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' VAL . 88.3 Cg_endo -81.11 140.0 12.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.608 2.206 . . . . 0.0 112.656 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.3 mt -148.4 161.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.185 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.6 t -157.61 128.49 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -141.93 154.09 44.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.311 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 86.1 m95 -79.36 173.15 12.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -146.36 95.75 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.821 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.25 176.48 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.104 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 79' ' ' THR . 2.8 p-10 -62.37 -54.92 33.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 t 176.54 38.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -135.15 130.56 19.37 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.209 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.32 -29.43 6.66 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.812 -1.328 . . . . 0.0 111.884 0.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.439 ' CE2' ' HD3' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -158.29 -39.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -147.98 161.67 33.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.598 ' HG3' HD12 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.27 108.42 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 112.454 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.26 -39.14 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.491 2.127 . . . . 0.0 112.291 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 88' ' ' PHE . 33.5 mm -63.38 113.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.9 ' HB2' HD12 ' A' ' 109' ' ' ILE . 4.2 m -143.63 128.89 18.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.191 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.38 156.89 43.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.723 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -93.68 130.02 43.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 104.18 23.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 141' ' ' VAL . 63.7 Cg_endo -89.78 143.6 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.221 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.819 HG21 ' HG2' ' B' ' 207' ' ' PRO . 48.3 p -77.59 169.15 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.82 -41.71 67.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.577 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -86.77 6.36 31.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.52 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.727 ' HG2' HG22 ' A' ' 141' ' ' VAL . 29.9 ttm -94.25 164.48 13.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.724 0.297 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.409 ' C ' HG23 ' A' ' 141' ' ' VAL . 2.2 m -138.96 118.01 12.54 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 0.0 111.675 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HA ' HG23 ' A' ' 141' ' ' VAL . 8.6 mt -72.46 140.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.938 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.8 112.96 25.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.8 p -69.76 144.78 52.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.11 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.17 -176.33 38.58 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.41 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -56.77 -18.55 13.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CD2' HD21 ' A' ' 111' ' ' LEU . 41.0 m80 -91.48 -21.01 21.13 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.967 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.6 149.21 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.874 0.368 . . . . 0.0 111.436 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.911 ' O ' HG22 ' A' ' 99' ' ' THR . 1.1 m-20 -85.27 -63.23 1.36 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.398 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.84 -26.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 10.74 33.32 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.261 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.19 75.67 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.887 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 5.1 mtmm -69.26 136.25 51.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 87' ' ' CYS . 63.5 mt -80.3 143.53 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.633 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.0 73.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' CD2' ' A' ' 102' ' ' HIS . 9.3 mt -134.98 150.04 72.06 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.46 52.29 4.27 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.634 2.223 . . . . 0.0 112.801 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 47.7 p90 -94.41 -52.61 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -74.79 -46.44 36.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.71 -22.17 66.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.808 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -95.05 -66.23 0.93 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -67.06 -123.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.633 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 66.04 51.87 1.26 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.009 0.433 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.77 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.59 -39.02 4.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.474 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 50.6 Cg_endo -72.63 -58.47 0.14 OUTLIER 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.182 0.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.47 -53.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.36 162.53 21.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -116.18 -179.88 3.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 28' ' ' VAL . 2.8 tp -52.17 -29.21 21.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.4 -45.03 73.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.41 -33.94 87.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.89 -64.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 132' ' ' ILE . 3.9 mt -57.72 -27.93 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -59.35 -38.8 81.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.378 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.06 -49.67 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.553 ' HG3' ' HA ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -58.99 -35.97 74.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 109.782 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.73 HG12 HD12 ' A' ' 59' ' ' ILE . 35.9 mt -68.23 -42.82 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.629 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 129' ' ' GLN . 60.4 t -66.78 -52.23 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.83 -51.75 69.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.959 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 20.0 m-30 -68.32 -13.37 62.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.12 -36.71 93.82 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.46 -43.16 4.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.693 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -88.08 108.14 19.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 34.3 Cg_endo -64.73 110.41 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.361 2.041 . . . . 0.0 111.877 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 88.4 Cg_endo -80.83 -35.13 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.415 2.077 . . . . 0.0 112.743 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.737 HG21 ' HB3' ' A' ' 91' ' ' PRO . 8.9 p -155.66 87.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -86.32 129.82 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.208 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' B' ' 208' ' ' THR . 47.0 t -89.53 162.44 15.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 146.15 78.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.531 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.246 0.91 0 C-N-CA 122.296 1.997 . . . . 0.0 112.326 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 111.494 -0.233 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.612 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 3.2 pm0 -60.61 172.74 0.74 Allowed Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 121.169 0.509 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.819 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.2 Cg_endo -92.04 -87.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.601 2.867 . . . . 0.0 110.168 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.712 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.14 -30.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.91 162.7 0.11 Allowed Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 121.526 -0.734 . . . . 0.0 110.997 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 70' ' ' ILE . 19.8 Cg_exo -63.79 160.56 36.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.276 1.984 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 95.9 Cg_endo -79.97 177.09 8.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.671 2.247 . . . . 0.0 112.615 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -153.31 -133.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.306 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.836 0.35 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.38 -24.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -21.19 51.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.191 0.52 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -52.76 -46.04 67.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -60.02 -46.76 88.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CG ' ' A' ' 10' ' ' LYS . 2.3 tt0 -70.33 -27.58 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.967 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.3 tp -59.28 -41.55 89.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.719 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.1 tttm -56.47 -43.67 79.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.972 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -70.01 -13.55 62.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.315 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.448 ' CG ' ' HA ' ' A' ' 8' ' ' LEU . 5.5 mmt -62.13 -27.22 68.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.217 0.532 . . . . 0.0 111.419 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -98.63 -82.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.389 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 12' ' ' VAL . 21.0 p 54.05 23.88 4.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.636 0.255 . . . . 0.0 111.441 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -154.2 3.13 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.73 ' CE1' HG12 ' A' ' 12' ' ' VAL . 3.6 m-30 -72.5 158.78 35.07 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 110.454 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.797 ' CB ' HG21 ' A' ' 79' ' ' THR . 6.4 tttt -61.4 -33.75 74.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.464 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 68.9 m-85 -139.28 63.55 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.477 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 ttp180 -48.55 -44.05 36.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.463 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -58.24 9.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.67 -22.79 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.299 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.695 HG21 ' CD2' ' A' ' 15' ' ' TYR . 66.6 m -81.35 -49.39 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 110.745 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 18' ' ' ARG . 97.4 t -62.03 -43.54 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -42.72 92.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.7 mt-10 -62.84 -43.54 98.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.55 ' CG2' HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.18 -59.1 5.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 27' ' ' ASN . 31.6 m -53.75 -43.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.493 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.694 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.4 m120 -56.63 -43.33 80.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.2 t -63.42 -51.81 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.434 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 33' ' ' LYS . 34.0 pt -71.59 -35.43 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.8 m -69.85 -29.48 66.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.198 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.1 tp -85.03 -43.92 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.474 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 36.3 m-85 -86.26 -34.86 20.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.246 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.7 17.95 1.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.522 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.57 -24.01 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -85.56 117.32 24.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.088 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -89.13 114.9 62.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.79 134.95 39.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.341 2.028 . . . . 0.0 112.456 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG13 ' ND2' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -131.25 134.06 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.4 tm? -97.2 89.36 4.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' CZ3' ' A' ' 75' ' ' TRP . 2.7 p30 -82.81 162.21 21.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.997 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 t -164.1 131.56 3.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.26 168.1 20.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 27.3 m -86.33 149.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.489 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' ASP . 68.3 m-85 -147.47 -67.19 0.26 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.77 80.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.025 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 14.7 m-20 54.75 23.74 5.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 43' ' ' VAL . . . 113.49 9.05 18.02 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.971 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.93 119.85 24.47 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 p -74.66 129.42 37.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -117.56 135.25 54.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.429 . . . . 0.0 110.833 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.91 92.28 2.54 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.245 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -99.24 117.51 33.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.649 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.43 ' HG3' HD11 ' A' ' 8' ' ' LEU . 5.6 tmm? -82.35 144.31 30.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.528 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' HG13 ' A' ' 38' ' ' VAL . 14.2 p-10 -148.96 169.92 19.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.177 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -136.71 138.95 41.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.447 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -146.03 145.56 30.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . -179.64 -139.1 3.56 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.88 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 p -144.66 111.54 5.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.786 0.326 . . . . 0.0 110.781 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 3.2 mt -92.03 136.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.334 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.1 Cg_endo -67.13 117.15 4.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.387 2.058 . . . . 0.0 112.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.597 HG13 ' HA2' ' A' ' 136' ' ' GLY . 18.9 t -112.16 110.84 53.47 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.059 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.39 147.6 65.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.83 2.353 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -131.76 29.27 4.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 70.67 71.66 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.4 -24.7 7.2 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.198 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -141.01 -176.56 4.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.794 0.331 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 61' ' ' VAL . 56.8 m -158.99 120.54 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 4.5 m-85 -97.56 -174.32 2.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -119.12 93.45 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 0.0 110.751 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.1 tp -74.19 129.88 83.61 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.42 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.9 Cg_endo -73.87 146.44 37.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.387 2.058 . . . . 0.0 112.039 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 28.3 mm -144.81 148.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.3 t -158.87 109.5 2.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -137.5 141.37 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CZ3' ' CG ' ' A' ' 40' ' ' ASP . 23.2 m95 -79.79 170.2 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -144.21 103.8 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.104 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 52' ' ' LEU . 3.8 mp -70.45 173.0 7.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.748 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -62.28 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.797 HG21 ' CB ' ' A' ' 16' ' ' LYS . 5.0 t -179.92 38.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.49 130.52 22.5 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.51 -26.28 9.84 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.314 -0.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 120' ' ' PRO . 83.5 t80 -159.18 -37.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.1 m120 -146.81 163.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.768 ' HG3' HD11 ' A' ' 124' ' ' LEU . 13.0 Cg_endo -55.86 105.57 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.849 2.366 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 88.4 Cg_endo -86.06 -44.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.718 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 33.2 mm -62.38 122.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HB2' HD12 ' A' ' 109' ' ' ILE . 6.3 m -144.81 130.35 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CZ ' HG23 ' A' ' 86' ' ' ILE . 11.9 m-85 -139.23 -170.89 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.5 p -144.7 144.83 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -98.73 105.19 29.19 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.218 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -87.71 124.97 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.914 2.409 . . . . 0.0 112.616 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 31.5 p -78.83 163.49 25.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.941 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -54.87 -42.74 72.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.43 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.23 0.37 41.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.819 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.427 ' CG ' HG22 ' A' ' 141' ' ' VAL . 54.7 ttm -93.02 164.91 13.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 m -137.73 116.03 11.86 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.511 ' HA ' HG23 ' A' ' 141' ' ' VAL . 3.0 mt -70.95 131.66 34.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.793 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -108.02 119.43 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.861 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -69.43 133.35 47.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.32 -176.72 37.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.48 -26.12 40.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 134' ' ' VAL . 3.9 m170 -94.79 -59.26 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.033 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 t -83.25 141.61 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.887 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -88.7 -62.49 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.277 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.87 -30.27 0.0 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.83 -7.97 35.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.896 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 118.28 -23.34 9.19 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.637 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 138.88 54.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.328 . . . . 0.0 111.086 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.4 mt -82.33 135.16 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.005 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -99.17 -47.73 5.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.015 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' HG ' ' CD2' ' A' ' 102' ' ' HIS . 1.4 tm? -47.06 105.05 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 115' ' ' HIS . 73.1 Cg_endo -76.12 98.97 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.221 1.947 . . . . 0.0 112.576 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -69.6 -40.11 76.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.988 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.12 -45.46 60.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -62.74 -19.37 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.803 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -95.38 -68.14 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.549 0.214 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 30.5 t-105 -75.29 -106.24 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.81 62.46 2.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.777 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -75.28 -35.95 2.03 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 49.8 Cg_endo -70.6 -54.1 0.15 OUTLIER 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.105 -1.206 . . . . 0.0 113.258 0.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.438 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 70.28 -60.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 110.912 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.98 150.79 25.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.74 -179.75 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.768 HD11 ' HG3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -47.0 -39.54 12.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.045 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.3 mp -68.68 -44.54 73.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.03 73.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.68 -60.31 3.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.2 mp -57.75 -30.14 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.46 -42.52 82.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.729 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.62 -48.1 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.469 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 72' ' ' ILE . 24.9 ttm -58.57 -33.77 70.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 59' ' ' ILE . 76.7 mt -70.08 -38.26 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.365 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 129' ' ' GLN . 59.8 t -65.98 -52.16 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.276 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.688 HG11 ' CE1' ' A' ' 102' ' ' HIS . 52.1 t -59.61 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 15.5 m-30 -66.52 -19.87 65.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.19 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.18 -41.42 96.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -108.94 -40.67 4.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.934 0.397 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.26 106.41 12.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.94 110.99 2.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.108 1.872 . . . . 0.0 112.064 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 83.5 Cg_endo -83.35 -28.78 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.336 2.024 . . . . 0.0 112.685 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -154.96 87.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.238 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.451 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 51.6 p90 -90.17 129.57 36.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 111.15 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.2 t -88.98 165.49 14.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.643 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -75.51 142.13 73.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.374 2.049 . . . . 0.0 112.34 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.688 0.203 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.6 OUTLIER -60.26 172.68 0.7 Allowed Pre-proline 0 CA--C 1.513 -0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 111.072 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.7 Cg_endo -88.98 -82.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.348 2.699 . . . . 0.0 109.928 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.33 -58.41 0.29 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.235 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.86 162.33 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 120.75 0.31 . . . . 0.0 111.19 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 6.7 Cg_exo -71.08 150.0 59.45 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 112.286 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 61.0 Cg_endo -73.68 172.68 15.28 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.398 2.065 . . . . 0.0 112.469 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -155.24 -139.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.095 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB3' ' OE1' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.21 -22.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.321 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -18.79 55.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.294 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.745 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 10.7 pt-20 -52.49 -46.06 66.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.54 -47.79 84.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.638 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -26.76 63.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.232 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 25' ' ' THR . 1.7 tp -60.01 -39.05 84.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.1 ttmt -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.065 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -72.18 -23.16 61.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.497 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.75 -22.69 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.412 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.46 -81.62 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.031 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.18 30.88 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.151 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.6 -6.1 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.874 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.1 m-85 -70.21 156.95 38.52 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 110.462 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.03 -33.7 73.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.034 0.445 . . . . 0.0 110.059 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 16' ' ' LYS . 50.3 m-85 -140.73 72.7 1.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.348 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -47.42 -46.63 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.413 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.74 -55.84 29.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.64 -22.7 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.4 m -81.0 -45.75 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.683 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 18' ' ' ARG . 77.8 t -57.85 -44.28 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.51 -42.48 92.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -43.67 96.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.614 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.858 HG21 HD21 ' A' ' 8' ' ' LEU . 2.6 m -60.69 -58.49 8.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.1 m -53.65 -41.73 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.368 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.4 m120 -55.42 -43.74 75.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.9 t -63.09 -48.07 89.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.179 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.0 pt -73.0 -28.93 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.394 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -67.8 -28.27 67.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -92.09 -45.93 8.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.91 -52.61 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.76 6.66 4.94 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.454 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -117.05 -15.28 10.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.377 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.13 109.32 18.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.79 0.329 . . . . 0.0 110.821 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -91.43 113.72 59.42 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD23 ' A' ' 55' ' ' LEU . 20.9 Cg_endo -62.17 120.52 8.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.193 1.928 . . . . 0.0 112.225 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -110.39 143.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -94.75 149.95 20.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.153 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' HD13 ' A' ' 39' ' ' LEU . 3.0 m-20 -156.14 161.99 40.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.8 p -164.75 129.54 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 0.0 111.237 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 4.0 t80 -140.06 164.33 30.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.451 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 49' ' ' SER . 32.5 m -85.5 146.31 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 52.8 m-85 -146.7 -66.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.715 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.16 84.33 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' PHE . 6.6 m-20 52.16 25.04 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.64 75.79 1.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.571 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.27 106.26 2.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' N ' HG12 ' A' ' 43' ' ' VAL . 96.0 p -49.21 134.31 18.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.351 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -120.41 135.59 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.855 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.68 77.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.433 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.79 108.48 20.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.917 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -81.06 163.21 23.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.042 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 38' ' ' VAL . 3.9 p-10 -149.28 172.11 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.719 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.8 HD21 HG23 ' A' ' 25' ' ' THR . 1.5 mt -135.77 138.87 43.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.867 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.54 148.9 33.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 35' ' ' LEU . . . 162.14 168.75 24.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.398 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 22.6 p -93.14 116.22 28.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.943 HD12 HG12 ' A' ' 132' ' ' ILE . 23.5 pt -94.06 150.28 38.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.24 114.19 3.14 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.435 2.09 . . . . 0.0 112.556 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.5 t -111.19 106.97 57.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 71.0 Cg_endo -76.18 130.32 12.01 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.49 2.127 . . . . 0.0 112.615 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -102.0 -159.98 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -54.27 -28.51 42.33 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 24.09 0.15 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.757 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.7 p30 -144.12 -167.25 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.305 . . . . 0.0 110.799 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -158.29 107.04 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 15.3 m-85 -97.12 -175.25 3.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -120.9 92.43 3.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.261 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.459 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.05 123.98 89.69 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 89' ' ' VAL . 96.6 Cg_endo -79.3 131.85 9.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.486 2.124 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 73' ' ' CYS . 21.4 mt -147.83 160.01 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 111.443 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.507 ' N ' HG22 ' A' ' 72' ' ' ILE . 15.0 t -156.57 131.93 9.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.185 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -144.18 155.42 43.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' A' ' 40' ' ' ASP . 82.0 m95 -79.7 -179.94 7.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.924 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.6 tp -144.69 129.9 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.746 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD13 ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -70.25 -157.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.402 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.98 33.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.33 18.78 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.235 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 81' ' ' PRO . 29.0 p90 -43.41 162.03 0.19 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.232 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 80' ' ' TYR . 54.3 Cg_endo -69.38 119.8 4.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.81 -1.329 . . . . 0.0 112.778 0.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -159.72 -38.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.517 ' CB ' HD11 ' A' ' 114' ' ' LEU . 0.8 OUTLIER 67.02 136.88 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.7 114.76 3.44 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.62 ' C ' HG12 ' A' ' 86' ' ' ILE . 73.9 Cg_endo -75.11 58.66 5.04 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.377 2.052 . . . . 0.0 112.368 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.62 HG12 ' C ' ' A' ' 85' ' ' PRO . 1.7 mm -162.65 115.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.839 ' HB2' HD12 ' A' ' 109' ' ' ILE . 1.2 p -146.27 121.22 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.931 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -143.51 160.43 40.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.985 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.793 HG13 ' HD3' ' A' ' 91' ' ' PRO . 8.6 p -94.34 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -105.31 76.47 0.33 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.793 ' HD3' HG13 ' A' ' 89' ' ' VAL . 69.3 Cg_endo -73.54 126.0 10.55 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.398 2.066 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.822 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.6 p -78.15 166.41 22.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.527 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -54.78 -38.8 67.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -88.08 6.03 38.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.82 ' HG2' HG22 ' A' ' 141' ' ' VAL . 19.9 ttm -94.22 164.23 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.772 0.32 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.473 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.01 113.57 10.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.034 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.69 ' HA ' HG23 ' A' ' 141' ' ' VAL . 6.7 mt -70.95 138.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.058 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -105.59 120.34 41.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.173 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.9 OUTLIER -70.38 134.55 47.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 111.018 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -169.92 177.35 43.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.29 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.4 -21.92 17.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.725 0.298 . . . . 0.0 111.467 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.664 ' CD2' HD23 ' A' ' 111' ' ' LEU . 70.9 m80 -94.25 -6.0 45.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.2 t -156.28 141.15 9.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-O 120.627 0.251 . . . . 0.0 111.348 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.86 ' O ' HG22 ' A' ' 99' ' ' THR . 2.4 m-20 -84.53 -66.85 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.9 35.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.325 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.04 4.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.489 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.734 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.91 -20.41 36.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.506 -0.855 . . . . 0.0 112.912 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 2.4 ptmt -69.83 143.92 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.419 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.839 HD12 ' HB2' ' A' ' 87' ' ' CYS . 61.7 mt -81.96 124.37 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.776 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.02 -27.93 14.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.437 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -51.86 107.17 0.77 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.68 79.0 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.458 2.105 . . . . 0.0 112.285 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.507 ' CD1' HD12 ' A' ' 111' ' ' LEU . 44.6 m-85 -67.25 -52.48 40.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.87 -36.12 69.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.95 -18.06 62.69 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -102.56 -67.2 0.89 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 38.0 t-105 -75.06 -104.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.137 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 54.48 64.69 1.73 Allowed 'General case' 0 C--O 1.227 -0.126 0 CA-C-O 121.036 0.445 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.758 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -75.1 -36.68 2.3 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.758 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 13.8 Cg_exo -69.83 -66.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 124.249 -1.146 . . . . 0.0 113.039 0.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 81.21 -50.48 0.28 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.018 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 t -83.72 135.31 34.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.56 -179.83 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.843 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -50.38 -40.5 49.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 28' ' ' VAL . 5.2 mp -68.19 -53.07 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.95 -30.62 66.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -65.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.5 mp -57.77 -29.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.753 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.92 -44.47 82.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.544 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.35 -47.39 89.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.145 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.0 ttm -58.63 -34.12 70.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.842 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.943 HG12 HD12 ' A' ' 59' ' ' ILE . 27.4 mt -70.03 -40.6 78.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.507 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 129' ' ' GLN . 55.0 t -66.22 -52.12 51.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.46 -51.36 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.796 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 6.0 m-30 -66.28 -17.0 64.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.105 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.607 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.07 -40.52 99.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.06 -41.6 6.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -87.83 106.92 13.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.96 110.55 2.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.393 2.062 . . . . 0.0 112.064 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 97.0 Cg_endo -78.95 -34.05 1.34 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.224 1.949 . . . . 0.0 112.977 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 95' ' ' MET . 9.9 p -156.13 90.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.993 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.3 p90 -89.25 130.33 35.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.349 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.9 t -89.46 164.99 14.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.821 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -75.66 149.68 83.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.59 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.252 1.175 0 C-N-CA 122.419 2.079 . . . . 0.0 112.269 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 N-CA-C 111.532 -0.218 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.62 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -63.86 171.87 2.17 Favored Pre-proline 0 CA--C 1.511 -0.521 0 CA-C-O 121.672 0.748 . . . . 0.0 111.067 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.822 ' HG2' HG21 ' A' ' 92' ' ' THR . 40.1 Cg_endo -94.11 -82.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 123.746 2.964 . . . . 0.0 109.661 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.29 -54.97 0.33 Allowed 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.508 178.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.05 159.91 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.459 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 11.4 Cg_exo -69.56 141.15 45.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.782 2.322 . . . . 0.0 112.033 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 51.9 Cg_endo -69.3 170.88 15.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.758 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.28 -139.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.439 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.853 0.359 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.73 -26.5 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.376 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 -24.3 47.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.73 -44.8 66.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.043 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -59.26 -43.58 92.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -60.21 -47.32 86.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -54.77 -47.12 74.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.351 0.596 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.72 -20.06 61.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.595 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 39' ' ' LEU . 2.3 ttm -61.78 -29.43 70.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.179 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -103.38 -85.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.224 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.0 m 53.31 22.54 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -155.28 4.36 0.2 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.741 ' CE1' HG12 ' A' ' 12' ' ' VAL . 2.6 m-85 -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' CB ' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.8 -29.25 70.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.059 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' HD2' ' A' ' 16' ' ' LYS . 72.0 m-85 -139.59 61.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.242 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.6 mtm180 -47.28 -51.45 19.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.46 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -57.16 -55.3 36.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.336 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.688 HG21 ' CD2' ' A' ' 15' ' ' TYR . 86.1 m -82.39 -45.57 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.722 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -63.12 -44.12 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.91 93.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' VAL . 43.1 mt-10 -62.87 -43.58 98.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.652 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.445 HG23 HD21 ' A' ' 55' ' ' LEU . 15.8 m -60.54 -58.85 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 27' ' ' ASN . 30.3 m -53.8 -44.73 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.5 m120 -55.62 -39.69 71.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.332 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.8 t -63.33 -53.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.409 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.91 -32.85 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.542 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -68.36 -29.58 68.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.063 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.7 tp -90.83 -46.12 8.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.6 m-85 -79.75 -46.67 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 70.13 10.57 7.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.392 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -117.07 -22.51 8.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.267 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.648 HD21 HG23 ' A' ' 59' ' ' ILE . 2.8 mm? -85.86 160.67 19.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -150.57 128.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.75 148.69 41.82 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.338 2.025 . . . . 0.0 112.648 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 56' ' ' THR . 2.9 m -135.03 144.35 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.885 HD11 ' HG2' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -90.72 94.82 9.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.317 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -85.37 162.58 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.661 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -163.84 98.62 0.87 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.518 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 4.0 t80 -140.51 168.16 20.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.226 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 49' ' ' SER . 29.7 m -85.41 147.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.824 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' ASP . 5.0 m-85 -146.01 -67.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.33 84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.261 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.5 m-20 51.97 24.15 2.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.816 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.85 77.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.645 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.58 98.72 1.97 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.095 0.474 . . . . 0.0 110.209 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.792 ' N ' HG12 ' A' ' 43' ' ' VAL . 10.2 t -55.26 132.65 48.31 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.61 ' NH1' HD12 ' A' ' 77' ' ' LEU . 4.1 ttm180 -138.18 135.2 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.885 ' HG2' HD11 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -78.88 114.47 17.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.31 138.9 25.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 0.0 110.886 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.51 ' CE ' HD23 ' A' ' 76' ' ' LEU . 8.6 tmm? -79.25 157.98 27.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.005 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' OD1' ' CD2' ' A' ' 52' ' ' LEU . 71.9 m-20 -142.8 160.69 39.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG23 ' A' ' 25' ' ' THR . 2.7 mm? -104.06 129.27 51.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 38' ' ' VAL . 11.7 t -144.04 156.68 44.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.42 -144.97 11.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -148.66 115.15 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.306 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.932 HD12 HG12 ' A' ' 132' ' ' ILE . 23.2 pt -93.52 146.84 32.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.009 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.2 116.49 4.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.559 2.173 . . . . 0.0 112.576 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 ' HA2' ' A' ' 136' ' ' GLY . 3.9 t -112.58 108.73 53.94 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.25 148.88 34.91 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.417 2.078 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 23.5 t80 -124.09 26.04 7.65 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' TYR . 7.6 mtp180 84.92 -35.63 0.05 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.555 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.11 -23.06 3.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.768 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -140.21 -163.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.671 0.272 . . . . 0.0 110.805 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -157.62 115.08 3.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.665 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 12.5 m-85 -96.64 -175.93 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.3 OUTLIER -123.25 91.33 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.976 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HD13 ' HD3' ' B' ' 210' ' ' PRO . 1.4 tp -73.22 133.16 81.38 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 72' ' ' ILE . 90.3 Cg_endo -77.44 155.89 32.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.438 2.092 . . . . 0.0 112.355 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 71' ' ' PRO . 15.9 mm -142.04 157.46 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.155 0.502 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 72' ' ' ILE . 10.4 t -156.43 87.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -101.39 125.93 48.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.332 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HE3' HD21 ' A' ' 52' ' ' LEU . 49.3 m95 -79.27 114.42 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.208 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' CE ' ' A' ' 53' ' ' MET . 2.4 tp -97.14 84.44 3.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.362 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.0 mm? -71.7 177.47 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.085 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HA ' ' CE2' ' A' ' 15' ' ' TYR . 5.2 m-20 -61.86 -44.23 97.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.767 0.318 . . . . 0.0 110.696 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 167.78 83.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.641 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -173.07 142.1 1.01 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.201 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.5 Cg_endo -74.44 -70.44 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.394 0 C-N-CA 123.209 -1.58 . . . . 0.0 112.736 0.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -64.68 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.121 0.486 . . . . 0.0 110.643 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 2.0 t30 -152.46 -65.87 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 114' ' ' LEU . 94.1 Cg_endo -77.83 110.44 2.92 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.449 2.1 . . . . 0.0 112.327 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 62.9 Cg_endo -87.73 -155.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.901 2.401 . . . . 0.0 112.306 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 11.2 mt -57.89 142.65 13.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.902 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 74' ' ' LEU . 11.3 m -143.36 127.63 17.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.459 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -149.62 166.36 29.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.797 178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.4 p -95.66 138.81 20.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.695 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -103.27 80.68 0.38 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' A' ' 141' ' ' VAL . 54.9 Cg_endo -68.68 143.86 57.85 Favored 'Trans proline' 0 C--O 1.23 0.086 0 C-N-CA 122.545 2.163 . . . . 0.0 112.555 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' HG2' ' B' ' 207' ' ' PRO . 72.2 p -77.18 167.64 21.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.48 -34.81 62.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 6.54 42.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.443 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -90.41 167.76 12.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.804 0.335 . . . . 0.0 110.831 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.678 ' C ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.56 115.22 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.194 0.521 . . . . 0.0 110.946 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 4.4 mt -69.71 156.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 14.8 tttt -137.55 113.14 9.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.818 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.3 p -69.77 171.7 8.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 147.48 179.17 23.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.376 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -21.41 16.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.194 0.521 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.763 ' CD2' HD21 ' A' ' 111' ' ' LEU . 21.0 m80 -95.37 -5.5 43.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 100' ' ' GLY . 2.2 t -154.72 154.08 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.818 ' O ' HG22 ' A' ' 99' ' ' THR . 50.9 m-20 -87.34 -63.99 1.22 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.156 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.14 -31.1 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.246 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 11.12 35.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.024 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.83 2.04 58.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.827 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 3.7 mtpt -69.8 136.33 50.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 111' ' ' LEU . 60.5 mt -81.21 122.36 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.827 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -103.83 29.5 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.763 HD21 ' CD2' ' A' ' 102' ' ' HIS . 4.4 mm? -81.4 148.29 62.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.867 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.23 14.6 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.787 2.325 . . . . 0.0 113.205 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -54.89 -45.06 74.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -72.49 -48.62 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.88 -29.54 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -66.66 0.9 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.357 0.598 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 122' ' ' SER . 1.5 t90 -66.77 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.634 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt 72.26 50.98 0.2 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.473 . . . . 0.0 110.58 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.755 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.31 -38.02 3.31 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.603 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.755 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.8 Cg_exo -70.65 -56.29 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 124.227 -1.155 . . . . 0.0 112.991 0.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 1.6 tt0 77.29 -60.62 0.44 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.718 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -83.24 151.15 25.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.92 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.99 -179.9 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 tp -53.25 -27.56 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 28' ' ' VAL . 5.9 mp -68.32 -50.59 52.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.17 -30.27 67.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.587 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.53 -64.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 132' ' ' ILE . 5.1 mp -57.71 -30.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.032 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.742 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.28 -48.19 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.457 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 14.4 ttm -58.63 -33.61 70.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.474 . . . . 0.0 109.977 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.932 HG12 HD12 ' A' ' 59' ' ' ILE . 33.9 mt -70.13 -40.0 77.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.5 t -67.13 -52.25 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 110.502 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 102' ' ' HIS . 79.1 t -60.33 -51.5 72.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.022 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE2' ' HG2' ' A' ' 131' ' ' MET . 9.1 m-30 -70.47 -0.3 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.88 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -77.16 -2.48 78.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.91 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -141.76 -43.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' OE1' ' CG ' ' A' ' 102' ' ' HIS . 1.2 pt-20 -88.68 112.73 52.2 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' CG ' ' HG3' ' B' ' 212' ' ' GLU . 54.1 Cg_endo -69.27 110.36 2.44 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.45 2.1 . . . . 0.0 112.046 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.7 -32.4 4.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.301 2.0 . . . . 0.0 112.566 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 95.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' B' ' 212' ' ' GLU . 48.7 p90 -88.0 127.07 35.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.032 0.444 . . . . 0.0 110.861 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 208' ' ' THR . 42.0 t -90.62 163.58 14.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.28 105.2 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.796 2.331 . . . . 0.0 112.383 179.764 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 111.507 -0.228 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.627 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.3 pm0 -60.93 172.43 0.86 Allowed Pre-proline 0 CA--C 1.511 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 111.124 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.669 ' HG2' HG21 ' A' ' 92' ' ' THR . 29.8 Cg_endo -93.45 -84.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 123.509 2.806 . . . . 0.0 109.213 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 66.62 -55.32 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.807 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.03 163.54 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 111.22 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.575 ' HD3' HD13 ' A' ' 70' ' ' ILE . 5.3 Cg_exo -75.81 154.84 39.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.611 2.207 . . . . 0.0 112.288 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 70.6 Cg_endo -74.42 175.69 10.67 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.671 2.248 . . . . 0.0 112.488 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -146.49 -140.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.715 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.09 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.183 0.516 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -92.01 -31.66 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.407 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -79.07 -47.66 15.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.488 ' OE2' HD11 ' A' ' 29' ' ' ILE . 2.6 mm-40 -52.39 -46.12 66.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -37.25 79.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -31.7 69.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.958 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -59.4 -56.09 26.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.738 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.811 ' HG3' HG21 ' A' ' 22' ' ' VAL . 6.7 tttm -54.11 -45.69 71.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -73.04 -21.09 60.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.584 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -63.44 -26.66 68.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -100.35 -84.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.773 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.435 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 71.13 -50.34 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -79.32 5.46 12.42 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.64 148.22 50.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.707 0.289 . . . . 0.0 110.495 179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.07 -32.42 70.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.233 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -139.49 68.08 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.311 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp85 -47.24 -52.66 15.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.03 -53.2 61.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.158 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -24.33 67.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.216 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 15' ' ' TYR . 82.2 m -82.26 -46.65 13.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -58.68 -43.8 88.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -42.53 93.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.787 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -62.53 -43.69 98.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.63 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.7 m -60.39 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.695 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.01 -40.61 46.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.23 -43.85 79.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 125' ' ' LEU . 41.3 t -62.61 -49.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.194 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.488 HD11 ' OE2' ' A' ' 5' ' ' GLU . 27.5 pt -71.58 -35.76 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.189 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.6 -21.93 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 tp -101.81 -44.07 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 71.5 m-85 -102.92 -38.09 7.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.293 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER 54.57 30.28 12.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' THR . 67.5 m-20 -112.44 -24.23 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.252 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.6 mm? -88.11 175.43 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.99 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 tptt -151.18 103.72 2.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' N ' HD23 ' A' ' 55' ' ' LEU . 18.4 Cg_endo -60.37 132.81 45.64 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.347 2.031 . . . . 0.0 112.276 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -135.94 150.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.843 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -91.49 149.34 21.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.833 0.349 . . . . 0.0 111.144 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -156.85 162.2 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -162.22 134.29 5.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 5.9 t80 -136.62 154.85 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.666 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 49' ' ' SER . 35.0 m -85.19 146.02 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.325 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 82.6 m-85 -146.47 -66.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.451 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -57.77 84.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 51.53 25.11 2.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.1 75.46 1.24 Allowed Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.217 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -156.84 107.83 2.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.261 0.553 . . . . 0.0 110.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 43' ' ' VAL . 54.0 p -48.32 142.88 5.13 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 121.209 0.528 . . . . 0.0 111.618 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.5 ttm-85 -124.54 136.26 53.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.659 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 105.89 2.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 76' ' ' LEU . 10.6 mt -143.31 113.65 7.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.813 ' SD ' HD22 ' A' ' 76' ' ' LEU . 2.6 ppp? -82.5 169.54 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.6 p-10 -151.53 146.16 25.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 35' ' ' LEU . 6.0 mt -100.93 144.85 29.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.742 0.306 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.566 HG22 ' CG1' ' A' ' 38' ' ' VAL . 12.1 t -145.52 143.01 29.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.57 -151.18 19.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.559 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 81.0 p -148.41 110.47 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.899 HD12 HG12 ' A' ' 132' ' ' ILE . 35.2 pt -90.86 149.04 39.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.383 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 38.3 Cg_endo -66.38 117.71 4.93 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.592 2.195 . . . . 0.0 112.382 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 136' ' ' GLY . 20.5 t -115.76 107.57 48.25 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.833 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.06 130.89 14.81 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.352 2.035 . . . . 0.0 112.221 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -110.28 30.41 6.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.67 28.53 9.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.73 -43.24 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.34 129.41 19.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.413 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.66 115.1 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 12.7 m-85 -97.36 -179.77 4.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.765 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -117.63 88.52 2.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 2.6 tp -73.07 130.05 85.44 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.515 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 72' ' ' ILE . 57.2 Cg_endo -71.1 151.4 61.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.363 2.042 . . . . 0.0 111.986 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 71' ' ' PRO . 33.1 mm -143.53 146.01 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.103 0.478 . . . . 0.0 111.388 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 12.3 t -158.37 103.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.361 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -135.8 146.97 48.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 111.444 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.37 141.65 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.394 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.813 HD22 ' SD ' ' A' ' 53' ' ' MET . 1.3 tp -98.69 143.53 28.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.408 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.9 OUTLIER -70.18 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.148 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' OD1' HD21 ' A' ' 52' ' ' LEU . 1.2 p-10 -171.43 40.72 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.19 0.519 . . . . 0.0 109.794 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 80' ' ' TYR . 67.5 m -153.88 -65.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.772 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 58.53 143.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.16 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.76 117.82 4.02 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.735 -1.361 . . . . 0.0 112.223 -0.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.562 ' HB3' HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -158.71 -32.34 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.7 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.753 ' HB3' HD11 ' A' ' 114' ' ' LEU . 1.2 t-20 69.88 141.17 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.281 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 76' ' ' LEU . 69.6 Cg_endo -73.41 113.55 3.81 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.591 2.194 . . . . 0.0 112.628 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.611 ' C ' HG12 ' A' ' 86' ' ' ILE . 82.9 Cg_endo -77.89 59.56 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.205 1.937 . . . . 0.0 112.303 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.611 HG12 ' C ' ' A' ' 85' ' ' PRO . 2.0 mm -161.93 129.31 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.418 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.81 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -145.93 144.14 29.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' A' ' 86' ' ' ILE . 70.4 m-85 -146.58 -176.06 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 107' ' ' GLY . 14.5 p -142.03 156.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.557 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 89' ' ' VAL . 1.7 mttm -104.83 89.44 2.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 86.7 Cg_endo -79.29 124.07 5.79 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.44 2.093 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 22.8 p -78.44 159.85 28.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -54.06 -32.33 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -94.54 5.84 50.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.808 ' HG2' HG22 ' A' ' 141' ' ' VAL . 15.4 ttm -90.61 167.38 12.59 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.726 0.298 . . . . 0.0 110.641 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 110.1 7.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.019 0.438 . . . . 0.0 111.577 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.5 mt -72.75 135.62 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.787 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 81.17 1.51 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.591 ' HA ' HG23 ' A' ' 103' ' ' VAL . 29.5 p -70.7 149.7 46.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.01 0.433 . . . . 0.0 111.155 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' LYS . . . 109.54 100.76 2.64 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.273 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 mttp 101.24 -28.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.499 0.72 . . . . 0.0 111.756 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' CE1' HG23 ' A' ' 109' ' ' ILE . 5.3 t-80 -146.68 9.05 1.02 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.268 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.1 OUTLIER -160.24 155.79 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 0.0 111.667 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.7 m-20 -93.73 -68.25 0.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 169.9 30.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.748 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.72 10.14 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.632 0.253 . . . . 0.0 111.644 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.883 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 89.53 -8.96 78.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.572 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -70.25 137.67 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.894 0.378 . . . . 0.0 110.845 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.81 HD12 ' HB2' ' A' ' 87' ' ' CYS . 21.8 mt -81.54 132.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 1.1 t80 -95.78 -148.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 101' ' ' LYS . 4.5 mm? 65.83 148.75 0.11 Allowed Pre-proline 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.287 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.33 57.34 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.609 2.206 . . . . 0.0 112.22 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -70.46 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.248 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 83' ' ' ASN . 1.1 mm? -71.85 -37.33 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.7 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -3.44 5.09 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.118 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.63 -75.42 0.51 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 122.328 -0.233 . . . . 0.0 111.518 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 119' ' ' HIS . 3.5 t90 -75.2 -87.22 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER 48.4 51.46 15.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.911 0.386 . . . . 0.0 111.871 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.73 -38.83 3.32 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 10.0 Cg_exo -72.12 -61.84 0.04 OUTLIER 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.319 -1.117 . . . . 0.0 112.829 0.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.35 -51.83 0.6 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.431 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.4 137.97 34.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.916 0.389 . . . . 0.0 111.104 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -110.7 -179.75 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -48.48 -35.98 14.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.227 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.71 -63.29 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -55.25 -28.71 50.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -54.77 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.742 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 132' ' ' ILE . 10.3 mm -57.78 -31.91 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.83 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.25 -42.96 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.086 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.23 -49.14 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.678 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 109' ' ' ILE . 5.3 tpp -58.8 -34.24 71.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.092 0.472 . . . . 0.0 109.942 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.899 HG12 HD12 ' A' ' 59' ' ' ILE . 28.9 mt -70.08 -38.75 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.374 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.0 t -66.14 -52.33 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.8 -51.37 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.691 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.62 -21.09 66.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.198 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.28 -46.73 85.78 Favored Glycine 0 CA--C 1.507 -0.413 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.301 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.41 -45.9 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -87.86 110.1 32.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.796 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.63 109.44 1.23 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.173 1.916 . . . . 0.0 111.961 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 70' ' ' ILE . 61.2 Cg_endo -72.36 -41.33 1.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.438 0 C-N-CA 122.383 2.055 . . . . 0.0 112.638 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.808 HG22 ' HG2' ' A' ' 95' ' ' MET . 12.0 p -156.39 94.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.052 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 50.8 p90 -89.32 131.9 35.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.014 0.435 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' B' ' 208' ' ' THR . 28.7 t -88.09 166.45 14.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.726 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.8 145.55 78.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.241 0.659 0 C-N-CA 122.379 2.053 . . . . 0.0 112.321 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.626 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -60.47 172.6 0.75 Allowed Pre-proline 0 CA--C 1.51 -0.558 0 CA-C-O 121.236 0.541 . . . . 0.0 110.949 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 2.4 Cg_endo -83.41 -78.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.122 2.548 . . . . 0.0 109.071 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.721 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.6 OUTLIER 64.52 -60.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.32 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.85 163.14 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.64 0.257 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 2.0 Cg_endo -80.13 129.09 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.049 2.499 . . . . 0.0 112.018 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 19.9 Cg_endo -60.41 164.72 12.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.469 2.112 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.85 -143.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.389 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.016 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 4' ' ' SER . 11.8 p -108.04 -43.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.342 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -79.22 -23.91 43.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.935 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -52.24 -46.07 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.659 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -60.46 -48.51 81.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.99 -20.44 64.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.086 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.13 -62.32 1.97 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.139 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 22' ' ' VAL . 11.7 mttt -56.97 -31.68 65.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -28.42 63.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.645 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.456 ' HE2' HD23 ' A' ' 39' ' ' LEU . 2.9 ptm -61.95 -27.13 68.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 111.437 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -83.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.154 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.65 31.58 5.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.49 -15.26 0.13 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CD2' HG21 ' A' ' 21' ' ' THR . 7.1 m-30 -67.37 160.17 27.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.926 0.393 . . . . 0.0 111.113 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.738 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.94 -34.61 76.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -137.38 72.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.825 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 22' ' ' VAL . 16.0 ttp180 -49.66 -47.8 49.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.48 -53.43 58.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.45 -22.17 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.631 HG21 ' CD2' ' A' ' 15' ' ' TYR . 95.4 m -85.11 -44.4 13.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.65 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 18' ' ' ARG . 49.8 t -67.57 -41.77 86.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.96 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -59.53 -43.56 93.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 28' ' ' VAL . 91.5 mt-10 -62.44 -43.51 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.574 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.643 HG23 HD21 ' A' ' 55' ' ' LEU . 22.1 m -60.3 -59.64 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.6 m -54.22 -44.12 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.363 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 125' ' ' LEU . 24.3 t-20 -56.51 -43.35 79.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.295 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 24' ' ' GLU . 40.5 t -63.17 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.397 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 35' ' ' LEU . 30.7 pt -73.04 -35.22 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.0 m -68.78 -28.4 66.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.75 -43.27 13.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.77 -49.72 8.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.28 6.01 4.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.407 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -115.02 -20.27 10.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.3 tp -86.12 112.6 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.759 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 121.38 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 55' ' ' LEU . 60.9 Cg_endo -72.89 138.52 28.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 112.185 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.5 p -138.02 143.1 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.032 0.444 . . . . 0.0 111.264 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.1 tm? -93.64 156.16 16.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 2.8 t70 -156.27 160.18 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -164.62 131.54 3.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 15.6 t80 -138.83 156.46 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.791 HG12 ' N ' ' A' ' 49' ' ' SER . 20.3 m -86.3 150.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 67.7 m-85 -147.63 -67.46 0.25 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.572 0.225 . . . . 0.0 111.356 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.09 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.486 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 51.19 25.04 2.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.066 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.89 76.4 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.57 98.75 1.97 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 120.813 0.339 . . . . 0.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.791 ' N ' HG12 ' A' ' 43' ' ' VAL . 4.3 m -46.43 146.43 1.45 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.581 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -131.92 139.67 48.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 114.69 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -143.32 105.54 4.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.415 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.28 162.81 22.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.549 ' ND2' HG13 ' A' ' 38' ' ' VAL . 8.4 p-10 -149.48 172.28 15.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD21 HG23 ' A' ' 25' ' ' THR . 2.3 mt -135.24 142.14 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.02 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -145.01 140.4 28.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.8 166.62 19.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 207' ' ' PRO . 52.8 p -92.1 125.92 36.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 70' ' ' ILE . 8.4 tt -95.82 136.98 21.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.215 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 59' ' ' ILE . 64.4 Cg_endo -74.85 114.17 3.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 111.84 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 132' ' ' ILE . 5.3 t -129.07 123.94 22.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.197 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 44.5 Cg_endo -67.57 131.76 25.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.524 2.149 . . . . 0.0 111.79 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' B' ' 210' ' ' PRO . 3.1 t80 -101.75 -136.11 0.32 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.6 25.97 1.86 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.27 -0.269 . . . . 0.0 110.738 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.65 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.563 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -148.05 157.99 43.81 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.575 0.687 . . . . 0.0 111.901 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 2.9 m -85.23 120.82 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' CE1' ' HD2' ' B' ' 211' ' ' PRO . 1.6 m-85 -96.11 -170.04 2.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.249 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.92 90.17 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG22 HG22 ' A' ' 59' ' ' ILE . 1.1 tp -76.91 129.84 77.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.199 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 Cg_endo -75.38 149.71 35.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.272 1.982 . . . . 0.0 111.623 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 71' ' ' PRO . 35.8 mm -145.14 153.59 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.194 0.521 . . . . 0.0 111.575 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 16.8 t -158.26 106.23 1.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.6 pt? -138.69 145.05 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.079 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.551 ' CE3' HD13 ' A' ' 52' ' ' LEU . 20.3 m95 -80.04 -179.15 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 84' ' ' PRO . 5.8 tp -143.63 97.55 3.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD12 HD21 ' A' ' 52' ' ' LEU . 2.7 mp -70.26 174.69 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.716 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' CD2' ' A' ' 15' ' ' TYR . 2.2 m-20 -61.39 -59.45 5.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 171.47 61.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.648 ' CE1' HD23 ' A' ' 77' ' ' LEU . 27.2 p90 -166.63 133.31 1.97 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.464 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 6.2 Cg_exo -73.2 -72.01 0.01 OUTLIER 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 123.378 -1.509 . . . . 0.0 111.737 -0.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CG ' ' N ' ' A' ' 83' ' ' ASN . 20.4 p90 -92.64 -52.54 4.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 3.7 m-20 -154.59 168.48 11.87 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.825 ' HG3' HD12 ' A' ' 76' ' ' LEU . 10.1 Cg_endo -52.04 106.8 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.58 -24.22 16.27 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.478 2.119 . . . . 0.0 112.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 5.3 mt -64.33 112.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.917 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -147.24 123.24 10.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.372 . . . . 0.0 111.792 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -147.41 -177.28 5.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.329 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 107' ' ' GLY . 12.3 p -134.97 141.06 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 110.959 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -101.91 90.17 1.83 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.431 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 55.8 Cg_endo -69.84 133.16 24.75 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.364 2.042 . . . . 0.0 112.183 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.624 HG21 ' HG2' ' B' ' 207' ' ' PRO . 71.5 p -77.27 166.22 23.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.771 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -42.12 70.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -81.47 -4.33 55.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.474 ' HE3' ' HB2' ' B' ' 207' ' ' PRO . 46.3 ttm -91.64 168.84 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.748 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.593 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -116.45 -156.39 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -165.3 141.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.773 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -137.52 118.55 14.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.364 . . . . 0.0 111.464 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.831 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.5 p -70.8 171.42 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.021 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 143.91 -177.37 22.66 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.236 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -56.98 -19.06 16.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 111' ' ' LEU . 49.6 m80 -100.06 -4.15 30.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 104' ' ' ASP . 10.7 t -154.81 156.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.98 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.831 ' O ' HG22 ' A' ' 99' ' ' THR . 13.0 m-20 -87.44 -64.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.763 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.67 -32.0 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.683 0.278 . . . . 0.0 111.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.09 11.36 37.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.686 0.279 . . . . 0.0 111.321 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.948 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.16 -6.49 59.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.483 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.69 142.12 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.612 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 87' ' ' CYS . 60.1 mt -79.89 122.51 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.121 0.486 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.2 111.18 6.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.442 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.796 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.7 pt? -175.67 -175.24 0.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 50.9 Cg_endo -71.86 69.59 2.95 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.699 1.6 . . . . 0.0 112.694 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.796 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -96.59 -71.27 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.253 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -43.55 61.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.879 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -20.37 65.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.342 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.08 -69.7 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.67 0.271 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -75.32 -131.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.559 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 82' ' ' TYR . 0.7 OUTLIER 71.15 46.7 0.43 Allowed 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 121.035 0.445 . . . . 0.0 110.747 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.774 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.3 OUTLIER -73.62 -38.76 4.25 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.334 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.774 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 8.8 Cg_exo -72.43 -68.72 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 124.27 -1.138 . . . . 0.0 112.845 0.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 82.56 -42.77 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.337 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -84.37 164.01 19.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.059 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.05 -179.9 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 76' ' ' LEU . 1.5 tp -49.1 -42.72 40.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 27' ' ' ASN . 2.4 mm? -68.73 -50.97 46.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.786 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.98 66.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.69 -63.69 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.357 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.771 HG22 HD11 ' A' ' 132' ' ' ILE . 4.9 mp -57.69 -30.57 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.784 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.04 -42.87 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.24 -48.99 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.34 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.63 ' SD ' HD13 ' A' ' 109' ' ' ILE . 1.8 tpp -58.6 -34.83 71.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.771 HD11 HG22 ' A' ' 128' ' ' ILE . 34.2 mt -69.58 -39.8 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.534 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.5 t -66.64 -52.23 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.386 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 102' ' ' HIS . 53.2 t -61.09 -51.63 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.92 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.9 m-30 -67.52 -14.19 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.26 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.75 -34.4 82.1 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.451 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.19 -39.94 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 110.88 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.72 108.22 19.45 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.174 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.39 110.9 3.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.387 2.058 . . . . 0.0 112.061 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 93.5 Cg_endo -80.36 -23.34 6.25 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 112.673 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -157.18 90.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 36.2 p90 -93.17 125.19 37.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' B' ' 208' ' ' THR . 47.5 t -91.2 159.97 15.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.997 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.0 140.11 69.92 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.362 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 122.455 2.104 . . . . 0.0 112.281 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 N-CA-C 111.561 -0.207 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -59.93 172.77 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.281 0.563 . . . . 0.0 110.993 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 92' ' ' THR . 21.1 Cg_endo -92.03 -81.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.342 2.695 . . . . 0.0 109.449 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.734 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.63 -59.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.249 178.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 90.55 161.37 0.07 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.506 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 5.9 Cg_exo -75.52 125.11 8.76 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.073 2.516 . . . . 0.0 112.37 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 29.8 Cg_endo -64.67 161.62 34.95 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.492 2.128 . . . . 0.0 112.615 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -116.58 166.26 12.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.563 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' B' ' 212' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.578 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.41 -26.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.17 -11.88 59.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -44.36 38.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -55.61 32.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -17.33 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -60.34 -37.86 81.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.213 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -53.23 -47.13 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.047 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -71.47 -21.96 61.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.456 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.29 -20.24 64.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.241 -179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CE1' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -102.74 -82.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.481 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 p 46.36 31.06 1.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.26 -13.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.85 ' CD2' HG21 ' A' ' 21' ' ' THR . 5.1 m-85 -67.73 156.98 35.71 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.113 -0.367 . . . . 0.0 110.53 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.38 -33.7 74.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 16' ' ' LYS . 55.7 m-85 -140.49 72.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.249 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.1 ttp85 -47.13 -47.81 23.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.34 -54.0 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -24.13 66.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.85 HG21 ' CD2' ' A' ' 15' ' ' TYR . 91.8 m -79.81 -46.28 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 18' ' ' ARG . 88.8 t -56.64 -46.82 82.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.875 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.59 -42.27 92.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.6 mt-10 -62.78 -43.46 98.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.64 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -59.37 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.5 m -54.03 -43.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.349 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 125' ' ' LEU . 3.5 m120 -55.71 -41.29 73.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.258 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 24' ' ' GLU . 48.9 t -63.12 -49.4 83.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.142 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 37' ' ' PRO . 37.1 pt -73.09 -31.77 36.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.5 m -68.64 -29.74 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.646 HD22 HD23 ' A' ' 125' ' ' LEU . 12.7 tp -87.39 -45.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -82.63 -52.41 6.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.8 2.88 3.39 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.9 -23.74 10.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.23 159.02 20.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.271 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.54 120.61 4.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.945 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.526 ' HA ' HD23 ' A' ' 55' ' ' LEU . 19.3 Cg_endo -60.99 120.54 8.3 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.243 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG13 ' CG ' ' A' ' 54' ' ' ASN . 1.4 p -106.03 145.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.838 HD13 ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -92.45 143.62 26.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.045 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.838 ' N ' HD13 ' A' ' 39' ' ' LEU . 1.1 t0 -156.97 162.35 39.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.472 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -164.6 132.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.353 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 14.9 t80 -140.13 168.17 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.597 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 49' ' ' SER . 35.6 m -85.25 144.97 8.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.104 0.478 . . . . 0.0 110.931 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 39.2 m-85 -146.22 -66.8 0.29 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.412 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -56.94 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' PHE . 30.7 m-20 52.09 25.44 3.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.658 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.33 75.69 1.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.91 109.8 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.439 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.7 p -51.38 141.97 14.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.918 0.389 . . . . 0.0 111.301 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.66 140.63 44.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.514 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 83.17 0.27 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.211 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.81 HD21 HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -100.03 105.66 17.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.727 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 ttp -80.96 160.17 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.636 ' CG ' HG13 ' A' ' 38' ' ' VAL . 3.5 p-10 -148.4 172.26 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.534 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 76' ' ' LEU . 3.0 mt -133.35 141.62 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 111.276 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 t -147.54 176.34 10.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.71 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.57 162.81 9.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.62 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -92.57 118.58 31.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 132' ' ' ILE . 3.2 mt -93.81 136.08 24.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.746 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 38.3 Cg_endo -67.35 117.11 4.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.38 2.053 . . . . 0.0 112.452 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG13 ' HA2' ' A' ' 136' ' ' GLY . 28.6 t -108.35 107.42 60.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.591 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.41 129.68 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.858 2.372 . . . . 0.0 112.361 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.32 -151.85 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -84.93 52.98 2.57 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.2 7.07 7.93 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.749 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -141.96 -174.01 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.741 0.271 . . . . 0.0 110.738 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -158.7 112.58 2.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.452 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.5 m-85 -98.21 -172.54 2.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -124.51 95.03 4.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.6 tp -74.72 131.31 79.77 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.188 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' O ' HD13 ' A' ' 72' ' ' ILE . 60.9 Cg_endo -73.04 143.43 36.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.379 2.053 . . . . 0.0 112.238 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 71' ' ' PRO . 24.3 mm -145.4 144.47 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 111.393 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.6 t -159.29 111.94 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.4 pt? -137.66 149.1 46.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -78.53 171.67 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.764 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -145.67 91.63 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -69.76 173.11 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.737 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 79' ' ' THR . 95.5 m-20 -62.52 -46.02 90.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.512 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 16' ' ' LYS . 1.6 t 169.05 68.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 17.7 t80 -167.09 137.3 2.42 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 39.6 Cg_endo -73.48 -70.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.5 -0.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.711 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -87.17 -68.28 0.76 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.748 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 20.2 t30 -151.86 -53.66 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.464 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 3.7 Cg_exo -77.45 111.66 3.21 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.654 2.236 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.408 ' O ' HG13 ' A' ' 86' ' ' ILE . 94.1 Cg_endo -80.85 -43.27 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER 178.95 146.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.318 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 109' ' ' ILE . 58.1 m -145.5 135.73 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.397 . . . . 0.0 111.558 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.18 165.44 29.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 107' ' ' GLY . 7.8 p -98.62 152.02 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -106.16 88.13 2.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.945 0.402 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.592 ' HG3' HD11 ' A' ' 97' ' ' ILE . 89.8 Cg_endo -77.95 123.32 6.2 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.701 2.268 . . . . 0.0 112.952 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.485 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.5 p -79.69 166.64 21.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.873 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -55.34 -38.89 69.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.319 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -88.05 0.79 55.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.949 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.45 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 51.1 ttm -93.89 165.51 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.622 0.249 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -136.98 115.37 11.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 91' ' ' PRO . 4.9 mt -70.91 135.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.211 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -107.19 110.99 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.37 160.8 31.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 153.72 -177.69 31.09 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.196 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -22.63 15.93 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.501 -0.411 . . . . 0.0 111.549 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.567 ' HD2' HD11 ' A' ' 111' ' ' LEU . 49.7 m80 -96.93 -4.13 40.56 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' GLY . 18.6 t -155.25 149.15 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 111.722 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.838 ' O ' HG22 ' A' ' 99' ' ' THR . 1.7 m-20 -85.77 -67.23 0.82 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.769 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.63 -27.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.45 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -94.78 10.84 33.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.528 0.204 . . . . 0.0 111.4 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.764 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 96.41 -9.86 67.08 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.033 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -68.57 146.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.781 HD12 ' HB2' ' A' ' 87' ' ' CYS . 38.4 mt -80.76 122.51 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -99.34 74.51 1.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.567 HD11 ' HD2' ' A' ' 102' ' ' HIS . 31.6 mt -146.42 144.04 20.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.92 -50.64 2.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.476 2.117 . . . . 0.0 111.848 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 111' ' ' LEU . 25.1 m-85 64.24 -74.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -70.98 -47.63 57.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -23.16 66.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.29 -72.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.011 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -75.13 -110.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HG3' ' CD2' ' A' ' 82' ' ' TYR . 28.0 tttt 57.7 56.31 4.94 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.902 0.382 . . . . 0.0 111.046 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.75 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.65 -38.67 3.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 12.2 Cg_exo -70.69 -64.38 0.03 OUTLIER 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.146 -1.189 . . . . 0.0 112.872 0.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 79.67 -54.09 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.69 156.94 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.977 0.418 . . . . 0.0 111.269 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -133.92 -179.5 5.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -40.87 -46.55 2.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.299 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.646 HD23 HD22 ' A' ' 31' ' ' LEU . 2.6 mp -69.11 -42.27 76.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.19 -29.27 74.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.34 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -57.29 -62.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.777 0.322 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.8 mp -57.79 -30.25 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.28 78.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.739 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.55 -49.07 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 21.3 ttm -58.74 -34.63 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.099 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 59' ' ' ILE . 78.4 mt -70.08 -39.16 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.545 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.7 t -66.09 -52.18 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.66 -51.33 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CG ' ' HG3' ' A' ' 140' ' ' PRO . 8.1 m-30 -67.08 -18.08 65.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.349 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.622 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -61.19 -39.85 97.74 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.622 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.06 -41.13 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 106.37 12.54 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.017 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.2 110.47 2.45 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.569 2.179 . . . . 0.0 111.936 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 135' ' ' PHE . 76.8 Cg_endo -85.23 -24.94 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.493 2.128 . . . . 0.0 112.754 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.73 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.432 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 46.0 p90 -90.36 127.82 36.29 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.181 0.515 . . . . 0.0 110.973 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' B' ' 208' ' ' THR . 41.3 t -89.71 163.27 15.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.763 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -75.79 148.57 82.33 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.716 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.251 1.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.435 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 111.563 -0.207 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.614 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.21 172.35 0.76 Allowed Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.348 0.594 . . . . 0.0 111.172 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.614 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.6 Cg_endo -89.26 -81.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 123.398 2.732 . . . . 0.0 109.714 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.1 -57.5 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.403 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.47 159.36 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 111.37 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 8.5 Cg_exo -69.03 149.23 71.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.553 2.169 . . . . 0.0 112.296 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 67.4 Cg_endo -74.58 174.51 12.5 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.47 2.114 . . . . 0.0 112.623 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -152.52 -139.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.461 -0.78 . . . . 0.0 111.145 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.23 -26.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -78.7 -11.87 60.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -44.4 51.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.957 0.408 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -55.56 32.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.558 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -16.5 63.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.545 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.511 ' HA ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -59.23 -49.13 79.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.135 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.631 ' HG3' HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -55.19 -38.71 68.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.359 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -26.69 63.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.5 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.52 -18.75 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.454 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -101.15 -80.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.487 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 46.04 27.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -154.12 10.89 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 21' ' ' THR . 1.1 m-85 -74.14 156.69 37.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.735 0.302 . . . . 0.0 110.807 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -61.52 -30.09 70.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE1' ' HE2' ' A' ' 16' ' ' LYS . 33.5 m-85 -142.74 56.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.925 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 ttp85 -44.31 -46.3 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.525 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.08 -58.07 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.493 HG21 ' CD2' ' A' ' 15' ' ' TYR . 68.2 m -81.01 -48.0 12.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.779 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.9 t -57.15 -45.22 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -39.21 83.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 28' ' ' VAL . 41.8 mt-10 -62.66 -43.48 98.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.0 m -54.18 -44.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.385 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' N ' HG23 ' A' ' 26' ' ' VAL . 33.2 m-20 -56.68 -43.52 80.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.283 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 24' ' ' GLU . 61.1 t -62.5 -50.57 79.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.232 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 35' ' ' LEU . 29.9 pt -70.52 -38.66 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 ' N ' HG13 ' A' ' 29' ' ' ILE . 75.0 m -68.21 -26.52 65.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.1 tp -94.5 -44.71 7.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.187 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 132' ' ' ILE . 63.9 m-85 -91.33 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.125 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.72 5.05 3.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.477 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -114.12 -24.3 9.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.671 0.272 . . . . 0.0 111.088 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.725 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.1 mp -87.77 98.76 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.512 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -90.89 113.42 58.0 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HG2' HD11 ' A' ' 8' ' ' LEU . 36.4 Cg_endo -65.16 149.68 88.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.28 1.987 . . . . 0.0 111.833 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' ND2' ' A' ' 54' ' ' ASN . 1.7 m -134.27 149.56 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.284 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -90.82 133.52 35.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.733 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' OD2' ' CZ3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -155.5 163.08 40.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.507 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -160.84 120.93 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.741 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 29.5 t80 -139.0 166.3 24.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.809 HG12 ' N ' ' A' ' 49' ' ' SER . 27.5 m -86.6 145.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.736 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' A' ' 42' ' ' TYR . 4.1 m-85 -144.55 -67.47 0.32 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.61 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.551 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' PHE . 2.4 m-20 50.56 24.55 1.67 Allowed 'General case' 0 N--CA 1.458 -0.064 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.57 77.76 1.35 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.154 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.1 98.6 2.03 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.809 ' N ' HG12 ' A' ' 43' ' ' VAL . 6.2 p -57.35 128.7 38.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.161 0.505 . . . . 0.0 111.271 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -126.44 134.83 50.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.637 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.5 103.98 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.592 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -144.56 133.47 22.56 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.534 0.683 . . . . 0.0 111.322 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.51 176.18 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.147 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' ND2' HG22 ' A' ' 38' ' ' VAL . 8.8 p30 -148.69 167.36 25.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 76' ' ' LEU . 3.9 mm? -108.88 131.97 54.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -144.69 138.63 27.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 -146.17 12.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.559 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -148.5 120.21 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.573 HD12 HG12 ' A' ' 132' ' ' ILE . 10.9 pt -92.98 142.44 25.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.11 116.29 4.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.54 2.16 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG13 ' HA2' ' A' ' 136' ' ' GLY . 13.0 t -106.8 105.56 55.49 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.511 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 74.5 Cg_endo -77.44 129.69 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.728 2.285 . . . . 0.0 112.447 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -101.55 -161.45 0.86 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -27.37 46.55 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.02 23.33 0.17 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.064 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 18.6 p30 -143.69 -170.16 3.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.688 0.28 . . . . 0.0 110.761 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.9 m -159.11 104.27 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.325 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.468 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 6.3 m-85 -98.32 -172.54 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.1 OUTLIER -124.45 100.08 6.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.724 -179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 72' ' ' ILE . 1.3 tp -74.54 134.77 75.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 89' ' ' VAL . 83.1 Cg_endo -82.27 139.34 10.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.485 2.124 . . . . 0.0 112.257 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -147.88 151.86 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.139 0.495 . . . . 0.0 111.157 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -156.83 114.07 3.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.2 pt? -135.41 140.85 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.985 0.421 . . . . 0.0 111.415 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.677 ' HE3' HD21 ' A' ' 52' ' ' LEU . 82.3 m95 -78.09 132.79 37.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.67 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 55' ' ' LEU . 5.2 tp -93.48 89.58 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.812 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -70.48 174.89 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 0.0 110.461 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' H ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -62.58 -47.4 84.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.694 179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 t 174.88 40.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.38 134.6 22.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.775 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.97 -19.38 17.63 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.621 -1.408 . . . . 0.0 112.734 -0.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.4 -46.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.555 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 2.2 t30 -151.9 -56.29 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.301 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CB ' HD11 ' A' ' 127' ' ' LEU . 3.0 Cg_exo -76.65 109.82 2.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.791 2.328 . . . . 0.0 112.589 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 83' ' ' ASN . 83.0 Cg_endo -92.76 -165.22 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.962 2.441 . . . . 0.0 111.92 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 88' ' ' PHE . 3.0 mp -60.24 135.09 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.71 ' HB2' HD12 ' A' ' 109' ' ' ILE . 31.3 m -140.28 134.2 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 111.209 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -145.61 160.31 41.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 71' ' ' PRO . 10.4 p -95.84 144.57 9.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -103.16 93.29 4.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.036 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 83.2 Cg_endo -80.43 124.59 5.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.459 2.106 . . . . 0.0 112.894 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 65.4 p -77.78 171.37 15.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.739 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -55.34 -41.95 73.18 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -84.77 -8.43 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.692 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG2' HG22 ' A' ' 141' ' ' VAL . 38.1 ttm -92.98 159.47 15.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.667 0.27 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 142' ' ' PHE . 12.1 t -139.85 129.07 23.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.152 0.501 . . . . 0.0 111.083 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mt -71.93 136.76 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.303 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.56 117.42 33.99 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.0 OUTLIER -70.43 158.4 36.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 146.93 -176.69 25.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.384 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -56.32 -19.73 15.71 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.46 -0.435 . . . . 0.0 111.62 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 111' ' ' LEU . 47.8 m170 -93.78 -14.61 26.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 100' ' ' GLY . 38.6 t -156.08 150.09 10.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.408 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.895 ' O ' HG22 ' A' ' 99' ' ' THR . 0.7 OUTLIER -85.35 -67.14 0.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.363 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.3 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.086 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 -11.94 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.552 0.215 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 119.49 -13.92 10.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.808 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 145.4 54.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 87' ' ' CYS . 32.9 mt -80.64 127.87 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -96.23 -17.79 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 102' ' ' HIS . 2.7 mt -49.34 125.06 14.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.055 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 50.66 3.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.551 2.167 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -57.37 -39.98 77.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 110.836 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.559 HD12 ' HG2' ' A' ' 84' ' ' PRO . 6.4 tp -71.08 -51.92 22.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -5.98 6.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.779 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -78.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.534 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 120' ' ' PRO . 12.2 t-105 -75.03 -86.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 47.52 23.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.437 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.741 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -73.01 -43.69 7.87 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.741 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 51.4 Cg_endo -75.52 -65.06 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.204 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.07 -42.51 0.41 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -82.5 142.79 31.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.387 . . . . 0.0 111.101 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.46 -179.73 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HD12 ' A' ' 128' ' ' ILE . 3.5 tp -45.5 -34.86 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.25 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 28' ' ' VAL . 1.1 mp -68.67 -57.15 6.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.5 -33.67 67.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.269 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -58.2 -65.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.944 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 132' ' ' ILE . 4.1 mt -57.69 -30.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.995 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.13 -41.27 78.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.79 -49.1 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.431 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 17.2 ttm -58.79 -35.41 72.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.057 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 128' ' ' ILE . 35.7 mt -70.06 -41.87 79.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.627 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 129' ' ' GLN . 58.3 t -66.21 -52.1 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.442 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 55.8 t -59.55 -51.33 74.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.845 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.44 -16.45 64.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.246 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -63.49 -40.73 99.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.342 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.27 -43.29 5.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 106.01 12.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 110.57 2.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.46 2.107 . . . . 0.0 112.037 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.449 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.6 Cg_endo -83.41 -25.35 2.63 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.551 2.168 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.3 p -155.95 87.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 96' ' ' THR . 48.8 p90 -92.24 130.09 38.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.371 . . . . 0.0 111.366 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.0 t -88.01 165.41 15.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.51 156.58 85.08 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.508 2.139 . . . . 0.0 112.312 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 120.713 0.214 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.611 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.8 OUTLIER -60.33 171.69 0.92 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.478 0.656 . . . . 0.0 111.051 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 17.1 Cg_endo -91.18 -83.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.504 2.803 . . . . 0.0 109.463 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.74 -54.39 0.36 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.469 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 89.49 156.1 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 16.9 Cg_exo -65.22 160.79 40.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.914 2.409 . . . . 0.0 112.407 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.468 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 87.7 Cg_endo -83.74 176.93 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.619 2.213 . . . . 0.0 112.817 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -159.6 -135.12 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.29 -179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.827 0.346 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.65 -27.76 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -22.33 46.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.049 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.61 -44.01 65.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 -43.24 95.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.79 -28.6 64.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.542 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.61 -56.57 20.4 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.453 0.471 . . . . 0.0 110.72 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -54.97 -44.79 74.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.922 0.392 . . . . 0.0 110.741 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -72.47 -19.19 61.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.02 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.659 ' HG2' HD23 ' A' ' 39' ' ' LEU . 2.1 ttm -63.72 -29.04 70.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.908 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' CD1' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -103.8 -87.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.847 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 12' ' ' VAL . 12.6 m 64.97 9.97 5.85 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 17.6 ttpt -156.91 13.89 0.26 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.835 0.35 . . . . 0.0 111.749 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -71.96 158.14 36.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.951 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -36.38 81.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.04 0.448 . . . . 0.0 110.153 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.53 70.96 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.536 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -48.18 -46.88 35.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.327 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -58.03 -58.08 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.386 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.0 -23.57 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.399 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 15' ' ' TYR . 84.6 m -81.34 -46.46 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.535 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 18' ' ' ARG . 69.4 t -65.33 -47.26 87.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.6 -45.69 91.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 28' ' ' VAL . 44.8 mt-10 -62.39 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.3 m -59.94 -58.86 6.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.931 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -54.15 -40.37 46.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.333 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -56.84 -45.06 82.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.124 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.46 -54.42 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.42 -39.85 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.542 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -68.08 -31.68 71.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.38 -31.08 21.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.38 -49.04 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.1 -3.35 2.18 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -117.06 -24.07 7.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -86.02 156.85 20.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.593 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -149.8 149.56 28.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.44 138.73 14.04 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.65 2.233 . . . . 0.0 112.545 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -138.85 142.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.61 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.9 tm? -90.67 149.1 22.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.849 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.1 t70 -157.38 162.41 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.942 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -163.23 116.34 1.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.752 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.407 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.3 t80 -140.12 169.18 18.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.809 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG12 ' N ' ' A' ' 49' ' ' SER . 16.1 m -84.35 149.85 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 46' ' ' ASP . 16.7 m-85 -147.27 -67.05 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.489 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -56.67 83.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.881 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' PHE . 63.7 m-20 52.16 24.31 2.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 0.0 111.365 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.47 77.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.531 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -155.55 98.1 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.699 0.285 . . . . 0.0 110.375 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.876 ' N ' HG12 ' A' ' 43' ' ' VAL . 1.9 m -50.82 139.87 16.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.489 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -141.59 135.49 30.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.642 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.5 112.42 11.81 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.487 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.855 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -146.25 131.86 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.14 0.495 . . . . 0.0 111.118 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 52' ' ' LEU . 39.4 ttp -80.49 162.67 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.144 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.9 160.06 43.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 35' ' ' LEU . 4.4 mm? -100.4 141.84 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 38' ' ' VAL . 10.0 t -145.74 150.44 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 173.93 21.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.62 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 207' ' ' PRO . 0.2 OUTLIER -92.12 122.3 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.051 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 132' ' ' ILE . 26.1 mt -95.73 135.59 22.89 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 90.2 Cg_endo -82.59 109.65 1.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.564 2.176 . . . . 0.0 112.553 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.9 t -104.78 112.15 65.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.8 Cg_endo -70.66 128.93 15.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.461 2.108 . . . . 0.0 112.537 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -161.14 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -54.43 -30.44 52.57 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.24 21.91 0.2 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.9 m120 -144.21 -162.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 110.633 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.1 m -158.2 115.08 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 26.4 m-85 -96.95 165.25 12.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -100.84 88.79 3.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -77.15 120.96 83.77 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.338 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.85 145.81 36.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.436 2.091 . . . . 0.0 112.142 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -148.24 170.06 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.276 0.56 . . . . 0.0 112.001 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' HG23 ' A' ' 72' ' ' ILE . 18.2 t -158.3 101.68 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.909 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.507 HD21 ' CE ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -99.43 125.74 45.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.936 0.398 . . . . 0.0 111.621 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HE3' HD21 ' A' ' 52' ' ' LEU . 95.9 m95 -81.46 103.87 11.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.334 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 124' ' ' LEU . 2.9 tp -95.68 96.38 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.591 HD21 ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -71.7 176.68 4.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.424 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' C ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -68.87 49.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.711 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER 53.39 24.33 3.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 0.0 111.366 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -112.13 135.03 21.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.73 -19.14 18.8 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.351 0.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -158.97 -45.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.77 125.16 4.55 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.16 111.7 3.34 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.464 2.109 . . . . 0.0 112.341 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 114' ' ' LEU . 87.8 Cg_endo -82.85 -10.87 10.37 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.593 2.195 . . . . 0.0 112.801 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.3 132.4 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.814 ' CB ' HD12 ' A' ' 109' ' ' ILE . 18.8 m -140.17 141.48 36.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 24.4 m-85 -145.11 138.63 26.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.072 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 107' ' ' GLY . 9.9 p -92.86 150.7 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -105.55 77.6 0.39 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.366 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' HG13 ' A' ' 89' ' ' VAL . 87.2 Cg_endo -76.28 124.04 7.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.347 2.032 . . . . 0.0 112.585 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' HG2' ' B' ' 207' ' ' PRO . 68.8 p -78.75 168.73 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -43.65 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.593 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -82.54 -2.54 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.338 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 36.1 ttm -93.27 164.49 13.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.545 0.212 . . . . 0.0 110.586 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 141' ' ' VAL . 3.0 m -137.88 123.91 20.25 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.299 0.571 . . . . 0.0 111.647 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 91' ' ' PRO . 6.3 mt -71.67 138.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.12 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -103.27 100.91 10.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.841 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 104' ' ' ASP . 2.0 p -70.9 147.26 48.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.01 -164.85 32.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.628 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -57.1 -17.71 11.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.828 0.347 . . . . 0.0 111.596 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -101.72 -12.02 18.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 25.8 t -155.02 153.37 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.679 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.803 ' O ' HG22 ' A' ' 99' ' ' THR . 30.2 m-20 -87.47 -66.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.488 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 170.59 -27.1 0.0 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.849 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.2 10.26 34.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.499 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.872 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 99.43 -20.3 50.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.799 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -68.49 141.88 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 0.0 110.726 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 87' ' ' CYS . 31.0 mt -80.78 134.95 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 32.2 t80 -140.81 98.67 3.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.905 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 113' ' ' TYR . 1.6 pt? -168.01 -179.27 0.72 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.206 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 111' ' ' LEU . 60.5 Cg_endo -76.35 87.94 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.987 1.791 . . . . 0.0 112.836 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.69 ' CD2' HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.29 -60.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.33 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -73.29 -52.77 12.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.99 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 1.1 p-80 -68.2 -6.7 24.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.101 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -94.85 -80.86 0.4 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 120.674 0.274 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CH2' ' CD2' ' A' ' 119' ' ' HIS . 32.2 t-105 -75.32 -107.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.921 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.1 61.49 2.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.968 0.414 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.721 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.17 -39.56 4.19 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.721 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 14.2 Cg_exo -69.46 -56.87 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.612 0.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 13.6 mm-40 69.76 -53.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.742 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 139.49 34.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 -179.57 3.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.834 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.001 HD11 HD11 ' A' ' 76' ' ' LEU . 6.2 tp -43.22 -38.72 2.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.388 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 mp -68.84 -50.2 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -59.99 -31.98 74.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -65.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 132' ' ' ILE . 4.0 mt -57.68 -31.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.62 -39.78 77.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.651 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 126' ' ' GLY . 58.4 t -64.84 -44.54 96.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.57 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.507 ' CE ' HD21 ' A' ' 74' ' ' LEU . 6.5 mtm -58.59 -39.47 80.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.078 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.662 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -65.29 -41.95 92.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 129' ' ' GLN . 46.2 t -66.48 -52.13 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.54 -51.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.87 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 131' ' ' MET . 22.6 m-85 -65.89 -15.08 62.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -58.96 -34.46 78.84 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.85 -39.59 3.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.815 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.77 107.66 14.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.87 110.57 2.4 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.263 1.976 . . . . 0.0 112.341 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 135' ' ' PHE . 97.4 Cg_endo -83.59 -32.94 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.469 2.113 . . . . 0.0 112.837 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -155.67 84.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.848 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.424 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 48.9 p90 -88.63 128.5 35.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 208' ' ' THR . 39.7 t -89.69 163.92 14.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.704 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 143.71 76.49 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 C--O 1.247 0.952 0 C-N-CA 122.471 2.114 . . . . 0.0 112.351 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.779 0.241 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.636 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 2.6 pm0 -59.83 173.87 0.5 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.264 0.554 . . . . 0.0 111.216 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.641 ' HG2' HG21 ' A' ' 92' ' ' THR . 16.6 Cg_endo -91.26 -77.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.296 2.664 . . . . 0.0 109.052 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 64.87 -57.51 0.27 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 88.83 158.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.659 0.266 . . . . 0.0 111.186 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.43 ' HD3' HD12 ' A' ' 70' ' ' ILE . 12.4 Cg_exo -67.26 121.83 9.02 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.839 2.359 . . . . 0.0 111.864 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.98 165.34 16.79 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.191 1.927 . . . . 0.0 112.452 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -141.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.285 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -93.68 -28.24 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -17.66 56.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.443 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.41 -46.04 66.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -48.03 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.7 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -26.01 63.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.813 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.4 tp -59.34 -43.42 92.77 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 12' ' ' VAL . 31.3 tttm -54.89 -47.14 74.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.775 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -71.26 -19.69 62.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -62.53 -22.14 66.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -102.34 -82.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 -43.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -79.51 -1.36 37.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.865 ' CD2' HG21 ' A' ' 21' ' ' THR . 3.0 m-85 -70.91 138.76 50.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.735 0.302 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tptm -59.72 -28.59 67.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.41 67.48 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.136 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.4 mtm180 -46.9 -56.26 6.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.265 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.86 -53.31 59.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.444 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -23.31 67.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.205 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.865 HG21 ' CD2' ' A' ' 15' ' ' TYR . 96.8 m -83.81 -44.02 14.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.9 t -61.59 -43.83 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -59.6 -42.93 93.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 28' ' ' VAL . 78.5 mt-10 -62.71 -43.42 98.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.724 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -59.83 -58.65 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 27' ' ' ASN . 25.4 m -53.96 -42.17 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' HB3' HD11 ' A' ' 125' ' ' LEU . 3.6 m120 -55.43 -41.02 72.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.4 t -63.18 -50.27 79.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.13 -29.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.5 m -68.77 -25.51 64.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.228 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.53 -43.73 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.341 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 23.9 m-85 -83.68 -32.16 25.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.206 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 54.85 15.08 1.02 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.77 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -117.56 -24.34 7.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.769 0.318 . . . . 0.0 111.075 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.87 165.22 15.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -150.83 139.79 13.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.645 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.95 137.8 30.03 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 56' ' ' THR . 0.8 OUTLIER -136.91 144.34 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -89.97 150.01 22.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.096 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.691 ' H ' HD13 ' A' ' 39' ' ' LEU . 2.2 m-20 -157.77 162.7 38.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.761 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -162.99 134.63 5.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 t80 -137.89 160.24 39.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 49' ' ' SER . 33.4 m -84.64 147.3 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.22 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 66.1 m-85 -147.05 -67.65 0.26 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.117 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.57 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.532 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.64 24.8 2.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.391 -0.193 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.76 75.7 1.24 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.13 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -156.58 106.37 2.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.381 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' HG12 ' A' ' 43' ' ' VAL . 75.8 p -48.07 142.96 4.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -130.0 135.8 48.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.629 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 112.6 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 52' ' ' LEU . 16.3 mt -143.28 122.95 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.03 161.12 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -148.43 156.85 43.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.74 145.1 31.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.197 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 38' ' ' VAL . 6.1 t -146.63 164.45 32.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.08 -146.23 17.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.807 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -147.99 119.11 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 132' ' ' ILE . 25.0 pt -93.92 145.35 29.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.155 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.43 116.79 4.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.555 2.17 . . . . 0.0 112.399 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 136' ' ' GLY . 6.2 t -116.57 110.31 42.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.56 145.77 38.04 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.821 2.347 . . . . 0.0 112.197 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -126.14 29.38 5.85 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 70.01 68.76 0.22 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 -25.32 5.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.289 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -141.37 -176.14 4.61 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -157.82 116.05 3.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.795 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 3.8 m-85 -98.43 -173.4 2.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.743 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.1 OUTLIER -122.05 92.36 3.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.77 0.319 . . . . 0.0 111.282 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.471 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.8 tp -73.5 125.84 90.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.01 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.4 Cg_endo -66.71 149.83 83.67 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.167 1.911 . . . . 0.0 111.972 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 71' ' ' PRO . 20.1 mm -143.87 144.74 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.079 0.466 . . . . 0.0 111.311 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.6 100.86 1.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.3 pt? -138.0 148.0 44.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.292 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.402 ' CH2' ' HB3' ' A' ' 40' ' ' ASP . 29.8 m95 -77.95 -173.11 2.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 124' ' ' LEU . 4.1 tp -140.18 138.03 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -70.0 -160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.276 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' OD2' HD21 ' A' ' 52' ' ' LEU . 1.1 p30 -168.71 31.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.775 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 79' ' ' THR . 43.2 m -145.13 11.37 1.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.022 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 44.9 t80 -33.35 140.1 0.24 Allowed Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 122.442 0.297 . . . . 0.0 111.676 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 59.4 Cg_endo -71.91 124.62 8.91 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.729 -1.363 . . . . 0.0 112.737 0.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' N ' ' HA ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -158.84 -40.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.681 ' HB3' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER 64.62 127.56 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.799 ' HG3' HD12 ' A' ' 76' ' ' LEU . 94.3 Cg_endo -78.84 112.5 3.12 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.525 2.15 . . . . 0.0 112.482 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.07 -23.88 28.9 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.382 2.055 . . . . 0.0 112.303 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.7 mm -63.28 105.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.737 ' HB2' HD12 ' A' ' 109' ' ' ILE . 2.7 m -145.25 124.97 13.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.226 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.37 147.65 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.014 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 107' ' ' GLY . 8.4 p -94.95 143.23 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.072 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -98.07 105.31 27.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.13 124.47 3.34 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.689 2.259 . . . . 0.0 112.622 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HG2' ' B' ' 207' ' ' PRO . 58.9 p -78.55 167.24 21.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.084 0.469 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -40.93 70.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.267 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -86.26 -2.02 58.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.245 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.467 ' HG2' HG22 ' A' ' 141' ' ' VAL . 49.2 ttm -93.4 163.63 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.781 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -140.71 129.62 23.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.153 0.501 . . . . 0.0 111.549 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 98' ' ' LYS . 5.3 mt -70.92 157.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.432 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.3 tmtt? -137.98 122.1 17.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.61 134.38 47.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.048 0.451 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.56 -179.03 35.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.58 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.827 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -55.36 -26.38 40.86 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.0 110.908 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 3.2 m170 -93.13 -59.51 2.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.16 138.43 19.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.853 ' O ' HG22 ' A' ' 99' ' ' THR . 86.8 m-20 -88.68 -67.55 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.653 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 172.58 34.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.764 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 4.7 1.79 Allowed 'General case' 0 C--N 1.341 0.202 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.892 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 93.0 -33.69 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -69.81 158.04 36.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.966 0.412 . . . . 0.0 111.351 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 87' ' ' CYS . 18.3 mt -81.77 141.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CG ' ' OD2' ' A' ' 104' ' ' ASP . 28.9 t80 -141.62 98.5 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.178 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -178.86 130.83 0.27 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.534 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.763 ' HD2' HD13 ' A' ' 111' ' ' LEU . 45.7 Cg_endo -68.62 62.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.496 2.131 . . . . 0.0 112.402 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 40.5 p90 -86.58 -46.94 9.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.803 HD23 ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -73.8 -44.3 56.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.732 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -64.17 -10.7 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.522 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.25 -52.39 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -75.12 -103.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.756 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HG3' HD23 ' A' ' 114' ' ' LEU . 34.2 mtpt 52.73 62.45 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.767 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -74.16 -38.68 3.75 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.767 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -70.54 -62.05 0.04 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.31 0.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 2.6 tm0? 74.75 -56.8 0.63 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.68 133.85 35.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -103.07 -179.69 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.978 HD11 HD11 ' A' ' 76' ' ' LEU . 8.6 tp -45.38 -37.02 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.1 mp -68.65 -36.63 78.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.83 -29.9 68.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 127' ' ' LEU . 5.5 tt -57.84 -60.28 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 128' ' ' ILE . 5.3 mp -57.78 -30.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.57 -41.27 80.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.57 -48.91 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.469 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 9.7 ttm -58.56 -34.81 71.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 0.0 110.066 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.939 HG12 HD12 ' A' ' 59' ' ' ILE . 83.1 mt -70.08 -39.57 77.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.434 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.4 t -66.47 -52.31 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.321 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.422 HG11 ' CE1' ' A' ' 102' ' ' HIS . 54.5 t -60.25 -51.55 71.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.805 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 11.9 m-30 -67.51 -13.56 62.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.313 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.24 -32.64 83.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.487 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 -41.79 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.387 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 11.8 mt-10 -89.07 106.6 13.83 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.14 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 110.18 2.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.773 2.315 . . . . 0.0 111.885 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 90.2 Cg_endo -81.46 -26.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.766 2.311 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.7 p -156.0 88.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.17 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 49.1 p90 -91.25 132.01 36.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.124 0.487 . . . . 0.0 111.041 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' B' ' 208' ' ' THR . 27.5 t -88.07 168.04 13.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.789 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -75.88 149.37 82.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.748 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.435 2.09 . . . . 0.0 112.272 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.531 -0.219 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.608 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.4 OUTLIER -60.34 172.6 0.73 Allowed Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-O 121.287 0.565 . . . . 0.0 111.212 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.1 Cg_endo -89.3 -80.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.297 2.665 . . . . 0.0 109.535 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.726 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.2 -58.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.359 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 92.69 160.82 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 120.677 0.275 . . . . 0.0 111.048 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.471 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 10.3 Cg_exo -69.05 149.8 71.8 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.671 2.247 . . . . 0.0 112.159 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 69.3 Cg_endo -74.57 174.87 11.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.461 2.107 . . . . 0.0 112.667 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -156.91 -143.11 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.973 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.964 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.6 -19.32 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.343 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -12.51 60.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 26' ' ' VAL . 3.1 tt0 -52.54 -46.13 66.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -60.97 -46.15 91.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -24.28 62.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -58.52 -48.26 81.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.723 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -52.12 -44.44 64.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.029 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -74.9 -21.31 59.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.421 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 2.4 ptm -63.42 -25.59 68.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG23 ' H ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -99.48 -80.07 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.429 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 50.12 29.08 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.677 0.275 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 4.6 tttp -156.31 77.27 0.93 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 6.8 m-85 -163.26 162.97 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.033 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 0.3 OUTLIER -59.35 -33.34 71.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.372 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' THR . 45.3 m-85 -139.54 72.52 1.4 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.6 ttp180 -47.82 -56.02 8.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -58.86 -52.27 66.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.315 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -25.8 68.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.316 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' TYR . 92.6 m -81.55 -44.44 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 18' ' ' ARG . 63.5 t -64.87 -37.91 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.609 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -59.49 -42.56 92.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.4 mt-10 -64.22 -43.59 94.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.477 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -60.75 -57.65 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 8' ' ' LEU . 28.7 m -53.54 -41.52 46.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.303 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.0 t-20 -56.05 -44.57 78.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.266 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG22 HD12 ' A' ' 125' ' ' LEU . 40.4 t -63.28 -47.43 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.309 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' LEU . 25.7 pt -72.99 -30.13 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.386 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 m -68.0 -28.0 67.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tp -89.04 -44.83 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 23.4 m-85 -79.56 -50.3 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 73.16 6.75 5.27 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.523 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.03 -19.57 9.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.323 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.7 tp -86.24 107.92 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -91.86 122.81 64.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.6 123.03 11.11 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.312 2.008 . . . . 0.0 112.179 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.4 p -112.7 144.12 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -92.56 157.32 16.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.622 ' H ' HD13 ' A' ' 39' ' ' LEU . 4.9 t0 -158.54 159.4 35.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -163.98 120.68 1.68 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.95 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.6 t80 -138.42 168.15 20.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.639 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 49' ' ' SER . 35.9 m -85.8 146.82 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.882 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 32.6 m-85 -146.92 -67.22 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.148 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -56.72 84.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.804 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' PHE . 61.8 m-20 52.01 24.83 2.82 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.544 0.527 . . . . 0.0 111.31 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.24 74.49 1.19 Allowed Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.486 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -156.82 112.38 2.9 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.639 0.257 . . . . 0.0 110.604 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.401 ' N ' HG12 ' A' ' 43' ' ' VAL . 19.6 p -51.5 145.06 9.28 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.236 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.79 136.11 28.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.817 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 119.35 13.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.89 111.05 6.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.012 0.434 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.44 ' HG2' HD22 ' A' ' 39' ' ' LEU . 3.4 tmm? -80.29 160.75 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 38' ' ' VAL . 2.3 p-10 -149.64 157.17 43.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.702 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.59 138.74 38.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -146.07 138.17 25.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.79 169.03 19.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.529 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.7 p -92.89 126.22 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.308 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 72' ' ' ILE . 4.1 mt -96.35 135.66 22.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.011 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 115.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.234 1.956 . . . . 0.0 111.746 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 132' ' ' ILE . 6.3 t -130.42 118.55 18.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.224 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 43.3 Cg_endo -67.58 130.57 22.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.657 2.238 . . . . 0.0 111.837 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' B' ' 211' ' ' PRO . 3.7 t80 -100.65 -133.35 0.28 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.79 24.72 1.68 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.163 -0.336 . . . . 0.0 111.045 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.99 -14.62 0.41 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.691 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -145.52 144.4 30.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.533 0.666 . . . . 0.0 111.721 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 61' ' ' VAL . 7.3 m -84.33 121.16 27.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.701 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.457 ' CZ ' ' CD ' ' B' ' 211' ' ' PRO . 1.4 m-85 -96.73 -172.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 207' ' ' PRO . 0.0 OUTLIER -122.56 86.71 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' HD3' ' B' ' 210' ' ' PRO . 1.7 tp -75.07 126.26 88.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 89' ' ' VAL . 57.4 Cg_endo -71.85 147.55 50.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.311 2.007 . . . . 0.0 112.053 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 71' ' ' PRO . 27.6 mm -144.94 148.93 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 t -158.12 105.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.35 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -138.44 150.08 46.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 111.335 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -78.81 175.07 10.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.077 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' HG3' ' A' ' 84' ' ' PRO . 10.2 tp -144.87 105.2 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -70.18 174.6 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' H ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.3 -58.54 6.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.719 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.8 t 179.08 49.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.644 ' O ' HD22 ' A' ' 77' ' ' LEU . 5.5 t80 -174.02 108.48 0.3 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.03 -166.5 2.05 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.315 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.97 0.46 31.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.686 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' O ' HD11 ' A' ' 114' ' ' LEU . 12.9 m120 -150.21 136.78 10.98 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 76' ' ' LEU . 45.9 Cg_endo -68.25 110.31 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.472 2.115 . . . . 0.0 112.321 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 -37.31 5.87 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.394 2.063 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 3.0 mt -63.55 109.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 109' ' ' ILE . 3.2 m -144.77 125.87 14.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.251 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -146.72 150.31 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.694 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.6 p -96.3 145.55 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.404 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -102.43 93.36 3.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.8 Cg_endo -73.08 126.26 11.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.539 2.16 . . . . 0.0 112.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG2' ' B' ' 207' ' ' PRO . 70.4 p -77.92 167.14 21.97 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.087 0.47 . . . . 0.0 110.913 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -55.04 -42.02 72.13 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 m -82.85 -3.28 56.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.733 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.49 ' HG2' HG22 ' A' ' 141' ' ' VAL . 46.1 ttm -92.98 166.41 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -137.22 124.0 21.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.305 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' O ' ' A' ' 105' ' ' ALA . 2.6 mm -70.1 124.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 103.71 14.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.493 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.836 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.6 p -70.19 154.11 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . 162.71 -177.52 38.78 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.064 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -23.44 19.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.779 0.323 . . . . 0.0 111.441 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 138' ' ' GLU . 45.1 m80 -98.19 -1.41 42.16 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' GLY . 3.7 t -154.34 150.19 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.954 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 99' ' ' THR . 0.9 OUTLIER -87.91 -67.03 0.85 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.228 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.715 ' O ' HG21 ' A' ' 97' ' ' ILE . . . 172.35 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.472 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -96.96 7.96 45.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.655 0.264 . . . . 0.0 111.27 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.766 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 98.19 -6.33 61.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -69.23 139.8 54.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 110.832 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.714 HD12 ' HB2' ' A' ' 87' ' ' CYS . 34.0 mt -81.23 122.74 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.999 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.01 45.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -126.1 101.96 28.21 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.24 63.1 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.429 2.086 . . . . 0.0 112.186 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 111' ' ' LEU . 41.0 m-85 -48.5 -45.59 37.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -71.86 -46.86 56.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.98 -17.4 62.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.272 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -78.08 0.46 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.971 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -75.36 -99.75 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.99 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HG3' HD23 ' A' ' 114' ' ' LEU . 1.0 OUTLIER 53.62 65.79 1.41 Allowed 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 121.059 0.457 . . . . 0.0 111.09 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.764 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -74.46 -38.0 3.2 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.764 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 40.1 Cg_endo -71.02 -65.19 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.939 -1.276 . . . . 0.0 113.312 0.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 77.05 -52.47 0.56 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.671 0.272 . . . . 0.0 111.115 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 132.72 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.968 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.8 -179.88 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 128' ' ' ILE . 5.4 tp -49.85 -38.94 37.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 28' ' ' VAL . 5.6 mp -68.09 -41.64 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.85 -30.48 76.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.407 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.14 -62.77 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 124' ' ' LEU . 5.0 mp -57.72 -30.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.802 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.15 -41.51 79.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.698 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.68 -49.01 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.509 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 30.8 ttm -58.67 -33.99 70.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.052 0.453 . . . . 0.0 110.049 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 61' ' ' VAL . 82.0 mt -70.0 -40.23 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.3 t -66.75 -52.07 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.392 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.78 -50.17 80.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.764 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.4 m-30 -65.25 -13.25 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.396 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.514 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -64.05 -34.4 89.82 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.551 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.31 -42.84 3.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 110.74 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' OE1' ' CE1' ' A' ' 102' ' ' HIS . 5.1 tt0 -88.74 107.92 20.14 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.95 110.42 3.08 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 98.0 Cg_endo -79.04 -27.51 4.5 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.48 2.12 . . . . 0.0 112.593 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.721 ' O ' HG13 ' A' ' 141' ' ' VAL . 8.9 p -156.49 91.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.087 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' B' ' 211' ' ' PRO . 25.3 p90 -92.33 132.41 36.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.509 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' B' ' 208' ' ' THR . 29.1 t -88.87 166.92 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.001 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.73 150.55 84.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.964 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.302 2.001 . . . . 0.0 112.199 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 120.716 0.215 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.606 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 0.7 OUTLIER -59.54 172.18 0.68 Allowed Pre-proline 0 CA--C 1.513 -0.465 0 CA-C-O 121.269 0.557 . . . . 0.0 111.194 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 9.3 Cg_endo -88.3 -80.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.322 2.681 . . . . 0.0 109.619 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.25 -59.67 0.26 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.127 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 93.72 162.96 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.855 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 70' ' ' ILE . 3.1 Cg_exo -77.27 124.11 7.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.532 2.155 . . . . 0.0 112.695 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 142' ' ' PHE . 38.9 Cg_endo -68.3 166.78 24.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.505 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -109.42 173.77 6.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.771 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.87 0.367 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 3' ' ' VAL . 21.2 t -100.67 1.17 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.62 51.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.188 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -46.09 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.688 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -28.27 64.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD21 ' HB ' ' A' ' 25' ' ' THR . 1.8 tp -59.68 -56.99 14.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.807 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.3 tmmt? -53.92 -45.73 71.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -70.98 -25.03 62.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.818 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -23.7 65.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -103.64 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m 55.51 24.62 7.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.328 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -152.84 -0.76 0.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.634 ' CD2' HG21 ' A' ' 21' ' ' THR . 2.1 m-30 -71.82 150.28 44.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.601 0.238 . . . . 0.0 110.471 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' CB ' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -61.5 -28.41 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.241 179.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.83 56.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.287 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.7 ttp-105 -46.71 -47.85 20.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.258 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.02 -52.88 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -28.45 68.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 15' ' ' TYR . 56.7 m -80.04 -47.97 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 18' ' ' ARG . 92.0 t -62.48 -41.63 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.649 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -59.48 -43.6 93.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.4 mt-10 -64.69 -43.57 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.677 ' HB ' HD21 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -61.11 -57.38 12.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.986 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 27' ' ' ASN . 35.6 m -53.15 -42.3 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.135 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.415 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t-20 -56.21 -42.91 77.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.024 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.78 HG22 HD12 ' A' ' 125' ' ' LEU . 39.0 t -63.17 -52.58 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 35' ' ' LEU . 24.4 pt -66.85 -34.24 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.187 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.0 m -67.93 -22.02 65.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.79 -44.53 5.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 83.6 m-85 -90.78 -45.47 8.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.057 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 65.39 15.86 10.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.355 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -117.03 -24.04 7.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.26 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 29' ' ' ILE . 4.4 mp -86.19 100.65 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.5 tttt -90.19 104.64 9.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.73 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 26.6 Cg_endo -62.53 122.26 10.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.242 1.961 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 56' ' ' THR . 3.7 m -102.96 148.25 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 39' ' ' LEU . 1.6 tm? -91.5 89.36 7.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.64 0.257 . . . . 0.0 111.315 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' ND2' ' A' ' 54' ' ' ASN . 12.1 t70 -85.91 159.5 19.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.783 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 t -165.36 104.03 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -141.44 169.44 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.531 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.778 HG12 ' N ' ' A' ' 49' ' ' SER . 31.0 m -85.94 148.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.564 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.482 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 69.3 m-85 -147.63 -67.49 0.25 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.773 0.32 . . . . 0.0 111.436 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -56.82 85.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.607 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 51.63 24.46 2.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.139 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.45 76.58 1.3 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -155.5 99.21 2.02 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 110.458 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.778 ' N ' HG12 ' A' ' 43' ' ' VAL . 7.6 t -52.83 130.42 33.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.304 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.772 ' HD3' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.41 134.8 47.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.63 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 111.82 15.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD12 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.83 127.12 13.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.06 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.7 tmm? -79.99 124.99 29.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.675 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 52' ' ' LEU . 94.5 m-20 -95.61 153.82 17.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.3 mm? -101.55 127.49 48.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.454 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.517 HG22 HG13 ' A' ' 38' ' ' VAL . 5.2 t -143.88 135.63 26.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.065 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.21 -147.33 9.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -148.79 112.82 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.723 0.297 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.867 HD12 HG12 ' A' ' 132' ' ' ILE . 32.8 pt -91.86 145.58 31.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.837 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.85 116.71 4.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.617 2.211 . . . . 0.0 112.866 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' A' ' 136' ' ' GLY . 15.1 t -107.83 104.56 53.64 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.259 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.66 129.63 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.638 2.225 . . . . 0.0 112.706 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -101.56 -162.0 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -55.38 -27.5 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.043 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.51 26.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.777 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -144.12 -176.08 4.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.651 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.6 m -158.52 104.05 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.555 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' B' ' 211' ' ' PRO . 11.0 m-85 -97.84 -174.4 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.0 OUTLIER -118.97 95.14 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 59' ' ' ILE . 2.2 tp -73.71 131.15 82.4 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.149 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.515 ' O ' HD13 ' A' ' 72' ' ' ILE . 59.8 Cg_endo -74.09 150.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.287 1.991 . . . . 0.0 112.11 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 71' ' ' PRO . 22.3 mm -142.77 157.55 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.205 0.526 . . . . 0.0 111.49 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 19.7 t -155.24 88.22 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.323 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.714 HD11 ' SG ' ' A' ' 87' ' ' CYS . 0.8 OUTLIER -102.81 125.87 49.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.832 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 52' ' ' LEU . 27.5 m95 -82.74 112.6 19.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.421 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -98.02 99.64 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 111.497 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' NH2' ' A' ' 50' ' ' ARG . 1.1 mt -72.27 172.39 10.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 15' ' ' TYR . 3.1 m-20 -65.98 -55.6 15.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.648 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.868 HG21 ' CB ' ' A' ' 16' ' ' LYS . 4.0 t 178.48 52.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.536 ' O ' HD13 ' A' ' 77' ' ' LEU . 3.8 m-85 -152.45 132.63 7.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.075 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -32.61 4.45 Favored 'Cis proline' 0 C--N 1.347 0.455 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.241 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.31 -42.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.455 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.869 ' HB3' HD23 ' A' ' 114' ' ' LEU . 6.9 t30 -149.08 131.8 7.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.444 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.58 108.73 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.61 2.207 . . . . 0.0 112.662 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.24 -19.34 2.47 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.729 2.286 . . . . 0.0 112.562 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' CG2' ' CE2' ' A' ' 88' ' ' PHE . 33.7 mt -63.4 115.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.714 ' SG ' HD11 ' A' ' 74' ' ' LEU . 3.7 m -144.52 126.55 15.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.405 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -147.13 154.33 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 71' ' ' PRO . 14.1 p -95.47 142.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -95.78 106.87 30.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.4 Cg_endo -88.91 125.37 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.899 2.399 . . . . 0.0 112.607 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.481 ' CG2' ' HG2' ' B' ' 207' ' ' PRO . 80.0 p -78.35 167.75 20.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.673 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -29.66 59.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.586 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -98.83 -1.66 39.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 141' ' ' VAL . 50.0 ttm -93.52 163.11 13.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.914 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -138.54 125.91 21.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.187 0.518 . . . . 0.0 110.9 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' HG23 ' A' ' 141' ' ' VAL . 4.1 mt -70.36 134.46 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.252 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -106.12 105.88 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.892 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.4 p -70.88 144.72 50.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.027 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.17 -175.27 41.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.34 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.99 -25.28 28.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.877 0.37 . . . . 0.0 111.078 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.452 ' CD2' HD23 ' A' ' 111' ' ' LEU . 9.5 m80 -95.1 -58.47 2.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.386 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -81.45 146.68 7.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.732 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.878 ' O ' HG22 ' A' ' 99' ' ' THR . 10.5 m-20 -88.38 -67.12 0.85 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 171.24 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.24 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.97 10.08 38.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 97' ' ' ILE . . . 98.61 -16.04 60.23 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.886 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.69 137.19 53.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 87' ' ' CYS . 30.3 mt -81.23 122.76 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.053 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -98.06 70.88 2.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.723 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -157.18 113.8 1.93 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.826 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 111' ' ' LEU . 50.3 Cg_endo -68.77 63.95 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.172 1.915 . . . . 0.0 112.587 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 111' ' ' LEU . 47.2 m-85 -59.34 -64.53 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 83' ' ' ASN . 6.4 mp -71.65 -34.29 69.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.345 0.593 . . . . 0.0 110.721 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -13.99 44.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.742 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -94.76 -66.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.047 0.451 . . . . 0.0 111.048 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 121' ' ' GLN . 8.6 t90 -74.99 -88.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.993 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 49.31 61.81 2.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.011 0.434 . . . . 0.0 111.4 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.766 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.56 -38.34 3.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.766 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 38.3 Cg_endo -70.76 -67.74 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.711 0 C-N-CA 123.914 -1.286 . . . . 0.0 113.277 0.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 80.55 -48.37 0.3 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.267 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 1.1 t -82.99 147.25 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.841 0.353 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.68 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -52.53 -27.73 17.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 28' ' ' VAL . 1.5 mp -67.62 -56.73 8.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -56.95 -31.75 61.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -67.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 132' ' ' ILE . 4.3 mp -57.81 -32.7 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -56.85 -44.02 81.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.828 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 126' ' ' GLY . 69.6 t -64.6 -48.15 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.474 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 72' ' ' ILE . 9.7 ttm -58.61 -33.2 69.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 109.915 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.867 HG12 HD12 ' A' ' 59' ' ' ILE . 33.8 mt -70.02 -40.48 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.444 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 129' ' ' GLN . 61.7 t -66.54 -52.28 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.34 -51.46 72.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.011 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 8.2 m-30 -66.84 -18.08 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.256 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -59.7 -39.47 95.27 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.03 -40.28 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.612 -0.346 . . . . 0.0 110.694 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.75 107.08 15.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.17 111.01 3.08 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.001 1.8 . . . . 0.0 112.067 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 96.3 Cg_endo -85.4 -26.12 1.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.884 2.389 . . . . 0.0 112.522 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.1 p -155.95 84.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.27 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' B' ' 212' ' ' GLU . 50.7 p90 -89.17 129.8 35.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.105 0.479 . . . . 0.0 111.225 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' B' ' 208' ' ' THR . 31.4 t -88.22 166.85 14.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 147.26 83.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.247 0.973 0 C-N-CA 122.58 2.187 . . . . 0.0 112.318 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 N-CA-C 111.524 -0.222 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.61 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.7 pm0 -59.64 172.25 0.68 Allowed Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 121.265 0.555 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' B' ' 206' ' ' GLU . 11.4 Cg_endo -89.16 -82.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 123.308 2.672 . . . . 0.0 109.658 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.4 OUTLIER 65.36 -57.64 0.3 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.151 178.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 208' ' ' THR . . . 91.88 158.26 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.575 0.226 . . . . 0.0 111.186 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.45 ' CD ' HD13 ' A' ' 70' ' ' ILE . 6.3 Cg_exo -71.17 151.5 61.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.602 2.201 . . . . 0.0 112.136 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 68' ' ' TYR . 62.8 Cg_endo -73.44 177.19 8.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.561 2.174 . . . . 0.0 112.364 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 142' ' ' PHE . 1.6 tm-20 -152.12 -67.51 0.17 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.446 0.641 . . . . 0.0 111.27 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.804 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.819 0.343 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.87 -26.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -13.39 59.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 111.584 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -52.5 -46.04 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.878 0.37 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -59.42 -44.77 92.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.714 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -28.92 65.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.952 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -59.31 -50.23 74.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.692 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' CG ' HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -55.0 -44.18 74.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.07 -24.62 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.56 ' CE ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -61.67 -21.35 64.36 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -105.47 -82.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.082 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m 55.78 30.8 16.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -154.21 -4.44 0.17 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.817 ' CD2' HG11 ' A' ' 12' ' ' VAL . 1.6 m-85 -71.22 160.89 32.02 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -62.01 -36.76 82.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 16' ' ' LYS . 68.5 m-85 -139.27 74.07 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.516 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 mtm180 -48.2 -50.25 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.387 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.6 -57.0 14.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -22.39 66.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.474 HG21 ' CD2' ' A' ' 15' ' ' TYR . 85.9 m -82.86 -45.8 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 62.0 t -67.26 -46.37 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.92 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -59.65 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -62.23 -42.83 99.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.5 m -59.88 -59.0 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 27' ' ' ASN . 27.7 m -54.4 -42.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' HD11 ' A' ' 125' ' ' LEU . 2.7 m120 -56.93 -43.39 81.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.212 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 24' ' ' GLU . 41.5 t -63.08 -51.59 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.565 HG21 ' HD3' ' A' ' 37' ' ' PRO . 22.9 pt -69.9 -41.13 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.51 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 29' ' ' ILE . 39.3 m -67.89 -27.78 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.541 HD22 ' CD2' ' A' ' 125' ' ' LEU . 29.3 tp -80.91 -38.97 27.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -80.44 -44.22 19.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.979 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.01 -3.2 2.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.83 -24.09 8.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.721 0.296 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 59' ' ' ILE . 2.3 tp -86.39 157.23 19.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' HG22 ' A' ' 56' ' ' THR . 1.7 tttt -150.54 143.42 16.42 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD3' HG21 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -72.9 148.02 44.97 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG13 ' ND2' ' A' ' 54' ' ' ASN . 1.2 p -136.58 142.23 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.304 0.573 . . . . 0.0 110.545 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.638 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.92 150.19 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.272 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.638 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -158.35 161.89 37.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.478 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -163.33 131.32 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.822 0.344 . . . . 0.0 111.304 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . 8.0 t80 -139.55 163.41 32.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.529 0.681 . . . . 0.0 110.276 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.36 146.07 7.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.805 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 42' ' ' TYR . 47.4 m-85 -146.12 -67.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -57.38 84.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.414 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' PHE . 1.2 m-20 51.71 25.02 2.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.484 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.88 74.04 1.15 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.093 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -156.75 111.13 2.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.571 0.224 . . . . 0.0 110.843 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 p -49.07 148.21 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.405 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -141.79 139.12 32.69 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 120.96 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -143.06 107.99 4.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.073 0.463 . . . . 0.0 110.968 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.12 156.88 26.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 38' ' ' VAL . 1.6 p-10 -148.85 165.18 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.753 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 35' ' ' LEU . 3.4 mm? -100.26 150.07 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.064 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' LYS . 8.5 t -147.65 165.68 29.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.21 163.8 14.86 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 p -91.96 128.31 37.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.811 HG12 HD13 ' A' ' 35' ' ' LEU . 10.0 mt -93.76 138.53 22.77 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 36.7 Cg_endo -66.39 116.11 3.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.434 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.695 HG13 ' HA2' ' A' ' 136' ' ' GLY . 21.4 t -112.34 108.34 54.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.586 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.1 Cg_endo -72.58 128.48 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.783 2.322 . . . . 0.0 112.474 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -97.41 -162.34 0.95 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -27.9 49.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.68 22.04 0.19 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 m-80 -143.84 -164.33 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.613 0.244 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 m -159.09 109.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.61 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.469 ' CZ ' ' HD3' ' B' ' 211' ' ' PRO . 53.7 m-85 -97.27 -176.06 3.41 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 206' ' ' GLU . 0.2 OUTLIER -120.12 94.24 4.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.702 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' HD3' ' B' ' 210' ' ' PRO . 2.0 tp -74.32 122.17 86.92 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 89' ' ' VAL . 94.1 Cg_endo -79.84 128.71 7.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.506 2.138 . . . . 0.0 112.169 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 73' ' ' CYS . 13.0 mt -149.64 160.53 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 111.849 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.513 ' C ' HD23 ' A' ' 74' ' ' LEU . 4.7 t -158.28 133.76 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.133 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -141.33 146.92 37.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 0.0 111.411 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.704 ' CE3' HD13 ' A' ' 52' ' ' LEU . 30.3 m95 -81.49 132.67 35.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.044 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 124' ' ' LEU . 3.1 tp -97.36 92.94 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.4 mt -69.37 168.58 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.389 . . . . 0.0 110.978 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 79' ' ' THR . 3.0 p-10 -62.21 -56.27 20.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 1.6 t 172.03 41.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.19 125.71 22.78 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.71 -20.82 13.69 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.76 -1.35 . . . . 0.0 112.361 0.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -159.17 -38.51 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.42 164.6 22.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' HD12 ' A' ' 76' ' ' LEU . 21.5 Cg_endo -60.98 108.77 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.648 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 86' ' ' ILE . 89.9 Cg_endo -84.11 -28.06 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 85' ' ' PRO . 4.1 mp -64.63 112.9 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.892 ' HB2' HD12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -148.51 121.65 8.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -145.58 156.91 43.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 71' ' ' PRO . 9.8 p -95.12 143.42 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 73' ' ' CYS . 7.0 mtmt -98.98 103.51 20.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.188 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 67.0 Cg_endo -88.35 124.28 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.628 2.219 . . . . 0.0 112.594 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.829 HG21 ' HG2' ' B' ' 207' ' ' PRO . 23.1 p -77.07 170.84 15.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.873 0.368 . . . . 0.0 110.511 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -53.65 -44.42 69.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -89.43 6.26 41.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.647 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.47 ' HG2' ' CG2' ' A' ' 141' ' ' VAL . 11.0 ttm -90.75 160.32 15.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.751 0.31 . . . . 0.0 111.082 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.08 114.13 10.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.352 0.596 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.692 ' HA ' HG23 ' A' ' 141' ' ' VAL . 7.4 mt -71.45 138.47 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.757 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 124.24 50.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.845 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 104' ' ' ASP . 1.2 p -70.62 139.75 51.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.019 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 103' ' ' VAL . . . -175.99 175.41 47.37 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.506 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HG3' ' CD2' ' A' ' 102' ' ' HIS . 5.2 pttt -54.5 -27.62 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.0 111.227 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 101' ' ' LYS . 77.1 m-70 -97.77 3.62 50.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' GLY . 39.9 t -155.72 138.28 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 111.592 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 99' ' ' THR . 58.3 m-20 -85.77 -62.79 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.983 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 104' ' ' ASP . . . 173.45 -28.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.501 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.11 10.49 35.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 89' ' ' VAL . . . 93.23 -7.2 75.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.915 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -69.17 134.24 49.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.343 . . . . 0.0 111.029 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 87' ' ' CYS . 9.0 mt -80.99 131.41 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.12 -164.41 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' HIS . 0.8 OUTLIER 67.38 149.11 0.12 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.56 -44.21 8.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.479 2.119 . . . . 0.0 112.593 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.33 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -72.32 -44.11 63.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.947 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.98 -14.25 45.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.735 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -94.82 -66.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.188 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 119' ' ' HIS . 23.6 t-105 -71.29 -90.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.047 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 114' ' ' LEU . 17.7 ptmt 44.3 59.58 3.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.939 0.4 . . . . 0.0 111.527 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.759 ' N ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -74.49 -38.03 3.18 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.759 ' HA ' ' N ' ' A' ' 119' ' ' HIS . 41.9 Cg_endo -71.01 -62.87 0.03 OUTLIER 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.943 -1.274 . . . . 0.0 113.281 0.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 76.02 -54.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 111.141 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 139.59 33.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.062 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.62 -179.59 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.689 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -43.35 -44.81 5.78 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.242 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mp -69.21 -46.73 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.58 -31.88 79.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.465 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 tt -57.84 -65.57 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 mp -57.74 -31.38 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.906 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -57.3 -41.29 79.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 126' ' ' GLY . 60.4 t -63.94 -49.42 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.541 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 109' ' ' ILE . 21.5 ttm -59.39 -36.52 75.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.048 0.452 . . . . 0.0 110.081 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 128' ' ' ILE . 40.6 mt -69.13 -37.57 76.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' GLN . 83.6 t -65.93 -52.07 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.1 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 102' ' ' HIS . 51.4 t -60.29 -51.69 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.693 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 140' ' ' PRO . 9.4 m-30 -68.53 -7.35 31.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.67 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.21 -31.16 69.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.46 -45.4 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.752 0.31 . . . . 0.0 110.817 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -90.53 103.71 7.43 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 27.3 Cg_endo -62.16 109.57 0.85 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.049 1.833 . . . . 0.0 111.716 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 135' ' ' PHE . 94.3 Cg_endo -79.65 -23.65 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 112.911 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 141' ' ' VAL . 7.2 p -156.74 88.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -87.43 127.61 35.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.233 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' B' ' 208' ' ' THR . 36.4 t -90.74 161.14 15.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.038 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -76.26 144.3 74.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.522 2.148 . . . . 0.0 112.321 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 N-CA-C 111.555 -0.21 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.618 ' HB2' ' CD ' ' B' ' 207' ' ' PRO . 1.5 pm0 -60.2 173.26 0.6 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.301 0.572 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' PRO . . . . . 0.829 ' HG2' HG21 ' A' ' 92' ' ' THR . 24.7 Cg_endo -92.31 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.466 2.777 . . . . 0.0 109.965 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 143' ' ' SER . 0.4 OUTLIER 63.29 -34.59 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.674 ' CB ' ' O ' ' A' ' 141' ' ' VAL . . . 60.78 163.21 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.207 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.695 ' HD3' HD13 ' A' ' 70' ' ' ILE . 14.1 Cg_exo -67.4 144.44 67.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 111.907 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.469 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 53.1 Cg_endo -69.23 172.64 11.76 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.76 2.307 . . . . 0.0 112.464 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.61 -138.63 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.415 179.915 . . . . . . . . 1 1 . 1 stop_ save_